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Background: In order to advance and build on the recent boom in mobile and web-based 
interventions for individuals with psychosis, a better understanding of current levels of 
adherence and predictors of adherence to mobile and internet interventions is required.  
Method: This paper systematically reviews rates of adherence, dropout and approaches to 
analyzing predictors of adherence to newly developed mobile and web-based 
interventions for people with psychosis. A systematic review of randomized controlled 
trials, feasibility trials and observational trials is presented. We also examine three 
theoretically proposed predictors of adherence; level of social support present in the trial, 
level of service user involvement and type of study. 
Results: All the included studies (n=17) reported a measure of adherence and a rate of 
dropout.  The studies varied in terms of their further analysis of adherence; five studies 
conducted statistical analyses to determine predictors of dropout, five studies conducted 
analyses on specific predictors of adherence to the intervention, four administered post-
trial feedback questionnaires to assess continued use of the intervention, and two studies 
evaluated different types of interventions with the aim affecting adherence.  Overall the 
percentage of participants adhering to interventions ranged from 60% to 100% with a 
mean of 79.5%. There was preliminary support for the three theoretically proposed 
predictors of adherence; adherence was slightly higher in RCT studies (compared to 
observational studies), in studies with higher levels of social support and in studies with 
higher levels of servicer user involvement.  
Conclusion: Adherence to mobile and web-based interventions is robust regardless of 
service-user (e.g. symptoms severity) and intervention (e.g. type of technological 
interface) specific factors. Future studies should consider reporting a universal measure of 
adherence such as percent of adherence and should aim to conduct complex analyses on 
predictors that may impact on adherence including social presence, service user 
involvement and the type of study.  
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1.1 Background  
The development of appropriate interventions for people with psychosis is challenging as 
adherence, defined as the extent to which a participant experiences or engages with an 
intervention (Christensen, Griffiths, & Farrer, 2009), is inconsistent with rates ranging 
from moderate to low. Of those who have access to interventions, drop out and non-
adherence rates are high, around 25% (Leclerc et al.; Nose et al., 2003; Sendt, Tracy, & 
Bhattacharyya, 2015); non-adherence to programs for people with first episode psychosis 
(FEP) is estimated to be between 30-57% (Stowkowy, Addington, Liu, Hollowell, & 
Addington, 2012). These rates are mirrored across both psychological and 
psychopharmacological interventions.   
Research is needed that targets adherence to effective treatments and interventions. 
Traditionally, poor adherence in people with psychosis has been explained by the 
presence of debilitating symptoms and the accompanying socio-economic, cognitive and 
functional impairments (Leclerc, Noto, Bressan, & Brietzke; Nose, Barbui, Gray, & Tansella, 
2003). These factors may combine to make illness self-management and engagement with 
community treatment difficult (Fagiolini & Goracci, 2009; Leucht & Heres, 2006). Although 
examining service-user, medication or environment related issues may be a helpful first 
step, the service users’ perspective on adherence is rarely consulted. Service users’ 
perspectives are important to consider as some interventions may be more suited to short 
term use while others may be more acceptable for regular, long term use. Service users 
provide a valuable voice that can provide direction and improve positive outcomes for the 
field (Alvarez-Jimenez, Alcazar-Corcoles, González-Blanch, et al., 2014; Eisner, Drake, & 
Barrowclough, 2013; Reeder et al., 2016; Wykes & Brown, 2016). 
Innovative and accessible ‘e’ mental health interventions, defined as ‘the use of 
information and communication technology to support or improve mental health care’ 
(Ben-Zeev, 2014; van der Krieke, Wunderink, Emerencia, de Jonge, & Sytema, 2014), have 
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been proposed as an alternative to traditional interventions that could have significant 
advantages for improving engagement and adherence to treatment for people with 
psychosis. It has been suggested that mobile and web based interventions may improve 
access to care, overcome stigma and introduce new models of care that combine mobile 
and face to face interventions (Alvarez-Jimenez  et al., 2012; Ben-Zeev, Kaiser, & Krzos, 
2014a; Marzano et al., 2015).  Researchers and clinicians have worked together to make 
use of the recent boom in technology to develop mobile and web-based interventions for 
a range of mental health disorders including depression, PTSD, panic, stress, insomnia and 
eating disorders (Griffiths & Christensen, 2007).   A review of computer based self-
management interventions for people with panic, phobia and OCD found that these 
interventions led to a reduction in symptoms and improved quality of life (Barlow, Ellard, 
Hainsworth, Jones, & Fisher, 2005). Historically clinicians and researchers have been 
hesitant to develop similar interventions for people with serious mental illness such as 
psychosis. This was because of the chronicity, complexity and risk associated with such 
disorders along with perceived lack of engagement with health services by this population 
(Bell, Grech, Maiden, Halligan, & Ellis, 2005; Kersting, A Schlicht, S Kroker, 2009; van der 
Krieke et al., 2014). 
Interestingly this is at odds with the service user perspective.  A recent survey by Miller, 
Stewart, Schrimsher, Peeples, & Buckley, (2015) of 80 inpatient-users and outpatients 
with schizophrenia found that 56% of individuals used text messaging, 46% had an email 
account and 27% regularly used internet forums.  Additionally, service users agreed that 
using such technology would help them to access mental health professionals and may 
help with social interactions. Lal & Malla, (2014) surveyed young adults with first episode 
psychosis and found that 85% reported that they would engage with a web-based 
intervention such as the you-tube platform for information on medication or symptoms. 
Along with these recent studies examining service user perspectives, several systematic 
reviews have established the acceptability and feasibility of mobile and online 
interventions for this service-user group (Alvarez-Jimenez, Alcazar-Corcoles, Gonzalez-
Blanch, et al., 2014; Naslund, Marsch, McHugo, & Bartels, 2015; van der Krieke L et al., 
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2013). Recent developments in technology-based interventions for people with psychosis 
include; internet-based psychotherapy interventions (see Alvarez-Jimenez et al., 2014 for 
a review), mobile short-message service or text messaging (e.g. Granholm, Ben-Zeev, Link, 
Bradshaw, & Holden, 2012), telephone or video two-way conferencing (Mohr et al., 2012) 
electronic systems that support with decision making, virtual reality programmes (D. 
Freeman, 2008), and smartphone programmes (Ainsworth, Palmier-Claus, Machin, et al., 
2013). Therefore, despite initial hesitations from clinicians and researchers, not only are 
people with psychosis interested in these interventions and engaged in the technology but 
there is an increasingly large evidence base to support the feasibility and acceptability of 
these mobile interventions for this service-user group. 
When considering the application of novel mobile and web-based technologies for the 
design of interventions for people with psychosis the current research may be missing two 
key points. The first is that adherence to these types of interventions may still be a 
significant barrier to treatment and the second is that the service user perspective is 
rarely consulted. A recent review of 12 studies showed that service users varied in their 
engagement with the technological interventions; some service users showed regular or 
intermittent use and approximately 25-30% of participants did not engage or dropped 
out1 (Alvarez-Jimenez, Alcazar-Corcoles, González-Blanch, et al., 2014). The authors 
suggested that future studies should report on the proportion of people who engage with 
the technology and good engagement should be measured more consistently. They also 
suggested that service-user involvement in the development and implementation of 
mobile and web-based technologies may be an important bridge between the ‘online 
world’ and meaningful recovery.  
This systematic review will update the review conducted in 2013 (Alvarez-Jimenez et al., 
2014) with the latest data on adherence to novel mobile and web-based interventions 
developed for people with psychosis.   
                                                     
1 Drop out is defined as an individual who does not complete the trial protocol or the trial assessments 
(Christensen et al., 2009) 
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1.2 The study of Adherence 
To date there have been no systematic reviews specifically exploring and synthesizing 
levels and predictors of adherence to mobile or web-based interventions for people with 
psychosis.  Alvarez-Jimenez et al., (2014) documented the feasibility and types of 
interventions but did not specifically examine and compare rates of adherence. Previous 
systematic reviews have developed methods for examining adherence to mobile or web-
based interventions for treatment of depression and anxiety (Christensen et al., 2009; 
Simco, McCusker, & Sewitch, 2014). Christensen et al., (2009) outlined four main 
approaches to examining adherence (see table 1 for an overview). The first is to examine 
factors that contribute to dropout from a trial, for example a comparison of baseline 
symptomology or demographic factors in participants who stay in the trial and those who 
drop out. The second is to conduct statistical analysis, including correlational or regression 
analysis within a trial in order to identify potential predictors of adherence. For example 
the relationship between various demographic, personality, disease specific, or 
environmental factors and the level of adherence (e.g. the number of mobile phone 
entries completed) to the intervention. Specific service user factors (e.g demographics, 
clinical severity) and intervention factors (e.g. week 1 vs. week 2 of intervention) are most 
commonly explored. The third is to use questionnaires to retrospectively examine 
participants’ experiences of adherence and perspectives on continued use. The fourth 
approach is to experimentally manipulate factors within a trial to impact upon adherence; 
for example to compare different technological interfaces, prescribed frequency of use, or 







TABLE 1 FOUR APPROACHES TO STUDYING ADHERENCE 
Approach Data Expected 
1. Analysis of Drop out data Comparison of adherent and non-adherent 
service-user data including demographic, 
symptom, cognitive or other data; baseline 
assessment of between group differences  
2. Within trials analyses to establish relationship 
between adherence and various factors 
Within study correlational, regression or other 
analysis of service-user specific factors or 
intervention specific factors that may impact on 
the level of adherence to intervention or 
technology 
3. Post-Trial questionnaire on participants 
experience 
Questionnaire data; qualitative or quantitative 
feedback on satisfaction, acceptability of trial or 
intervention with specific questions on usability, 
helpfulness and continued use 
4.  Experimental Manipulation of Factors 
impacting adherence 
Comparison of interventions or interfaces that are 
specifically designed to impact on adherence  
 
Terms in this area often have many different definitions and the ones used in this review 
are based on previous reviews (e.g. Alvarez-Jimenez et al., 2014; Simco et al., 2014) so 
that it is possible to compare the results. Internet/online interventions are web-based 
interventions enabling peer to peer contact, service-user to expert communication or 
interactive psycho-education or psychotherapy. Mobile based interventions are defined 
as interventions delivered via mobile phones using SMS, MSS mobile or web applications. 
Adherence is defined as the extent to which a participant experiences or engages with a 
mobile or internet based intervention (Christensen et al., 2009). Two types of adherence 
will be investigated; 1) mean percentage of the intervention completed 2) per cent of 
participants that complete the intervention (Simco et al., 2014). As mentioned previously, 
drop out is defined as non-completion of the trial protocol or the trial assessments 
(Christensen et al., 2009).  Entry refers to data on the frequency and use of an 






1.3 New Potential Predictors of Adherence 
In addition to the four approaches to studying adherence in Table 1, this study will briefly 
evaluate three theoretically proposed predictors of adherence that have been suggested 
in recent literature and reviews; (1) level of social presence/contact, (2) servicer user 
involvement in the development of the intervention and (3) type of trial (highly supported 
RCT intervention or observational study with limited support from the research team). 
These three predictors have been proposed as providing key insight into the barriers or 
bridges to adherence (Alvarez-Jimenez, Alcazar-Corcoles, González-Blanch, et al., 2014; 
Christensen et al., 2009; Mohr et al., 2011; Wykes & Brown, 2016). In line with Alvarez-
Jimenez et al.,’s (2014) recommendation to involve service users, each of these predictors 
specifically relates to the experience of the service user. These have not been 
systematically reported or explored in previous reviews. Each potential predictor is 
discussed in detail below.  
The first potential predictor of adherence is the level of social presence/contact. This 
refers to the frequency and quality of clinician, researcher or peer presence or contact 
throughout the intervention (Alvarez-Jimenez et al., 2013). Several studies have identified 
contact and support from clinicians or peers in the form of telephone, email, online 
forums or e-chats can help improve adherence to mobile and internet based interventions 
(Mohr et al., 2010; Tate, Jackvony, & Wing, 2006). Mohr, Cuijpers, & Lehman, (2011) 
suggested a model, ‘supportive accountability’ whereby supportive social presence may 
positively influence accountability, expectations, and bond during a mobile or web-based 
intervention. This predictor has some credibility as Day et al., (2005) found that for acute 
inpatients with psychosis, a positive relationship with a clinician was related to adherence 
to medication and positive attitude towards treatment. In addition, Leclerc et al., (2015) 
established that a good therapeutic alliance improved adherence to psychosocial 
treatment. The idea of ‘supportive accountability’ is similar to the well-researched and 
effective guided self-help programmes that have been developed for mental health 
disorders such as anxiety and depression (see systematic reviews by (Cuijpers, Donker, van 
15 
 
Straten, Li, & Andersson, 2010; Van’t Hof, Cuijpers, & Stein, 2009). In the guided self-help 
model there is usually a coach, therapist, or clinician who can actively guide clients 
through the intervention protocol and potentially monitor treatment response (Cuijpers et 
al., 2010; Seekles, van Straten, Beekman, van Marwijk, & Cuijpers, 2011). Cuijpers (2011) 
defines guided self help as ‘support given by the therapist  (that) should primarily be of 
supportive or facilitative nature, and is meant to support the patient in working through 
the standardized psychological treatment’. Although this overlaps with the model of 
supportive accountability, in this study we seek to explore, how different, potentially less 
formal levels and methods of support embedded or alongside technology, might affect 
adherence for people with psychosis. In order to profile the characteristics of effective 
online or mobile interventions this review will conduct a preliminary examination of the 
level of social presence and human support that is offered in each intervention. 
The second potential predictor of adherence is the level of service user involvement in the 
development of the intervention and providing feedback. This has been highlighted as 
vital for effectiveness and adherence to interventions (Alvarez-Jimenez et al., 2014; Wykes 
and Brown, 2016). The sense of involvement in the project may promote self-efficacy and 
therefore accountability to the intervention (Mohr et al, 2011). Recently, Wykes and 
Brown (2016) emphasized the importance of providing service users with choice, for 
example the choice of digital or face-to-face intervention. Choice leads to a greater feeling 
of control; this may tap into intrinsic motivation that is important for adherence to 
interventions (Mohr et al., 2011). This review will highlight any studies that involve service 
users in the development and improvement of the interventions and the potential impact 
on adherence. 
The third potential predictor of adherence is study type. Levels of adherence may be 
different if the service user is actively participating in a clinical trial that is specifically 
testing an intervention (i.e. RCT), or if they are using open access, self-directed technology 
that is not associated with a clinical trial.  Trials of web based interventions show high 
levels of adherence while observational studies of open access websites often reveal poor 
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adherence and dropouts (Christensen et al., 2009). This may be because of differences in 
incentives (e.g. payment for participation) or because there is often more research and 
clinician support associated with clinical trials. It will be important to design technologies 
and programmes that will maintain high adherence outside of the context of a clinical trial 
(Christensen et al., 2009). 
1.4 Aim of review 
As this review is an update of a previous review (Alvarez-Jimenez et al., 2014) we have 
chosen a narrow time frame and to replicate the narrow search criteria of the previous 
review. We sought to do this for four main reasons: 
1) Due to the rapid proliferation of publications in this field in the last 5 years (over 2000 
OVID search hits), we sought provide a narrow focus to make the data more concise and 
accessible to readers who wish to be up to date (Higgins and Green, 2011, Cochrane 
Handbook for Systematic Reviews of Interventions). Additionally an update of a review 
should occur every two years, especially in a rapidly growing field (ibid). 
2) We sought to build on the findings from the Alvarez-Jimenez et al., (2014) review and 
examine adherence across the most recent studies and technological developments. The 
original study documented levels of adherence and we sought to expand on this and 
examine how this has developed in the last 2 years. Using these search terms we were 
able to include 17 new and relevant papers. 
3) We expanded slightly on the narrow search terms used by Alvarez-Jimenez et al., (2014) 
to include ‘bipolar disorder or manic depression or manic depressive illness or manic-
depressive psychosis’ with the aim of capturing the recent developments for these patient 
groups, and in particular, any overlap with schizophrenia spectrum disorders.  
4) We chose to update the Alvarez-Jimenez et al., 2014 review because one of the main 
findings from the previous review was that mobile and online interventions may improve 
socialization and social connectedness. We therefore conducted a specific analysis of 
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social factors (e.g. the social presence analysis). We sought to provide an overview of this 
potential predictor in order to introduce readers to this potentially important new area.  
Along with reporting and synthesizing data according to the four approaches to studying 
adherence mentioned in Table 1 ((1) Analysis of Drop out data (2) Within trials Analyses to 
establish relationship between adherence and various factors (3) Post-Trial questionnaire 
on participants experience (4) Experimental Manipulation of Factors impacting adherence) 
this review will also provide a brief preliminary examination and overview of potential 
predictors of adherence including; level social presence across trials, service user 
involvement and the type of study (RCT or observational).  
2. Method 
This systematic review was conducted following the PRISMA guidelines and 
recommendations for conducting and reporting systematic reviews (Preferred Reporting 
Items for Systematic Reviews and Meta-analyses, PRISMA, Moher, Liberati, Tetzlaff, & 
Altman, 2010). The criteria are listed in the Appendix 4 with page numbers for where 
compliance is noted in the text. 
2.1 Search Strategy 
The following databases were systematically searched from August 2013 until May 2015: 
OVID including MedLine, EMBASE and PsychInfo, Pubmed and Web of Science.  The 
following terms were used in the keyword search of abstracts and titles (internet or online 
or web-based or website or mobile) AND (bipolar disorder or manic depression or manic 
depressive illness or manic-depressive psychosis or psychosis or schizophr* or psychotic). 
Additionally, hand-searching was performed on five key journals (Schizophrenia Bulletin, 
Schizophrenia Research, Journal of Medical Internet research, Telemedicine and e-health, 
Psychiatric Services) along with the reference lists of included primary studies. The term 
‘adherence’ was purposely not included in the search terms as this would significantly 
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limit the number of included studies. Most studies do not include references to reported 
adherence in the title or abstract (Simco et al., 2014). 
2.2 Eligibility criteria 
Studies that were considered for inclusion in this systematic review including the following 
PICOS criteria (Higgins & Green, 2011): (1) Population: Adults (18-65 years); at  least 75% 
of participants have a diagnosis of schizophrenia spectrum disorder according to DSM-IV 
or ICD-10. (2) Interventions, trials or observational studies involving: online, mobile, e-
technology or web-based interfaces enabling peer-to-peer contact, patient-to-expert 
communication or interactive psycho education/therapy; flexible, accessible monitoring, 
self-help, symptom management, (3) Study design: As this study aims to provide an 
overview of the current state of the field, generous inclusion criteria for type of study 
were adopted. Types of studies: (i) All types of primary group studies including 
randomised controlled trials, cross-sectional, longitudinal as well as comparison studies 
with and without a control group, cross-over trials, case controls or cohort studies, 
observational studies, feasibility or acceptability studies.  (ii) English language (4) 
Outcomes: At least one measure of adherence. The following exclusion criteria were used; 
conference abstracts and theses not published in a peer-reviewed journal (see Appendix 1 
Form A for inclusion criteria of studies). 
Titles and abstracts of articles were scanned independently by two researchers (CK and 
ZH). Articles deemed potentially eligible were retrieved in full and independently reviewed 
(CK and ZH) using a standard form listing inclusion criteria (Form A Appendix 1). 
Disagreement between researchers was dealt with by consensus with a senior member of 
the research team (TW).  
2.3 Data extraction and analysis 
A standard form was used to extract data from selected studies to create two results 
tables (please see Appendix 2 for tables 2 and 3). Tables 2 and 3 are composed of three 
sections; a) Randomized Intervention studies, b) Feasibility or Acceptability studies, c) 
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Observational studies. Table 2 includes the following study characteristics; (i) study 
source, sample size, gender, age, diagnosis, study design (ii) purpose of intervention, (iii) 
control group. Table 3 includes characteristics of interventions: levels of adherence, 
dropout, type of social presence, service user involvement and measurement of 
participant feedback. The above data were extracted independently by two researchers 
(CK and ZH). Any discrepancies were identified and investigated by referral back to the 
original article by consensus of the research team. 
2.4 Assessment of methodological quality and procedures 
The Clinical Trials Assessment Measure (CTAM) (Tarrier & Wykes, 2004) was designed to 
assess trial quality specifically in trials of psychological interventions for mental health. It 
contains fifteen items grouped into six areas that are important for assessing bias in 
psychological interventions including; sample size, recruitment method, allocation to 
treatment, assessment of outcome, control groups, description of treatments and 
analysis. Each study is rated out of a total of 100. This scale has good inter-rater reliability 
(.96) and high concurrent validity (=.97).  Eleven of the studies were considered to be 
intervention based studies or randomized controlled trials and were assessed using this 
measure. Six trials were assessed using the Downs and Black scale (1998) for non-
randomized controlled trials or observational studies. This scale consists of 27 questions 
assessing key areas of methodological quality for non-randomized trials for systematic 
reviews. It includes questions on reporting, external validity, bias, confounding and power. 
This scale was modified slightly for the current study. The question on power (27) was 
simplified to a rating of 1 or 0 which has been done in other reviews (van der Krieke et al., 
2014; Samoocha, Bruinvels, Elbers, Anema, & van der Beek, 2010). Each study is rated out 
of a total of 28 points. Scores are classified in the following ranges; excellent score 26-28, 
good score 20-25, fair score 15-19 and poor less than 15. Two reviewers (CK and ZH) 
independently assessed the trial quality for all of the included studies. All of the first 
authors of the included articles were contacted to approve that CTAM or Downs and Black 
rating for the article and if necessary provide further information about the study. This 
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was to ensure that the quality of the trial was not confused with the quality of the 
reporting in the study. 
3. Results 
The included studies were heterogeneous in terms of intervention and measurement of 
results; hence we report a narrative synthesis of the findings. Information on study 
selection and study characteristics is followed by a synthesis of data on each of the four 
approaches to measuring adherence. Finally, data and information on the three potential 
new predictors of adherence is presented. 
3.1 Study Selection 
The search strategy returned 2627 titles and abstracts. After removal of 797 duplicates, 
1830 titles and abstracts were screened and 96 full text papers were assessed for 



























FIGURE 1 PRISMA FLOW CHART 
3.2 Study Characteristics 
Study characteristics are summarized in Table 2 (Appendix 2). Five were randomized 
controlled interventions2, six were feasibility, acceptability studies and six were 
observational studies. In total, 558 participants with a diagnosis of schizophrenia spectrum 
disorders and a mean age ranging from 20 to 48 years participated in the 17 studies. 13 
studies included individuals with schizophrenia or schizo-affective disorder, one study 
                                                     
2 For clarity, randomized controlled trials are defined as trials with a randomized control group and pre and 
post outcome measures; Feasibility or acceptability studies are defined as studies that assess the usability, 
feasibility, and acceptability of an intervention and may have a case control group or single group design; 
Observational studies are studies where the researcher observes and records behaviour in a systematic way 
without manipulating variables, e.g. experience sampling methods (Yang et al., 2010). 
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included individuals with first episode psychosis, one study included individuals with a 
dual diagnosis of schizophrenia and substance misuse and two studies included individuals 
with non-affective psychosis.  
Tables 3 summarizes the characteristics of the interventions and studies. There was 
heterogeneity in the design and aim of the interventions. Of the mobile based trials six 
used momentary experience sampling methods to measure mood (Brenner & Ben-Zeev, 
2014; Kimhy et al., 2014a) or symptoms (Hartley, Haddock, & Vasconcelos e Sa, 2014; 
Kimhy, Vakhrusheva, Liu, et al., 2014b; Kimhy, Vakhrusheva, Khan, et al., 2014a; Sanchez, 
Lavaysse, Starr, & Gard, 2014; So et al., 2013). Two mobile phone interventions involved 
personalized text messages or phone calls from a researcher or clinician (Beebe, Smith, & 
Phillips, 2014; Dror Ben-Zeev, Kaiser, & Krzos, 2014) and one involved an online mobile 
interface for psychoeducation (Ben-Zeev, et al., 2014).  Of the web-based interventions 
two involved modules of psychoeducation (Gleeson et al., 2014; van der Krieke L et al., 
2013) and four involved an element of online psychosocial training (Kurtz, Mueser, Thime, 
Corbera, & Wexler, 2015; Nahum et al., 2014; Smith et al., 2015; Ventura, Wilson, Wood, 
& Hellemann, 2013). 
3.2.1 Quality Assessment 
Trial quality results are presented in Appendix 3 for the eleven RCT/feasibility and the six 
non-randomized studies respectively.  All of the primary authors of the included studies 
were consulted and confirmed the quality ratings provided in Appendix 3.  
The RCT studies (n=5) and feasibility or acceptability studies (n=6) were rated using the 
CTAM. In terms of the RCT studies and feasibility studies, the average trial quality score on 
the CTAM was 57.54 and ranged from 36-88.  Evidently the feasibility trials had a lower 
average rating (41.8) than the RCT trials (76.4).  These studies would have received a 
lower quality rating because the design did not include control groups or large sample 
sizes (see studies: Nahum et al., 2014; Gleeson et al., 2014; Ben-Zeev et al., 2014a, Ben-
Zeev et al., 2014b, Ventura, 2013, Palmier-Claus, Ainsworth, & Machin, 2013a). There was 
variability in the methodological quality of the RCT and feasibility trials. For example, only 
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four of the studies had outcome assessments conducted by assessors blinded to group. All 
of the studies had interventions carried out by independent assessors, (not therapists or 
clinicians), and had adequate handling and assessment of dropouts if dropout exceeded 
15%.  All of the RCT studies were deemed to be of adequate trial quality (rating of 65+, 
Wykes, Steel, Everitt, & Tarrier, 2008), except for Palmier-Claus et al., 2013b which 
received a rating of 62. 
The mean quality rating for the non-randomized studies was 20.3 and ranged from 17 to 
24. Three studies fell into the ‘good’ classification range and three fell into the ‘fair’ 
classification range.  This is in line with previous reviews (van der Krieke et al., 2014). Only 
two of the studies provided information on the power analysis. The questions on 
randomization were included and scored to keep consistency but in every case they did 
not apply as these were not designed as randomized controlled trials.  
3.3 Adherence: Types of Measurement across studies 
The most common measures of adherence were percent of intervention completed by 
participants and percentage of participants completing the intervention. Figure 2 displays 
the types of adherence measure used and the level of adherence for each study.  For the 
five studies reporting the percentage of participants completing the intervention, 
adherence ranged from 60% to 100% with a mean of 79.5%. For the 12 studies reporting 
mean% of the intervention completed by participants’ adherence ranged from 59-98% 
with an average of 60.46%. All of the studies also listed the number of participants that 
dropped out of the trial. This ranged from 0-37% with a mean of 12.42% drop out across 




FIGURE 2 ADHERENCE ACROSS ALL STUDIES; AVERAGE PERCENT OF ENTRIES COMPLETED IN EACH STUDY 
FOLLOWED BY PERCENTAGE OF PARTICIPANTS COMPLETING THE INTERVENTION. 
Some studies also analyzed factors that may predict adherence. Five of the 17 studies 
analyzed the data of individuals who dropped out of the study before the completion of 
the trial, to determine any differences in symptoms or service-user demographics 
between the adherent and non-adherent groups. Five studies analyzed specific predictors 
of adherence; these could include person-specific predictors (disease severity, age, and 
gender) or intervention-specific (type of technology, duration of intervention). Eight of the 
studies also included a post-trial questionnaire of participants’ perceptions and 
experiences of the intervention, ease of use, acceptability of the trial and overall 
satisfaction.  Two studies conducted an experimental manipulation to potentially affect 
adherence. Additionally, two studies found that adherence to the trial had an impact on 
the intervention outcomes. The specific findings for each of these four approaches to 
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3.3.1 Approach 1: Analysis of dropout  
Five studies analyzed the relationship between specific variables and dropout. The studies 
produced different results depending on which variables were investigated and which 
analysis was adopted. Van der Krieke et al., (2013) found that the drop-outs tended to be 
younger and male although Palmier-Claus et al., (2013a), using logistic regression, found 
that higher severity on the PANSS positive symptom subscale (but not age or gender) 
predicted nonadherence with the trial. Sanchez et al., (2014) found no cognitive 
functioning data related to people who completed the study. Finally, Hartley et al., (2014) 
and So et al., (2013), who investigated an inclusive set of variables (age, symptoms, 
severity of delusions, education or gender), found no differences between those who 
completed the trial and those who did not.  
3.3.2 Approach 2: Analysis of within trial predictors of adherence  
Very few studies (n=5) conducted analyses within the trial to examine predictors of 
adherence. The types of analysis completed included Pearson product-moment 
correlations, one-way ANOVA’s and multiple regression analyses. In terms of service-user 
specific factors, Van der Krieke et al., (2013) analyzed the chronicity of symptoms and 
reported that service-users with first episode psychosis used a web-based decision aid 
autonomously more often than service-users with chronic psychosis. For example, they 
used their own computer and used the web programme without assistance from the 
research team more often. They also found that 56% of the participants who completed 
the intervention were service-users in long-term care.  However, the report does not 
provide specific statistical data. 
Ben-Zeev et al., (2014b) found no relationship between baseline cognitive functioning, 
negative symptoms (PANSS negative symptom subscale), persecutory ideation 
(suspiciousness item from PANSS) and the use of the FOCUS mobile intervention (days 
used, number of times used per day). Palmier-Claus et al., (2013a) also found no 
relationship between age, gender, PANSS subscales and Calgary Depression Scales and the 
total number of entries completed by each individual. They also examined symptom 
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severity and compared three groups of individuals with acute, remitted and ultra-high risk 
of psychosis and found no significant differences between the groups. Finally, Kimhy et al., 
(2014a) conducted a correlation analysis to examine associations between ratings of 
emotions and number of experience sampling method (ESM) responses. They found no 
significant associations.  
In terms of intervention specific issues, Palmier-Claus et al., (2013b) found no relationship 
between the length of time taken to complete an entry significantly and the number of 
entries completed by an individual. They also examined number of entries completed 
across the number of weeks of the study. They found that more entries were completed in 
the first week than the second week of the intervention and participants rated more 
highly the question ‘were there times when you felt like not answering?’ during the 
second week. 
In summary, in terms of predictors of drop out or adherence, few studies (n=10) 
conducted analysis and those who did revealed limited findings.  In terms of service user 
specific factors, one study found that PANSS positive symptoms predicted non-adherence, 
another found that people with first episode psychosis used the intervention 
independently. For intervention specific factors, one study found that more entries were 
completed during week 1 of an intervention. 
3.3.3 Approach 3: Post-Trial questionnaires on participants perspective on 
adherence 
Eight studies retrospectively asked participants to provide questionnaire-based qualitative 
or quantitative feedback about their experience of the trial or intervention. All the studies 
used different rating scales (e.g. Treatment Experience Questionnaire in Smith et al., 2015; 
idiosyncratic quantitative feedback questionnaire in Palmier-Claus et al., 2013b; 
idiosyncratic SocialVille programme rating in Nahum et al., 2014) so it is difficult to draw 
comparisons across studies.  Only four studies specifically asked if participants would 
continue to use the intervention (Nahum et al., 2014; Gleeson et al., 2014; Smith et al., 
2015; Palmier-Claus et al., 2013b; see figure 3). For three studies the mean percent of 
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participants who agreed to continue to use the intervention was 74.8%.  The fourth study, 
Palmier-Claus et al., (2013b), asked participants to indicate for how long they would be 
willing to use the smartphone or text message intervention. The majority of participants 
(42%) indicated that they would be willing to complete either the mobile or text-based 
intervention for 2-3 weeks.  Ratings of ‘continued use’ could be a helpful measure of 
current and future adherence given that the interventions may help with maintenance 
treatment. Another important factor to consider is the problem of assessing satisfaction 
and use of a trial non-independently. It is commonly found that satisfaction ratings are 
raised when questionnaires are administered by members of the trial. In the future, 
independent data collection, perhaps from service user researchers not associated with 
the trial may provide a more unbiased and critical view of the interventions. 
 
FIGURE 3 PERCENT OF PARTICIPANTS AGREED TO CONTINUED USE OF INTERVENTION; THIS EXCLUDES THE 
PALMIER-CLAUS ET AL., 2013B RATING AS IT MEASURES FOR HOW LONG THE INTERVENTION WOULD BE 
CONTINUED. 
3.3.4 Approach 4: Analysis of specific intervention manipulations and effect on 
adherence 
Two interventions were designed to manipulate conditions that may have an impact on 
adherence. Palmier-Claus et al., (2013b) compared two different types of interventions; 
SMS text-only interface or a smartphone graphical application.  They assessed the 
acceptability and feasibility of each device and found that participants completed more 
data points when using the smartphone interface (average entries=16.5) compared with 
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preferred the smartphone application (67%) and found it easier to use (71%) although this 
difference was not statistically significantly different. 
Beebe et al., (2014) examined the impact of telephone interview, text message or both 
interventions to assist with medication adherence. They found that mean psychiatric 
medication adherence scores were highest for the telephone interview plus text 
messaging group compared to the telephone interview only group (by an average of 5.3%) 
and the text only group (by an average of 13%). Although this result is related to 
medication adherence, not adherence to the mobile intervention, it is an interesting 
example of how the design of the study (text message vs. telephone interview) can be 
manipulated to impact on clinical outcomes (e.g. medication adherence). 
Interestingly two interventions found that adherence significantly affected the 
intervention efficacy. Smith et al., (2015) found that completing more training trials of a 
virtual reality job interview training correlated with fewer weeks searching before 
securing a job (p<0.001) and greater self-confidence (p=0.03).  
Ben-Zeev et al., (2014b) analyzed symptom change throughout the intervention and any 
related association to adherence. They conducted Pearson correlations of change on the 
Beck Depression Inventory (BDI) and PANSS scores along with the percent of days 
participants used the mobile intervention and found that change in participants’ BDI 
scores was significantly correlated with use of mobile intervention; the less frequently 
that participants used the FOCUS mobile intervention the greater the reduction in 
depression score. Change in PANSS scores was not associated with use of the FOCUS app.  
In summary, the four approaches to studying adherence (1) Analysis of Drop out data (2) 
Within trials analyses to establish relationship between adherence and service user or 
intervention factors (3) Post-Trial questionnaire on participants experience (4) 
Experimental Manipulation of Factors impacting adherence, provided an overview of how 
adherence is measured across mobile and internet interventions for people with 
psychosis.  Drop out ranged from 0-37% with an average of 12.42% across both 
observational and intervention studies. The percentage of participants adhering to 
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interventions ranged from 60% to 100% with a mean of 79.5%. Less than 50% of trials 
(29% 5/17) further explored specific factors or predictors of adherence, but those who did 
found limited associations between baseline clinical or demographic factors and 
adherence. Post-trial questionnaires in four studies found that 74.8% of participants 
agreed to continued use of the intervention. Finally, 11% of studies conducted an 
experimental manipulation to investigate the effects on adherence, for example, 
manipulating the mobile interface (either text message or smartphone) and found that 
smartphone interventions were preferred by service users. 
3.4 New Potential Predictors of adherence 
Along with synthesizing the information from studies reporting on the four methods of 
analyzing adherence above, this review also provides a brief original exploration of three 
potential predictors of adherence; level of social presence, level of service user 
involvement and type of study.  
3.4.1 Potential Predictor: Social Presence Analysis 
In order to assess Mohr et al’s (2011) theory that increased social presence will lead to 
better adherence we examined the amount of contact for each trial and the level of 
adherence to the intervention. As there is heterogeneity across the trials we provide a 
narrative synthesis. Across all 17 studies the mean number of contacts per week from a 
researcher or clinician was 4.8 and it ranged from 0 to 28 contacts per week. This included 
face-to-face, mobile, web-based or telephone based contacts.  As expected, the highest 
number of contacts was in the clinician- or researcher-led mobile interventions, with a 
mean of 19 contacts per week.  The highest number of contacts across all studies was the 
mobile intervention by Sanchez et al. (2014), where participants were interviewed over 
the phone about their environment, goals, and activities four times a day resulting in 28 
contacts a week. The lowest was in the ESM based studies with an average of one contact 
per week. Psychoeducation web-based studies had a mean of 3.6 contacts/week and 




FIGURE 4 SOCIAL PRESENCE (E.G. MAXIMUM INSTANCES OF POTENTIAL RESEARCHER OR CLINICIAN CONTACT 
PER WEEK) AND ADHERENCE (E.G. % OF PARTICIPANTS COMPLETING THE INTERVENTION), ORDERED FROM 
LOWEST AMOUNT OF SOCIAL PRESENCE TO HIGHEST AMOUNT 
Overall the amount of social presence varied between the different interventions. 
Interestingly in interventions where there was little or no contact with researchers or 
clinicians, such as the ESM-based interventions, there was still a high adherence rate with 
a mean of 74.6%; ranging from 59% to 98.1%. However, the adherence rates for ESM-
based interventions (74.6%) were on average 10% lower than for the other types of 
interventions; clinician/researcher led mobile interventions had a mean adherence rating 
of 83%, web-based psychoeducation interventions had a mean adherence rating of 85.5% 
and web-based training studies had a mean adherence rating of 85.7%.  
Anecdotally the importance of social presence is confirmed from participant reports. 
Gleeson et al., (2014) found that 90% of participants cited the use of an online facilitator 
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contributed to their sense of safety when using the online programme.  All participants 
either agreed or strongly agreed with statements such as they always felt supported by 
the online facilitator and 60% reported an increase in feelings of social connectedness. 
Ben-Zeev et al., (2014a) examined therapeutic alliance and found that participants rated 
the relationship with the mobile interventionist significantly higher (more positive) than 
for their community-based clinicians.  Based in these preliminary findings it will be useful 
for future studies to explore the relationship between social presence and adherence.  
3.4.2 Potential Predictor: Service user involvement 
The second potential predictor is the level of service user involvement in the development 
and feedback on the intervention. Of the 17 studies included, only two studies described 
service user involvement in terms of the development or initial piloting of the 
intervention. Six studies also included retrospective questionnaires about participant 
experience however participants were not specifically consulted about the development 
of the current intervention. 
Co-production, meaning the collaboration of service users and researchers, in the 
beginning phases of intervention development has a potential influence on participants’ 
perception and adherence to the intervention. Ben-Zeev et al., (2014b) used feedback and 
recommendations from a pilot with service users to develop a mobile intervention, 
FOCUS, to facilitate real-time mobile illness self-management. They found that 
participants rated the intervention highly with 90% acceptability and the average percent 
of entries completed was 86.5%. Gleeson et al’s (2014) HORYZONs programme was 
developed with a service user focus group.  It was found that 95% of participants used the 
social media component, 60% completed the therapy modules and 75% reported a 
positive experience with the program.  It would appear that the interventions that are 
developed with service users in focus groups or interviews had high ratings of adherence 




3.4.3 Potential Predictor: Type of Study and Level of Adherence 
Of the 17 studies included, twelve were feasibility, acceptability or observational studies 
and five were RCTs. In the five RCTs the reported adherence level for the percent of 
participants completing the trial (N=3 studies) was 86.3% and mean % of entries 
completed was 85.8 (N=2 studies).  In the observational or feasibility studies only one 
study reported the percent of participants completing the trial, which was 60%.  The 
remaining 11 observational or feasibility studies reported the mean number of entries 
completed as 78.82%. Evidently there are no large difference between RCTs and 
observational/feasibility studies in terms of reported levels of adherence, however, 
adherence to RCT’s was slightly higher by approximately 8%. 
 
FIGURE 5 COMPARISON OF REPORTED ADHERENCE FOR RCT AND OBSERVATIONAL STUDIES COMPARISON OF 
REPORTED ADHERENCE FOR RCT AND OBSERVATIONAL STUDIES. THE BAR CHART IS DIVIDED INTO FOUR 
SECTIONS: % OF PARTICIPANTS COMPLETING THE INTERVENTION OR AVERAGE NUMBER OF ENTRIES FOR RCTS 
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4. Discussion  
This review provides an overview of rates and measurement of adherence to web-based 
or mobile interventions or trials for individuals with psychosis. The studies varied in terms 
of the types of adherence measurement used, within-trial predictors that are associated 
with adherence, questionnaires used to assess participants’ perspectives on factors 
impacting adherence, and any experimental manipulations conducted to impact on 
adherence. Despite previous reviews of the acceptability and types of interventions (e.g. 
Alvarez-Jimenez et al., 2014), this is the first review to document rates of adherence and 
to explore predictors of adherence to mobile and web-based interventions or trials for 
people with psychosis. Although all of the studies reported either the percent of 
individuals completing the intervention or the average percentage of entries completed in 
the intervention, only 29% analysed specific predictors of drop-out, 23% examined 
person-specific or intervention-specific predictors of adherence, 23% assessed 
participants’ perspectives on continued use of the intervention, and 11% conducted an 
experimental manipulation to investigate the effects on adherence. The brief review of 
the theoretically proposed predictors of adherence in terms of level of support, 
involvement and trial type confirmed these factors are important areas of future 
investigation as discussed below. 
4.1 The Measurement of Adherence 
In terms of reported levels of adherence to mobile or web-based interventions, this 
review finds that adherence rates to mobile and web-based interventions for people with 
psychosis are in line with adherence rates for similar technology-based interventions for 
other mental health disorders.  In the current review, for the five studies using the 
measure of the ‘percentage of participants completing the intervention’, adherence 
ranged from 60% to 100% with a mean of 79.5%. For the 12 studies reporting ‘mean  % of 
the intervention completed by participants’ adherence ranged from 59-98% with a mean 
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of 60.46%3. In line with the current adherence rates, Simco et al., (2014) found that the 
mean per cent of individuals completing self-care interventions (including computer or 
web-based) for depression or anxiety was 66%. A systematic review of computerized CBT 
intervention for depression and anxiety found that only a median of 56% of participants 
completed the online interventions (Waller & Gilbody, 2009).  Christensen et al., (2009) 
found that for participants with depression, completion of an online treatment ranged 
between 50-70% whereas rates for completion of an online site for Personality Disorder 
ranged from 80-100% completion; social phobia reported 70-90% completion and the only 
PTSD intervention reported completing rate of 64%.  Overall the current review finds 
similar, if not higher, levels of adherence to web-based or mobile interventions for 
psychosis.  
 
In terms of adherence across different types of interventions for psychosis (e.g. face to 
face; medication based interventions) this study finds that reported rates of adherence for 
web-based or online interventions are in line with face-to-face interventions. Startup, 
Jackson, & Startup, (2006) found that completion rates of a one-to-one CBT intervention 
for psychosis was 55%.  Similarly, Alvarez-Jimenez et al., (2009) found that the completion 
rate for a one-to-one CBT intervention for first episode psychosis (FEP) was 68.3%. Overall 
adherence to web-based and mobile interventions for people with psychosis may be 
higher than face-to-face interventions, with rates of 79.5%. 
 
4.2 Quality of studies 
As might be expected the RCT studies were rated more highly (76.4%) than feasibility trials 
(41.8%). This is consistent with the characteristics of the CTAM quality measure as it is 
most suitable for RCTs. All of the RCT studies were rated above 65, except one (Palmier-
Claus et al., 2013b), which is deemed to indicate that the trial quality is adequate (Wykes, 
2008).  In the future, for RCTs, an analysis that compares the effect size of interventions 
                                                     
3 Table 3 notes the different criteria or thresholds that studies may have used to determine ‘completion’ or 
‘compliance’ rates for the study or intervention 
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and trial quality would help to clarify the effectiveness of mobile or web-based 
interventions. In terms of observational studies these studies were classified as either fair 
or good trial quality. Few trials (n=4) used a method of blind rating of outcomes. This is 
particularly important when assessing service user satisfaction with the intervention, as 
researcher involvement may unintentionally bias the ratings of service users. 
 
4.3 Predictors of adherence 
Specific Predictors: Service User or Intervention Factors 
The current review found only four studies that examined specific predictors of 
adherence. Younger age, and less chronic symptoms were significant (van der Krieke et al., 
2013) and a higher rate of adherence was found in the first intervention week than the 
second (Palmier-Claus et al., 2013b). Although other predictors of adherence were 
examined (cognition, negative symptoms, persecutory delusions) none were found to 
have a significant effect.  
Complex analyses, such as the multiple regression analysis performed by Palmier-Claus et 
al., (2013a), of specific predictors such as service-user factors (symptoms, socio-economic 
factors, interpersonal factors, cognitive factors) along with e-mental health intervention 
factors (complexity of the interface, cost, and access) should be a priority for future 
studies. This will inform which service-user group may benefit from different type of 
interventions. 
New Predictors of Adherence 
Although specific predictors of adherence were not commonly analyzed and few were 
found to be significant, the proposed theoretical predictors of adherence proved useful 
areas to examine in the future. Recently Mohr et al., (2011) proposed that web-based and 
mobile interventions for e-health could benefit from alignment with a new theoretical 
model of adherence; ‘supportive accountability’. They argue that adherence can be 
improved by including a level of human contact or support along with accountability to 
another person e.g. a coach, moderator or therapist. They outline how this model is 
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moderated by reciprocity in the relationship, motivation of the service-user, and the 
communication interface (e.g. computer or mobile).  “Support” in this review was defined 
liberally as any type of contact with a clinician or researcher involved in the trial.  15 of the 
17 studies reported some level of clinician, or researcher contact. This ranged from very 
limited initial interaction with a researcher to multiple daily support calls from a dedicated 
mobile interventionist. Presently, it is difficult to draw clear conclusions, as only two 
studies specifically reported qualitative data on the effect of the involvement of 
supportive online interventionists (Gleeson et al., 2014) or therapeutic alliance (Ben-Zeev 
et al., 2014a). However, it was clear that the interventions with limited support (e.g. ESM 
based studies) had lower rates of adherence by approximately 10%. In the future it would 
be interesting for studies to experimentally manipulate the level of support and then 
measure the impact on adherence, or correlate the ratings of therapeutic alliance in the 
intervention and the level of adherence. This will clarify the impact of social presence. 
Alvarez-Jimenez et al., (2014) and Wykes and Brown (2016) recommended that service 
user involvement in intervention development might be an important predictor of 
adherence. Both groups recommend co-production as the way forward. In the current 
dataset only two trials included service users in the development of the intervention so it 
is difficult to draw conclusions about the impact on adherence. However, adherence and 
service user feedback from both of these interventions was very high (adherence at 86.5% 
and 95%). This is an important area that requires future study and analysis. 
Finally, it appears that the effect of study design (observational, feasibility or RCT 
intervention) may slightly impact levels of adherence. Rates for RCTs (N=5, adherence to 
trial approximately 86%) and feasibility or observational studies (N=11, adherence to 
study approximately 78%) were similar although higher for the RCT designs. This indicates 
that participants may adhere when involved in a supported, structured controlled trial as 
opposed to when asked to engage with a programme or technology without the specific 
aim of psychosocial improvement. The five RCT’s in this review varied in terms of the 
amount of social presence but every study had at least one contact per week with a 
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dedicated researcher. It is important to consider that participants recruited to RCT studies 
may be different from participants recruited to observational studies. Those who are 
willing to participate in an intensive, structured RCT may be at different stages of recovery 
or have different motivation (i.e. payment or extra support) than those who consent to an 
observational study and this could impact on adherence.  For example, another area of 
future investigation would be to look at the impact of participant payment on adherence. 
Some trials may try to increase motivation to adhere to the trial through payment for 
participation. It would be interesting to compare rates of adherence with paid and unpaid 
trials.   
 
4.4 Strengths and limitations of the review and recommendations 
One of the main limitations of this study is the difficulty of comparing rates of adherence 
across studies with different interventions and different outcomes. Although most studies 
provided data either as percent of individuals completing an intervention or the mean 
percentage of an intervention completed, these two measures cannot be directly 
combined. It is therefore difficult to compare adherence levels across different types of 
interventions or trials. It is also difficult to compare measures of adherence because 
different studies may have excluded participants from the calculation of adherence if they 
did not met a specific threshold e.g. at least ½ or 33% of entries completed. A universal 
measure of adherence as proposed in previous reviews should be adopted. Christensen et 
al., (2009) proposed that the ‘percent of adherence’ may be a good universal indicator. 
Along with a universal measure of adherence it may also be interesting for studies to 
provide more detailed information on the quantity or quality of adherence. For example, 
Simco et al., (2014) recommended including not just the percentage of an intervention 
completed but the number of exercises per week, plans to continue use, or log-ins per 
week to get a more qualitative perspective on use. One interesting area of future research 
would be to examine the duration, frequency and intensity of the intervention and the 
affect that this may have on adherence. Trials that last for several months may have more 
variable adherence than those that last of only one week.  
38 
 
Several studies used participant feedback questionnaires, however, they were all 
different; some previously published but most were idiosyncratic and this variability also 
hinders comparison. Many questionnaires did include similar questions on satisfaction, 
ease of use and helpfulness of the intervention, or continued use of intervention, 
however, not all.  A standard questionnaire specifically for web-based and mobile 
interventions would provide detailed and comparable information on the service user 
perspective and experience. 
This review included different study designs and different types of interventions. It is also 
important to note that the narrow search terms used in this review may have limited the 
number of included studies, particularly ESM studies, therefore these results should be 
considered exploratory. In the future increases in efficacy RCTs would allow an 
examination of the impact of adherence on the outcome of interventions. RCTs comparing 
different types of mobile or internet interventions (e.g. self-monitoring, mood 
management, psychoeducation) will also be important to establish efficacy and suitability. 
Some service users may have preferences for different technologies and different 
intervention targets. This review was time limited. We only included studies that have 
been published since the previous systematic review in the field in 2013 in order to 
provide an overview of the most recent and relevant findings in the field and to include 
the next generation of mobile and web-based technologies as recommended by Alvarez-
Jimenez et al., (2014) and Ben-Zeev et al., (2014).  The recent boom in mobile and web-
based interventions will mean that there may soon be more trials and data on adherence 
for mobile and web-based interventions for psychosis than the current limited dataset. It 
should be noted that the age of the population included in this review ranged from 18-65. 
Future reviews should examine separate age cohorts in order to examine the effect of 
chronicity of disease as well as digital literacy on adherence. First Episode Psychosis 
services include people aged 16 in the UK so this early age range should be included in 
future reviews as they are likely to be the most digitally literate group.  
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This review is limited in that we only examined adherence, we did not look at the 
effectiveness of interventions or other specific outcomes. This will be an important area to 
explore further as adherence may not be directly related to efficacy; some participants 
may stop using an intervention early because they have learned the benefit however, 
others may not have used it enough to receive a benefit. The relationship between 
adherence and efficacy may vary depending on intervention and service user. We also did 
not assess or compare the types of outcomes measured, for example, some studies 
conducted cognitive assessments and others used only measures of symptoms. In the 
future it will be important to compare and contrast the use of different outcome 
measures. Finally, this review only included English language reports.   
There are some important disadvantages to consider when selecting a narrow search 
criteria and time frame. For example, the Cochrane Reviews Handbook (Higgins and 
Green, 2011) outlines how the resulting evidence for the research question may be 
sparse, the findings may not be generalizable to other settings, populations or 
interventions, and the findings may not include all of the potential relevant data. With this 
in mind the analysis of adherence, particularly for the ESM studies, and the preliminary 
analyses examining type of study i.e. comparing the ESM /Observational studies with the 
RCT’s should be considered exploratory. Further investigation is needed to examine 
potential differences in adherence between these different types of studies. Here we 
provide an up to date review that aims to be concise and accessible. Due to the rapid 
growth of research in this area and the use of many new technologies this review 
highlighted how participants obtained high levels of adherence across many different 
types of studies and interventions. 
In summary, this review has provided a systematic overview of the current state of 
adherence to mobile and internet based interventions for people with psychosis. We have 
assessed a range of different novel technological interventions from text message based 
to web based to virtual reality based programmes.  Importantly, we discovered that 
adherence across different types of studies and a diverse range of interventions is 
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moderate to high. We also provide an initial exploration of theoretically proposed 
predictors of adherence and confirm that these would be useful and interesting areas for 
further exploration. The focus on service users experience is an important direction for 
the field. 
4.5 Future directions and Implications 
This review has revealed several important implications that may inform interventions and 
the development of a model of adherence (summarized in Table 4 below). Instead of 
developing new interventions, several researchers have noted that what the field of 
mental health desperately needs is research and strategies to support service users to 
engage in current evidence-based effective treatments (Christensen et al., 2009; LeClerc 
et al., 2015). The development of a theoretical framework that would help us to 
understand the barriers to accessing and maintaining treatment adherence would be 
extremely valuable. This theoretical model could be a multi-level framework that includes 
service-user-specific factors, demographic factors and the intervention factors that may 
best predict adherence to interventions. For example, service-user-specific predictors of 
adherence may indicate that older, chronic service users may more readily engage in a 
web-based intervention with a high level of social support whereas FEP service users may 
be more likely to engage with a short, independent, mobile intervention. This should be 
systematically investigated. It may be that older service users have developed better 
coping strategies but may want to work alongside clinicians and researchers whereas 
young service users may benefit from an initial introductory trial and then prefer an 
intervention they can access independently. 
Along with a model of service-user or intervention predictors of adherence, the 
experience of the service-user may be a key factor in improving adherence. Adherence 
appears to be higher in studies with higher levels of social presence and in the few studies 
that included service user involvement in the development of the intervention. A model 
that combines service-user or intervention predictors with service user experience may be 
the best way forward. For example, Drake et al., (2015) used structural equation modeling 
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to examine the relationship between important predictors of adherence to medication in 
FEP. These included medication attitudes, self-esteem and insight.  They found that low 
insight at first presentation predicted readmission whereas good insight at six-week 
follow-up also predicted remission. They recommend that a multilevel intervention that 
includes different psychological interventions including motivational interviewing and 
psychoeducation along with text message reminders for medication use would perhaps be 
the most effective in promoting medication adherence without risking damage to the 
individuals’ self- concept. This is in line with recent recommendations from Mohr et al., 
(2011) who suggested a model of adherence to technological interventions that includes 
‘supportive accountability’, whereby the service user is involved in a reciprocal, respectful 
relationship. They conclude that if this model is used the intervention is more likely to 
appeal and be maintained by the service use as this approach may tap into the services 
users’ intrinsic motivation (personal objectives and self-reflection) and promote increased 
independence and self-determination instead of questioning the service users’ 
competence. We propose that the service user experience may play a vital role in 












Current Findings and Implications for a Model of Adherence 
Specific Predictors 
 Adherence to mobile and web-based interventions is not necessarily predicted by 
service-user specific factors such as age, symptoms, or gender; however, FEP may 
prefer an intervention that they can independently access 
 Adherence is moderate to high across different intervention specific factors such 
as amount of time to complete an entry and across different study designs 
however service users may prefer the smartphone interface and may adhere 
more in the first week of an intervention 
 
New Predictors 
 Adherence was higher in the interventions that provided more frequent social 
support 
 Service user involvement in the development of an intervention may promote 
adherence and satisfaction with intervention 
 
TABLE 4 CURRENT FINDINGS AND THE POTENTIAL IMPLICATIONS FOR A FUTURE MODEL OF COMPLEX 
FACTORS THAT AFFECT ADHERENCE 
In conclusion, this systematic review provides an overview of how adherence is measured 
and rates of adherence to mobile and web-based interventions or trials for psychosis. It 
has been well established that these types of interventions are feasible and acceptable for 
this service-user group; what currently needs exploration is how to best support service 
users to maintain adherence with these innovative interventions. Future areas to explore 
include the role of service-user specific and intervention specific predictors of adherence, 
the role of social support and the importance of the involvement of service users in the 
development and assessment of mobile and web-based interventions. These will be 
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c) Observational/Experience Sampling Method Studies 
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TABLE 3: Characteristics of Interventions and rates of adherence 
 



























et al., 2013) 

















Once  or twice 
per week based 
on participants 
preference 












with range of 
perspectives 



























3 days a week Open interviews 
with 15 patients 
to evaluate the 
intervention 
30 used the 
web program 
































SST group: 2x 










for 23 weeks 
 
Computer skills: 
Target 50 hours 




per week for 50 








Smith et al., 
2015 
 Up to 10 hours 
of virtual 
interviews over 
the course of 5 
visits 



















al.,  2014 















an average of 
5.3% 
 
































None reported None 
reported 































































































easy to use, 
useful and fun 
Ben-Zeev et 
al., 2014 b 
 1 month Average % of 
entries  
completed:86.5 
(rate of access 
to the system 
for all 
participants) 
1 dropout,  Researcher called 
participant to 




















PANSS and BDI 
Palmier-
Claus et al., 
2013a (see 
Palmier-






Claus et al., 
2014) 
6x a day for 
7 days 
Average % of 
entries  
completed:72 









least once per 
week to offer 
advice and 
encouragement 


















6 weeks, 2 
hours/week 




rate across all 
participants) 
1 Regular phone 
contact with the 
study team 













































6x a day for 7 
days 


















10x a day for 2 
days 










10x a day for 6 
days 









least half of the 
entries (n=27)) 
 5 dropped 
out 






Once in a 













10x a day for 1 
days 
Average % of 
entries  
1 Introduction 
session for 20 
None 
reported 








min on first day 
So et al., 
2013 
14 days 7x a 
day, randomly 
Average % of 
entries  
completed:70.7 
(response rate in 
participants who 
completed at 
least 1/3 of 
entries) 
5  Contacted by 
researcher at 
least 2x during 
1st week,  to 
offer support 









None reported 16 participants 









Phone call 4x a 
day for 7 days 










were called 4x a 
day 








None reported Response rate 














Trial Quality Characteristics 
 



























44 2,0= 2 0 10,6,0,0,0= 16 0 5,6,4= 15 3,3,5= 11 
*Ben-Zeev et 
al., 2014 a 
36 2,0=2 0 10,6,0,0,0= 16 0  5,6,4= 15 3,0,0,= 3 
*Ben-Zeev et 
al., 2014 b 





0 10,6,0,0,0=16 0 5,6,4=15 3,3,5=11 
*Palmier-
Claus et al.,  
2013a (see 
Palmier-Claus 








*Indicates the study is designed as a Feasibility or Acceptability trial. For Ratings of treatment description: Q14 score 3 if website or mobile 





et al., 2014) 
Palmier-Claus 
et al., 2013b 
(also reported 
in Ainsworth 
et al., 2013 
62 2,0=2 10,3,0=13 10,6,0,0,0=16 10 5,6,4=15 3,0,3=6 
Van der 
Krieke et al., 
2013 
78 2,5=7 10,3,0=13 10,6,10,0,0=26 6 5,6,4=15 3,3,5=11 
*Ventura et 
al., 2013 
44 2,0=2 0 10,6,0,0,0=16 0 5,6,4=15 3,3,5=11 
Kurtz et al., 
2015 
88 2,5=7 10,0,3=13 10,6,10,3,3=32 10 5,6,4=15 3,3,5=11 
Smith et al., 
2015 
79 2,0=2 10,3,0=13 10,6,10,3,3=32 6 5,6,4=15 3,3,5=11 
Beebe et al., 
2014 
75 2,0=2 10,3,0=13 10,6,10,3,0=29 10 5,6,4=15 3,3,0=6 
76 
 






Kimhy 2014a Kimhy 2014b Hartely 2014 So 2013 Sanchez 2014 
Question 1 1 1 1 1 1 1 
Question 2 1 1 1 1 1 1 
Question 3 1 1 1 1 1 1 
Question 4 1 1 1 1 1 1 
Question 5 2 2 2 2 2 1 
Question 6 1 1 1 1 1 1 
Question 7 1 1 1 1 1 1 
Question 8 1 1 1 1 1 0 
Question 9 1 0 1 0 1 0 
Question 10 0 1 1 1 1 1 
Question 11 0 UTD4 UTD 0 1 1 
Question 12 0 UTD 1 1 1 0 
Question 13 1 1 1 1 1 1 
Question 14 0 0 0 0 0 0 
Question 15 0 UTD UTD UTD 0 UTD 
Question 16 1 1 1 1 1 1 
Question 17 1 1 1 1 1 1 
Question 18 1 1 1 1 1 1 
Question 19 1 1 1 1 1 1 
Question 20 1 1 1 1 1 1 
Question 21 1 1 1 1 1 1 
                                                     
4 Unable to determine 
77 
 
Question 22 1 1 1 1 1 UTD 
Question 23 0 0 0 0 0 0 
Question 24 0 0 0 0 0 0 
Question 25 0 1 1 1 1 1 
Question 26 1 UTD UTD 1 1 0 
Question 27 0 0 UTD 1 1 0 























Section/topic  # Checklist item  Reported 
on page 
#  
Risk of bias across 
studies  
15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, 
selective reporting within studies).  
19 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if 
done, indicating which were pre-specified.  
14 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for 
exclusions at each stage, ideally with a flow diagram.  
17 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-
up period) and provide the citations.  
47-56 
Risk of bias within 
studies  
19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 
12).  
19 
Results of individual 
studies  
20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for 




Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and measures of 
consistency.  
na 
Risk of bias across 
studies  
22 Present results of any assessment of risk of bias across studies (see Item 15).  19 
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression 
[see Item 16]).  
20-27 
DISCUSSION   
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider their 
relevance to key groups (e.g., healthcare providers, users, and policy makers).  
28-32 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete 
retrieval of identified research, reporting bias).  
32 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for 
future research.  
34 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of 
funders for the systematic review.  
na 
 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(6): 
e1000097. doi:10.1371/journal.pmed1000097  








Chapter 2: Main Research Project 
 
 
The effect of self-monitoring using a 
novel mobile technology and 
intervention on metacognition in 








Professor Dame Til Wykes 
Dr Clare Reeder 







Background: Metacognition, or the ability to reflect on one’s thoughts and knowledge, is found 
to be impaired in people with schizophrenia, and may underlie deficits in clinical and cognitive 
insight into mental disorder. Researchers have proposed the ‘digital placebo effect’ (Torous 
and Frith, 2016): the use of a digital device indirectly improves symptoms of mental disorder. 
We examined if an intensive, real-time self-monitoring intervention indirectly improves insight, 
i.e. understanding of mental disorder, in people with schizophrenia. 
Methods: A mixed methods feasibility design was adopted. Participants were allocated to one 
of two conditions (i) recording their symptoms four times a day for a 12 week period using the 
‘ClinTouch’ mobile phone application (app) in addition to treatment-as-usual (Experimental 
group) or (ii) Treatment-as-usual (TAU) alone. Participants were asked to complete baseline 
and week 12 measures including the Beck Cognitive Insight Scale (BCIS), CHOICE cognitive 
behavioural therapy scale and the Scale of Unawareness of a Mental Disorder (SUMD-A). 15 
participants from the experimental group consented to a brief qualitative interview about their 
experience of self-monitoring.  We examined descriptive statistics and trends in the data for 
improved insight for the experimental group. This was expanded on by insight related themes 
from the qualitative interviews. 
Results: 44 participants with a diagnosis of a psychotic disorder were recruited from outpatient 
services to two groups (Experimental group N=22, TAU N=22).  There were no statistically 
significant differences between the groups on insight variables at week 12, however, the 
experimental group showed trends for improved insight on variables of the SUMD-A and BCIS 
and significantly improved positive symptoms compared to the control group. The qualitative 
analysis highlighted that all participants reported either they ‘developed a new understanding’ 
or ‘emerging self–reflection’. Participants varied in terms of their adherence to the self-
monitoring protocol. Trends in the data suggest that greater use of the app led to decreased 
insight and higher symptoms. 
Conclusions: This research project provides limited statistical evidence supporting the 
hypothesis that self-monitoring indirectly improves metacognition. Metacognition may be 
better measured using a questionnaire that takes into account themes such as ‘emerging 
insight’ or ‘noticing of patterns’. The adherence data suggests that participants who stopped 
using the app may have begun to develop insight, notice their symptoms increase and found 
this unhelpful. In contrast participants who continued to use the app may have needed more 
time and support to develop an understanding of their experiences. This is the opposite of the 
predicted ‘digital placebo effect’ as people may indirectly experience worsening of symptoms 
and less insight the longer they use the app. Future research should unpick both the positive 
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Schizophrenia is one of the most debilitating neuropsychiatric disorders as symptoms 
typically emerge in young adulthood and relapse is common throughout the lifetime. 
Symptoms include disturbance in thinking, disorganized speech, flat affect, lack of 
volition along with symptoms of psychosis; hearing voices and/or delusions (World 
Health Organization, 2016).  80% of people who develop a first episode of 
schizophrenia will relapse within 5 years (Robinson et al., 1999). Each episode of 
relapse significantly increases the risk for additional episodes (Wiersma, Nienhuis, 
Slooff, & Giel, 1998) and increases impairment in functioning and quality of life (Penn, 
Waldheter, Perkins, Mueser, & Lieberman, 2005). Research is needed that targets 
effective relapse prevention in order to promote recovery. 
1.1 Relapse Prevention: the importance of ‘insight’ 
There are several risk factors that predict relapse including non-adherence to 
medication, persistent substance abuse, carers’ criticisms, and poor premorbid 
adjustment (Álvarez-Jiménez et al., 2012). In a systematic review Lacro et al. (2002) 
found a non-adherence rate to psychological and pharmacological treatment of 47% 
and concluded that one of the most highly reported, yet potentially amendable 
predictors of non-adherence was poor insight into having a mental illness (Drake et al., 
2007).  
1.1.1 Clinical and Cognitive Insight 
A pivotal study by Amador and Gorman (1998) found that 50-80% of people with 
schizophrenia did not believe that they had a mental illness. Insight is a term that may 
refer to different dimensions such as; awareness of having a mental disorder, 
awareness of the effects of medication, and understanding the consequences of 
disorder (Amador Strauss & Yale, 1993; David, 1990). Impaired insight has been found 
to lead to poorer psychosocial functioning, poor adherence to psychiatric treatment 
and increased severity of positive and negative symptoms in people with schizophrenia 




main factors contributing to treatment non-adherence and relapse in schizophrenia 
(Henriksen & Parnas, 2014).  
Beck et al., (2004) make the important distinction between clinical insight and 
cognitive insight. Clinical insight is described above; awareness of having a mental 
disorder, the effects of medication and psychosocial consequences and is measured by 
scales such as the Scale for the Unawareness of Mental Disorder (SUMD) (Amador et 
al., 1993). Beck et al., (2004) argued that these scales miss out on the cognitive 
processes that may contribute to impaired insight, such cognitive insight or the ability 
to evaluate, detect and correct misinterpretations about their experience. The higher 
order evaluative process of cognitive insight may be an important mediator of 
improved clinical insight and therefore functional outcomes and relapse prevention.  
Donohoe et al., (2009) investigated whether illness awareness (clinical insight) was 
related to other aspects of self-awareness such as cognitive self-monitoring or 
awareness of errors. They found that those with better clinical insight, as measured by 
the Schedule for Assessment of Insight (SAI) (David, 1990), also had more cognitive 
insight into their performance on neuropsychological tasks. Support for a distinction 
between clinical and cognitive insight comes from a study which found that each 
affected different symptoms (Greenberger & Serper, 2010). Those with higher 
cognitive insight were found to have less severe preoccupation with symptoms and 
whereas those with higher clinical insight had increased depression symptoms.  
Underpinning the development of cognitive and clinical insight is thought to be a core 
cognitive skill; metacognition (David, Bedford, Wiffen, & Gilleen, 2012; Lysaker et al., 
2005) 
1.1.2 Underlying deficit in Metacognitive Regulation and Knowledge 
Lysaker et al., (2005) found that poor insight into mental illness was related to deficits 
in the core cognitive skill ‘metacognition’.  This is the ability to reflect on one’s 
thoughts and knowledge and has also been found to be impaired in people with 
schizophrenia (Bentall, 1990; Vohs & Lysaker, 2014). Metacognition involves two 




(see Table 1 for summary of definitions). Metacognitive regulation is the process of 
monitoring and regulating your own cognition. Frith (1992) suggested that those with 
schizophrenia have lost some of the ability to think about thoughts and feelings in a 
reflective and meaningful way; for example, hearing voices may result from 
impairment in the ability to represent your own or others mental states and may lead 
to the misattribution of internal events as external. Metacognitive knowledge is 
knowledge or understanding about how the mind functions and beliefs about your 
own mind or cognition (e.g. I have a good memory).  Morrison, Haddock, & Tarrier 
(1995) suggested that people with schizophrenia have incorrect knowledge or beliefs 
about the controllability of thinking that may lead to hallucinations such as thought 
insertion. Clinical and cognitive insight relates to beliefs and knowledge that is specific 
to a mental health disorder (such as knowledge of the consequences of disorder i.e. 
social isolation and knowledge of errors in thinking i.e. I cannot trust people).  
Therefore deficits in both areas of metacognition (regulation and knowledge) may 
underlie both types of insight and may be a significant barrier to acquiring new 
knowledge that may be important for recovery and relapse prevention. 
1.1.3 The putative key to improved insight: self-monitoring 
There may be several different pathways to improved awareness of symptoms and 
behaviour. Previous research has suggested that better self-esteem (Cella, Swan, & 
Medin, 2014; Paul H Lysaker et al., 2011), improved mood, lower positive and negative 
symptoms (Palmier-Claus, Taylor, & Gooding, 2012) and metacognitive training (Moritz 
et al., 2014) are associated with higher clinical and cognitive insight. Reeder, Rexhepi-
Johansson, & Wykes (2010) suggested that what is important for an individual’s 
functional outcome is not necessarily the metacognitive belief that an individual holds 
(i.e. I have a poor memory) but how this affects real life functioning (i.e. I should 
rehearse and monitor my memory). Metacognitive regulation and the process of 
actively monitoring your own cognition, may guide behavior and cognitive resources 
more efficiently (Cella et al., 2014; David et al., 2012; Flavell, 1979). David et al., (2012) 
suggests that the act of monitoring may reveal abilities or impairments that lead to an 




Increasingly there is support for the role of self-reflection in relapse prevention and 
recovery (Henriksen & Parnas, 2014; Lysaker, McCormick, & Snethen, 2011). Lysaker 
has criticized the traditional approach to recovery and relapse prevention as focusing 
mainly on the reduction of observable symptoms whereas equally important is the 
capacity to understand the self and others (Lysaker & Dimaggio, 2014). Pitt et al., 
(2007) found, from a service user perspective, recovery meant a better understanding 
of oneself and feelings of empowerment. Meaningful recovery goes beyond a decrease 
in measureable symptoms and entails the ability to recapture a coherent 
understanding of oneself (Connell et al., 2015). It is important to consider that 
recovery may have different meanings for different individuals; it could mean a 
decrease in symptoms for some or the ability to understand and live with symptoms 
for others.  The key mechanism may be self-reflection and the development of an 
integrated understanding of experiences (Lysaker et al., 2015). 




                                                     
5 For simplicity the general term ‘insight’ will be used to refer to both (clinical and cognitive) types of 
metacognitive knowledge throughout the methods and results sections  
Term Definition Measure 
Metacognitive Regulation The process of self-monitoring and 
reflection on one’s own thinking 
-Adherence to the self-
monitoring protocol  
-Qualitative Interview 
Metacognitive Knowledge5 Understanding and beliefs about 
one’s own thinking, experiences, 
and how the mind works 
-Knowledge and beliefs 
assessed through SUMD-A and 
BCIS 
-Qualitative Interview 
Specific metacognitive knowledge  
a) Clinical Insight 
Awareness of having a mental 
disorder, reasons for use of 
medication and psychosocial 
consequences 
-Scale to Assess Unawareness 
of Mental Disorders -
Abbreviated (SUMD-A) 
Specific metacognitive knowledge 
b) Cognitive insight 
Ability to evaluate, detect and 
correct misinterpretations about 
ones thinking and experiences 





1.1.4 ‘The Digital Placebo Effect’ 
Recently, investigators have noted a phenomenon whereby participants report 
improved symptoms and functioning after using a mobile application that had no 
explicit or direct therapeutic intervention. For example, Kauer et al., (2012) found that 
after monitoring mood and recording symptoms using a smartphone app, adolescents 
with depression experienced a significant improvement in symptoms. Torous and Frith 
(2016) coined the term ‘digital placebo effect’, whereby the individual experiences 
positive effects as a by-product of using mobile mental health applications. They 
suggest that this placebo effect is a combination of various processes that we have yet 
to fully understand. However, psychological theory would suggest that the act of 
monitoring leads to increased understanding of external and internal states (Burnette, 
O’Boyle, VanEpps, Pollack, & Finkel, 2013). This can result in improved health 
management for example, diabetes control (van Vugt, de Wit, Cleijne, & Snoek, 2013), 
HIV medication adherence (Smith, Hull, Israel, & Willson, 2003) and weight loss 
(Hutchesson, Tan, Morgan, Callister, & Collins, 2016). 
Instead of an unknown ‘placebo effect’, one of the key processes may be the 
modification of peoples’ beliefs and expectations.  A daily medication tracker could 
lead to better understanding of the effects of medication, or a longitudinal mood-
monitoring app may yield an improvement in reported mood states due to awareness 
of different triggers and daily fluctuations. The potential for mental health apps to 
indirectly improve the symptoms and functioning of individuals with schizophrenia is a 
promising area of research.  
The current study explored the notion that the ‘digital placebo effect’ may result from 
changes to peoples’ beliefs and understanding about their illness. This current work 
suggests that intensive self-monitoring with a mobile app may indirectly lead to 






1.2 Mobile Technology interventions and Metacognitive Measures 
1.2.1 Novel Mobile phone app: Clintouch 
A multi-centre research study undertook a proof of concept feasibility trial6 to examine 
the use of a new mobile technology called ClinTouch. ClinTouch is a mobile phone 
application that supports self-monitoring of symptoms and mood by alerting, 
collecting, recording and uploading self-report patient information on symptoms and 
mood. Four times a day, service users responded to mobile phone prompts and were 
asked fill out a series of 18 questions about their current symptoms and mood. The 
feasibility, safety and validity of using similar new mobile technology has been 
previously tested (Ainsworth, Palmier-Claus, & Machin, 2013; Palmier-Claus et al., 
2012). The ClinTouch technology was designed to create real time alerts for health 
care workers as it can actively track early warning signs and prompt early intervention 
when there is increased risk of suicide or deliberate self-harm. Along with facilitating 
crisis intervention from health care professionals, mobile phone based assessments 
require the participant to engage in increased evaluation of symptoms, mood and 
behaviour therefore increased self-monitoring. This current research study was an 
addition to the larger multisite proof of concept study and specifically explored how 
intensive self-monitoring using the ClinTouch app may prompt metacognitive 
regulation and lead to improved clinical and cognitive insight.  
It is important to note that the aim of the larger multi-site project was to examine the 
feasibility of using the Clintouch mobile app along with a new intervention called 
CareLoop.  CareLoop is a new website based technological interface that was 
developed as a staff intervention. When the service user received the ClinTouch 
mobile phone a new account for that service user was set up on the CareLoop website 
by the keyworker or care coordinator from the community mental health team.  This 
online account received up to date symptom information from the ClinTouch mobile 
app, and used a formulae to detect individualised and generalised signs of relapse and 
Deliberate Self-Harm (DSH). If signs of relapse or DSH are detected the server 






generates an email alert which was sent to key worker and duty worker 
recommending intervention.  All of the participants recruited to this current smaller 
exploratory study partook in both the ClinTouch and CareLoop intervention. An 
analysis of the CareLoop data was beyond the scope of this project however it is an 
important consideration when considering the analysis of adherence, as discussed in 
the limitations sections 
1.2.2 Measuring Metacognition 
Metacognition consists of two main components; 1) regulation or the process of 
monitoring and evaluating thinking (e.g. thoughts or beliefs about symptoms) as well 
as 2) knowledge or beliefs and understanding of thoughts and experiences (Quiles, 
Verdoux, & Prouteau, 2014).  
Metacognitive regulation was measured by examining adherence to the ClinTouch 
mobile phone protocol as detailed in the methods section 2.4.1.These four different 
measures of adherence were used as it is anticipated that the level of adherence 
would vary i.e. different participants may use different strategies. For example, some 
participants would fully adhere for the first week and then decline in their entries, 
some would use the app regularly, but not four times a day, and others would adhere 
less initially and then engage fully by week 12. As this was an exploratory study, 
analyses of these four measures helped to profile the nature of adherence to this 
protocol.  
Metacognitive knowledge was measured using three different scales in order to 
capture the complexity of knowledge and insight into mental illness. As suggested by 
Beck (2004), insight is not just awareness of a mental disorder, but also awareness of 
errors in thinking and an alternative understanding of experiences. Clinical insight was 
measured using the Scale of Unawareness of Mental Disorder-Abbreviated (SUMD-A) 
(Michel et al., 2013); cognitive insight was measured using the Beck Cognitive Insight 
Scale (Beck, 2004); finally, the CHOICE cognitive behavioural therapy measure was 
used to captures any changes in awareness or improved understanding of the 




have specific factors relating to service users self-reported experience of coping and 
recovery (Greenwood et al., 2010). These three measures have high reliability and 
validity, have been specifically designed for use by service users with schizophrenia, 
are fast to administer and have been used extensively in the literature. Appendix 1 
presents examples of the measures in the form of a Case Report form (CRF). 
In addition to these questionnaire measures, service users were interviewed about 
their understanding and experience of schizophrenia, and their experience of self-
monitoring using the app. Qualitative research on service users perceptions and 
experiences of mobile and internet based apps explored any themes or narratives of 
insight that were not captured by the questionnaires (Palmier-Claus et al., 2013; Drake 
et al., 2012). 
1.3 Aim 
The primary aim of this exploratory study was to assess if an intensive, real-time self-
monitoring intervention could indirectly prompt metacognitive regulation and 
therefore improve clinical and cognitive insight in people with schizophrenia.  This 
study used both quantitative and qualitative methods: 
 Hypothesis 1) Will self-monitoring improve insight measures at week 12? It was 
hypothesized that intensive self-monitoring would result in improved insight, as 
measured by three different questionnaires, at week 12; the BCIS, SUMD-A and 
the CHOICE measures.  
 Hypothesis 2) Will adherence to the protocol lead to improvements in insight and 
symptoms?  It was hypothesized that high levels of self-monitoring, as measured 
by high levels of adherence to the ClinTouch protocol, would lead to increased 
insight at week 12.  
 Hypothesis 3) Will improved insight lead to change in symptoms and functioning? 
It was hypothesized that improved insight would lead to improved PANSS positive 
symptoms, but worse depression symptoms. 
To better inform the quantitative hypotheses, brief structured qualitative interviews of 




complement and expand on the quantitative data by exploring interview topics of 
clinical insight, cognitive insight, and metacognitive regulation.  
2. Method 
2.1  Study Design 
A mixed methods design was adopted whereby quantitative data is complemented 
and expanded upon with qualitative data (Morgan, 1998).  This was a longitudinal, 
exploratory study with participants drawn from two sources and comparing an 
experimental group (self-monitoring with ClinTouch mobile app for 12 weeks) with a 
treatment as usual (TAU) group. 44 participants were recruited across two sites 
(London and Manchester see below) and were allocated to the experimental (n=22) or 
TAU groups (n=22). As not all participants were randomly allocated baseline 
differences between the groups were examined using independent samples t-tests. 
Both groups were assessed at baseline and week 12 on measures of metacognitive 
insight, symptoms and functioning. After ethical approval had been granted for an 
amendment to include the brief qualitative interviews7, 15 participants remained in 
the experimental group and all of these participants consented to the interview. 
Assessments were not blind to group allocation. 
 
Ethical approval for this study was granted by NHS Ethics, NRES Committee West 
Midlands-South Birmingham by a substantial amendment to the Proof of Concept 
(PoC) Feasibility Trial of ClinTouch-CareLoop Enhanced Management (CEM) versus 
Management As Usual (MAU) in people with schizophrenia, REC reference: 
14/WM/0045, dated November 21 2014 (see Appendix 9 for letters of approval and 




                                                     
7 Ethical approval for an amendment which included the brief qualitative interviews was granted in May 




2.2  Participants 
Sampling 
41 Participants were recruited from the Croydon Outreach Assessment Support Team 
(COAST) in South London and Maudsley (SLaM) in south London. This is an early 
intervention community mental health team for people with psychosis. Three 
participants were recruited from South Mersey Community Activity Team in MMHSCT 
in Manchester which is a treatment and recovery community mental health team for 
people with psychosis.   
 
Inclusion/Exclusion criteria 
Participants were invited to participate in the study if they met the following criteria: 
1. Diagnosis of schizophrenia or related psychotic disorders, meeting or having met the 
Diagnostic Statistical Manual-IV criteria for such a diagnosis  
2. Aged between 18 and 65 years  
3. Able to provide written and witnessed informed consent  
4. Can read and write in English at a level sufficient to understand and complete study 
related procedures   
5. Not acutely unwell at point of study entry  
Exclusion Criteria   
1. Current inpatient status  
2. Unable or unwilling to give written consent  
 
Sample size: 
For an exploratory study the sample size should be adequate to estimate the critical 
parameters to the necessary degree of precision. Considering a drop-up rate of 
approximately 10%, a sample size of 22 per group will ensure 20 completers per group, 
as recommended by sample size for exploratory studies focusing on parameter 









2.3  Measures 
Insight measures 
Clinician/Researcher report: SUMD-A (Michel et al., 2013) 
This 9-item scale has three subscales; Mental disorder index (MD), Positive symptom 
index (PS) and Negative symptom index (NS). Service users are rated by the clinician or 
researcher on a three point scale (1= Aware, 2=slightly unaware, 3= seriously unaware) 
for each of the 9 items. The key measure is the sum total of scores across all 9 items. 
The index scores for the three subscale measures are calculated based on the sum 
total of specified items. As cited in the study by Michel et al., 2013, the abbreviated 
measure has high item-internal consistency (Pearson’s coefficients from .79 to .90) and 
high reliability (Cronbach’s alpha coefficients from .76 to .83). Additionally, it showed 
medium to high external validity with the PANSS scale (r=.25 to .55). This clinician-
rated scale provides an objective measure of insight that can be compared with 
participant self-report measures. 
 
Participant report: The Beck Cognitive Insight scale (BCIS) (Beck et al., 2004)  
This 15-item self-report scale includes subscales of self-reflectiveness and self-
certainty as well as a composite scale (self-reflexivity minus self-certainty) to provide 
an overall insight measure. The subscales of self-reflectiveness and self-certainty are 
calculated by summing the specified questions. Higher scores on this composite 
measure indicate more insight. As discussed in the original study by Beck et al., (2004) 
large to moderate effect sizes were found when correlated with the SUMD-A and this 
is thought to show sufficient convergent validity for a research-based scale. 
Additionally there was good construct validity, r=.65, correlating change in symptom 
scores with insight scale scores. 
 
Participant report: CHOICE (Greenwood et al., 2010)  
This questionnaire contains 21 items that are rated by self-report from 0-10 on two 




subscale and the severity of distress subscale. Higher values indicate better functioning 
on both subscales. As reported in the study by Greenwood et al., (2010) this measure 
has high internal consistency (e.g. Cronbach alpha =.83 for severity and .88 for 
satisfaction dimensions).  It has high reliability (test-retest ICC = .73 95% CI = .51-.86, 
P< .001) for severity and (ICC = .79 95% CI = .61-.90 p<.001) for satisfaction. 
 
Symptoms 
The Structured Clinical Interview-Positive and Negative Syndrome Scale, SCI-PANSS, 
(KAY, FISZBEIN, & OPLER, 1987) is a 30-item rating scale rated by the clinician or 
researcher based  on service users’ responses to a series of questions pertaining to the 
last seven days. It is subdivided into three symptom categories: positive symptoms 
(e.g. delusions, hallucinatory behaviour), negative symptoms (e.g. blunted affect, 
emotional withdrawal), and general symptoms (e.g. anxiety, depression). Researcher 
CK completed a PANSS training course and was certified as a PANSS rater by the PANSS 
Institute (US) (January 2015). CK and another PANSS trained researcher (ZH) 
established high interrater reliability (Interclass correlation coefficients > 0.80). 
 
Functioning 
The Global Assessment of Functioning, GAF (American Psychiatric Association, 1994) is 
a standardised measure used to assess overall level of functioning on a scale from 0-
100. The clinician or researcher makes an overall judgment about current and highest 
level of psychological, social, and occupational functioning based on level of 
functioning at the time of evaluation. Researcher CK consulted guidelines for the 
ratings using the GAF (Caldecott-Hazard & Hall, 1995). 
 
2.4 Quantitative Analysis 
Exploratory studies are used to estimate important parameters needed to design the 
main study. According to Lancaster, Dodd, & Williamson, (2004) the analysis of a 
exploratory study should be mostly descriptive with the main focus on parameter 
estimates such as standard deviation and confidence interval estimation. Therefore, 




readers’ attention to potentially notable, but not statistically significant effects (i.e. p 
values <.15).  Statistically significant effects are noted at the traditional threshold (p 
values < .05). As this study is an exploratory study we have refrained from controlling 
for multiple testing. The traditional feasibility estimates of methodology such as 
parameters of recruitment, attendance and retention rates will not be covered in this 
report as this will be reported by the larger multisite Careloop/ClinTouch Proof of 
concept trial.   
 
2.4.1 Statistical methods 
Baseline Analysis: 
All statistical analyses were conducted in SPSS version 22. Inspection of histograms and 
the Kolmogorov–Smirnov test statistic (i.e. significance indicates that the distribution 
of the data significantly differs from a normal distribution) was used to determine 
whether parametric or non-parametric testing was appropriate. As not all the sample 
was randomly assigned to experimental or TAU groups, baseline differences between 
groups were examined using independent samples t-tests. Welch’s t-test for unequal 
sample size was used to examine baseline differences between drop out and adherent 
participants. 
Exploratory Analysis: 
Hypothesis 1: Will self-monitoring improve insight measures at week 12? 
The first aim was to determine if intensive self-monitoring resulted in improved 
insight, as measured by three different insight questionnaires at week 12. Three 
separate ANCOVAs comparing groups (experimental vs. control) at week 12 on 
outcome measures (SUMD-A, BCIS and CHOICE questionnaires) while controlling for 
baseline questionnaire scores were used to detect changes in insight. However, these 
results will be reported and interpreted with caution as hypothesis testing is not 
generally recommended for exploratory studies due to the small sample size (Arain, 





The means and confidence intervals (CI) are presented to examine if there are any 
trends (e.g. CI that is skewed indicates a trend in the hypothesized direction) for 
clinically important treatment differences within the limits (Loftus & Masson, 1994;  
Wykes, Parr, & Landau, 1999). The purpose was to explore the likely ranges for 
intervention effects at 12 weeks by assessing confidence intervals of mean difference 
scores. The mean difference and upper and lower limits of the 95% confidence 
intervals were computed from ANCOVA estimated marginal means (e.g. means 
adjusted for the effect of the covariate). 
 
Hypothesis 2: Will adherence to the protocol lead to improvements in insight and 
symptoms?   
The second aim explored the hypothesis that increased self-monitoring, as measured 
by higher levels of adherence to the ClinTouch protocol, led to higher levels of clinical 
and cognitive insight as measured by improvement in the BCIS, SUMD-A and the 
CHOICE. Pearson partial correlation coefficients were conducted using the following 
measures of adherence: 
(i) Total number of entries completed over the 12 weeks 
(ii) number of days when at least one entry was completed 
(iii) Number of entries during the last week of the protocol (week 12) 
(iv) number of entries during the first week of the protocol (week 1) 
The change in scores on insight variables, PANSS variables and GAF score were 
correlated with the above measures of adherence. Change scores were calculated as 
week 12 score minus week 0 score.  For example, a negative change score for the 
PANSS and SUMD-A (e.g. Week 12 score (10) minus Week 0 score (15) = -5) indicates 
improvement. As these methods are exploratory, all of the statistics and p-values are 
presented for the main adherence measure of interest, ‘total entries completed over 
the 12 weeks’ (see table 5). Additionally, only the significant correlations and trends 
for notable correlations (p<.15 and r value > .300) are presented for the other three 
measures of adherence (see table 7). This analysis is conducted on the experimental 
group only. 




A supplementary analysis was completed to examine any changes in insight or 
symptoms for adherent and non–adherent participants in the experimental group. 
‘Adherent’ refers to those participants who completed at least 33% of entries (N=14); 
‘non-adherent’ participants (N=6) did not reach this threshold (Palmier-Claus et al., 
2012). Adherent and non-adherent participants were compared for baseline 
differences using Welch’s t-test statistic for unequal sample sizes. Partial correlations 
controlling for baseline scores, between the adherence measures listed above and 
change in insight and symptom variables were examined separately for each group. It 
was predicted that those in the adherent group would have stronger correlations 
between adherence measures and change to improved insight.  
Finally, participants were categorised into three different adherence groups; 1) low: 
<33% of entries completed, N=6 2) mid: >33 but <66% of entries completed, N=9 and 
3) high:  >67% of entries completed, N=5.  Welch’s t-tests for unequal sample size 
were conducted on change scores (week 12 minus week 0 scores) and week 12 scores 
for all insight and symptoms measures to compare the three different groups in terms 
of change in insight/symptoms and week 12 insight/symptoms. It was predicted that 
those in the high adherent group would have the most improved insight and the 
highest insight scores.   
Hypothesis 3 Will improved insight lead to change in symptoms and functioning?  
In addition to examining any potential change in insight measures we also predicted 
that the experimental group would show an improvement in symptoms and 
functioning at week 12 as a by-product of self-monitoring, when compared to the TAU 
group. ANCOVA’s were performed on symptoms and functioning variables at week 12, 
comparing the experimental and TAU groups. It was predicted by Ampalam, Deepthi, & 
Vadaparty, (2012) that improved insight may lead to a worsening of depression 
symptoms. Pearson’s partial correlations controlling for baseline PANSS positive 
symptom or depression symptoms (PANSS general item 6) were performed on the 
change scores (week 12 minus week 0) of insight (SUMD-A sumtotal or BCIS 
composite) and PANSS PS or depression variables, to examine if change in insight was 




1) Improved insight will correlate with fewer symptoms of delusions and hallucinations 
as measured by the change in the PANSS positive symptom scale. 
2) Improved insight will correlate with higher symptoms of depression as measured by 
change in the general item 6 on the PANSS.  
 
2.5 Procedure 
Questionnaire measures were assessed at 0 weeks (baseline) and 12 weeks (outcome).  
After the baseline assessment, participants were randomized or allocated to the 
experimental or TAU group. In the experimental group they received the ClinTouch 
mobile app and detailed instructions on the ClinTouch mobile procedure (see Appendix 
3). Participants in the experimental group received weekly follow-up phone calls to 
provide technical support and to discuss any questions or difficulties.  
 
2.5.1 ClinTouch Procedure 
Participants chose whether to use a loaned ClinTouch Smartphone with the application 
already installed, or their own smart phone. Samsung Galaxy smartphones and the 
Vodafone UK mobile phone service was used to supply the SIM cards and monthly Top 
up credit.  When the participant preferred their own phone, researcher CK 
downloaded the application to the service users own phone and ensured that it was 
functioning correctly at the baseline testing session. When the ClinTouch mobile app 
beeped the participant was alerted to respond to 18 questions that covered positive 
psychotic symptoms, anxiety and mood. This took about two minutes to complete. 
Each participant received four alerts a day for 12 consecutive weeks. Please find 
attached a list of the questions that the participants will be prompted to answer 
(Appendix 4).  
Development of ClinTouch questions: These questions have been extensively piloted 
and assessed (Palmier-Claus et al., 2012; Ainsworth et al., 2013). Briefly, the 18 
questions were developed based on the PANSS and two items of the Calgary 
Depression scale (Addington, Addington, & Schissel, 1990). Participants were asked to 




amount of time required to complete the questionnaire the questions were split into 
two question sets that were presented alternatively.  
2.5.2 Participant Payment 
Participants in the experimental and TAU groups received payment for each testing 
session (baseline session £15 and week 12 session £20). If they were allocated to the 
experimental group, they received a prepaid mobile phone credit (£30) for 3 months. If 
they agreed to take part in the qualitative interview they were paid an additional £5.  
 
2.6  Qualitative Methods 
A brief structured qualitative interview with open-ended questions was used to 
provide additional insights into the main hypotheses; 1) Will self-monitoring improve 
insight measures at week 12? 
 and 2) Will adherence to the protocol lead to improvements in insight and symptoms? 
(Morgan, 1998).  The data were analysed following the principles of Framework 
analysis, supported by an approach known as Iterative Categorization (Neale, 2016). 
Framework analysis is a transparent and systematic technique that is particularly 
suitable for qualitative data that have been collected with a clear structure; for 
example, a predetermined sample with a-priori research questions (Neale, 2016; 
Palmier-Claus et al., 2013). Framework consists of several systematic stages including 
1) coding 2) applying an analytical framework 3) charting data into the framework 
matrix and 4) interpreting the data (Gale, Heath, Cameron, Rashid, & Redwood, 2013). 
The steps for data coding and analysis are outlined in detail below.  
 
2.6.1 Structured Interview 
The structured interview topic guide covered the following three topics: self-reported 
change in clinical insight (awareness of a mental health problem), cognitive insight 
(awareness of thoughts and cognitions pertaining to mental health problem), and 
metacognitive regulation (the process of self-monitoring and reflection of one’s own 




from care-coordinator and additional metacognitive knowledge) however analysis of 
these questions is beyond the scope of this project. For each topic, the researcher 
asked a series of open-ended questions, using prompts and probes. The interviewer 
also prompted throughout for moments of self-understanding or understanding the 
connection between mood, symptoms and behavior connected to self-monitoring 
using the Clintouch app (see Appendix 5 for the topic guide).  
2.6.2 Data Collection and recording 
 All 15 participants who completed the experimental mobile phone intervention 
between May and December 2015 were approached to take part in the qualitative 
interview. During the baseline assessment at week 0, the nature of the qualitative 
interview was explained and participants were asked if they would like to take part.  
Written information and a consent form were then provided. All of the participants 
consented to complete the interview and attended the subsequent interview session 
during the outcome assessment at week 12. Interviews took place at a community 
mental health team base.  The interviews were audio-recorded. When presenting the 
data, quotations will be used with an anonymous participant code (e.g Participant 1). 
2.6.3 Data coding 
Due to the nature of the data (i.e. clearly structured interviews) it was not necessary to 
use specialist software to transcribe or analyze the data. The audio recordings of the 
interviews were not transcribed verbatim but were summarized in brief, descriptive 
text.  Researcher CK summarized the audio recordings into shorter descriptive phrases 
that retained the content of the participants’ narrative, using an excel spreadsheet. 
Participants’ responses to each interview question were entered into a framework 
matrix; i.e. a Microsoft excel (2010) spreadsheet was designed whereby each column 
represented a question from the interview topic guide and each row represented a 
participant case. This method of coding the data according to a predetermined 
structure (the interview topic guide) is known as deductive coding. During the 
deductive coding process new, inductive codes were noted as they arose from the 




‘confusion’ where added to the coding structure as additional columns to the 
spreadsheet. Exemplar quotes were noted with a Q. Appendix 6 provides an overview 
of the methodological strategy used including examples of the stages of data coding 
and data analysis.  
2.6.4 Data Analysis 
Once the coding of the data was complete the data were analyzed through a process 
of iterative categorization. This is a transparent and systematic analytical technique 
that can be used alongside many different qualitative research methods including 
Framework (Neale 2016). Iterative categorization has two main assumptions; 1) that 
the study has a clear aim and objective 2) that the interview topic guide or protocol 
used for data gathering was designed based on theoretically relevant literature that 
informed the aims and objectives of the study. A Microsoft word file for each of the 
interview questions was created. The summaries of the participants’ responses to each 
question were analyzed and categorized into different themes and subthemes. These 
themes emerged from the participant responses. Additionally, some simple numeric 
data was produced, such as frequency of a yes or no response, in order to complement 
the quantitative questionnaire data. 
2.6.5 Participants 
13 males and 2 females completed the interview. The median age of participants was 
26 years.  The majority of participants indicated that they were from a minority ethnic 
group (80%). The majority (73%) were unemployed and single (93%). 
TABLE 2 DEMOGRAPHIC CHARACTERISTICS OF INCLUDED PARTICIPANTS  
 Interviewees (n=15) 
Gender: males % (n) 86 (13) 
Age: median (range) 26 (20-29) 
Ethnic minority: % (n) 80 (12) 
Years of education: median (range) 13 (9-17) 




Relationship status, Single: % (n) 93 (14) 
Unemployed: % (n) 73 (11) 








Demographic and clinical characteristics of participants are presented in Table 3. 81 
participants were approached, 37 declined, 44 consented to participate in the study. 
22 participants were recruited to the experimental group and 22 were recruited to the 
TAU group.  After consenting to participate four participants dropped out of the study 
(lost mobile phone N=1, mobile phone beep was too frequent N=1, inpatient 
admission N=1, refused to complete week 12 assessment N= 1). Please see figure 1 for 
a CONSORT diagram overview. There were no predictors of drop-out based on baseline 
PANSS, GAF, SUMD-A, BCIS and the CHOICE scores. Visual inspection of the data also 
confirmed no notable clinically relevant differences. In order to provide a descriptive 
overview of the data, (as outlined by Lancaster et al., 2004 for exploratory studies), 
means and standard deviations of insight, symptoms and functioning measures are 
presented in Table 4 along with confidence intervals of the mean difference between 








































allocated to TAU N=10  
Approached for participation (n=81) 
Randomized (n=32) 
Declined to participant (n=37) 
Allocated to the experimental 
condition N=20: baseline 
assessment week 0, 12 weeks 
of Clintouch app use + TAU, 
outcome assessment week 12 
Allocated to the TAU 
condition N=12: baseline 
assessment week 0, TAU, 
outcome assessment week 
12 
Dropout N=2 
 Total analysed: 20 
Dropout N=2  
Total analysed: 20 
Additional participants 











Gender: males % (n) 75 (15) 55 (11) 
Age: median (range) 26 (20-35) 27 (19-
40) 
Ethnic minority: % (n) 75 (15) 80 (16) 
Years of education: median (range) 13 (9-17) 14 (10-
18) 
Accommodation, Local housing 
authority:  
% (n) 
45 (9) 35 (7) 
Relationship status, Single: % (n) 90 (18) 90 (18) 
Unemployed: % (n) 75 (15) 75 (15) 
Number of psychiatric admissions to 
hospital: median (range) 
1 (0-3) 1 (0-3) 
 
3.1 Group matching 
Independent samples t-tests on all PANSS, GAF and SUMD-A sum baseline scores 
indicated that the experimental and TAU groups were well balanced (PANSS positive 
(p=.387), negative (p=.371), general (p=.735) and total (p=.810) scales; GAF score 
(p=.814) and SUMD-A sum total scores (p=.123)). 
3.2 Hypothesis 1: Will self-monitoring improve insight measures at week 12? 
Table 4 shows the mean and standard deviations of the key metacognitive outcome 
measures and the symptom and functioning measures. 95% confidence intervals for 
the adjusted mean difference (controlling for baseline scores) between week 12 scores 










TABLE 4 MEANS, STANDARD DEVIATIONS (SD) FOR THE MAIN OUTCOME VARIABLES. CONFIDENCE 
INTERVALS (CI) ARE CALCULATED FOR THE MEAN DIFFERENCE BETWEEN GROUPS AT WEEK 12 ADJUSTED 
FOR BASELINE SCORES; 1 INDICATES TREND FOR SIGNIFICANCE IN THE HYPOTHESIZED DIRECTION, * 
INDICATES SIGNIFICANT ANCOVA 
 
3.2.1 BCIS: Cognitive Insight 
The ANCOVA analyses revealed no significant differences between groups on the self-
reflexivity subscale (F(1,37)=2.02, p=.163) or self-certainty subscale (F(1,37)=.169, 
Measure Baseline Scores: mean 
(SD) 





TAU Adjusted Mean 
difference (MD), 
95% CI  
SUMD-A 
total 
12.4 (4.37) 14.9 (5.59) 12.2 (2.76) 15.75 
(5.90) 
MD: -2.22 95% 
CI: -4.73 to .2981 
SUMD-A MD 
index 
4.05  (1.39) 5.05 (1.9) 3.8 (1.19) 5.20 
(2.1) 
MD:-.748, 95% 




3.85 (1.78) 4.70 (2.45) 3.35 (1.42) 4.55 
(2.45) 
MD: -.863, 95% 
CI: -2.069 to .344 
SUMD-A NS 
index 




-2.081 to .697 
BCIS 
Composite 
6.75 (3.72) 4.80 (6.5) 7.0 (4.5) 3.75 
(5.32) 
MD:2.08 95% CI:  
-.44 to 4.611 
BCIS Self 
Reflexivity 
12.65 (4.09) 12.9(4.67) 13.75 (4.39) 12.15 
(4.53) 
MD: 1.733, 95% 
CI:-.733 to 4.199 
BCIS Self 
certainty 
5.9 (2.73) 8.10 (2.93) 6.75 (2.38) 8.40 
(3.16) 
MD:-.313, 95% 
CI: -1.85 to 1.232 
CHOICE 
Severity 
6.59 (1.64) 5.64 (1.83) 6.38 (1.73) 6.11 
(1.74) 
MD:-.417, 95% 
CI: -1.22 to .390 
CHOICE 
Satisfaction 
5.95 (2.07) 5.41 (2.53) 5.80 (2.2) 5.39 
(2.22) 
MD:-.019, 95% 
CI: -.862 to .824 
PANSS total 74.45 (15.38) 75.65 
(15.99) 
64.65 (14.60) 70.05 
(18.78) 
MD:-4.491, 95% 
CI:-12.2 to 3.24 
Positive 
Scale 
19.05(4.72) 17.70 (5.02) 15.40* (4.53) 17.00* 
(5.58) 
MD:-2.55, 95% 
CI: -5.0 to -.088 
Negative 
Scale 
17.50 (5.37) 19.10 (5.79) 16.25 (4.65) 17.95 
(6.13) 
MD:-.497, 95% 
CI: -2.77 to 1.77 
General 
Scale 
37.90 (8.66) 38.85 (8.94) 33.0 (7.84) 35.1 
(9.21) 
MD:-1.55, 95% 
CI: -6.05 to 2.94 
GAF 46.85 (13.49) 45.95 
(10.35) 
53.15 (12.86) 54.3 
(16.49) 
MD: -1.85, 95% 




p=.684)8. An ANCOVA controlling for baseline BCIS composite score revealed no 
significant differences between groups at week 12. However, the confidence intervals 
indicated a trend for significance (F(1,39) = 2.806, p = .102, MD:2.08, 95% CI: -.44 to 
4.61) whereby the experimental group had higher insight at week 12 than the TAU 
group (means: experimental 7.00, TAU 3.75) after controlling for baseline. 
3.2.2 SUMD-A: Clinical Insight 
The results from ANCOVAs on all three subscales at week 12 variables were non-
significant; positive symptoms subscale (F(1,37)=2.099, p=.156), and negative 
symptom subscale (F(1,37) 1.018, p=.320). However, there was a trend for significance 
in the hypothesized direction on the SUMD-A medical disorder subscale 
(F(1,37)=2.808, p=.102; MD:-.748, 95% CI: -1.653 to .157), with lower scores of 
unawareness (meaning greater insight) for the experimental group (means: 
experimental 3.8, TAU 5.20). 
For the SUMD-A sum total, there was a trend for difference between groups at week 
12 with an ANCOVA approaching significance (F(1,39)= 3.192, p =.082; MD: -2.22 95% 
CI: -4.73 to .298) whereby the experimental group had lower scores of unawareness 
(meaning greater insight) at week 12 (means: experimental 12.2, TAU 15.7). 
3.2.3 CHOICE: Self-reported awareness of coping and recovery 
The ANCOVA revealed no significant differences in week 12 scores between groups on 
the CHOICE satisfaction subscale (F(1,37)= .002, p=.964) or the CHOICE severity 
subscale (F(1,37)= 1.096, p=.302).  
In summary, there were no statistically significant differences between the groups on 
these measures of insight at week 12. However, there are trends in the hypothesized 
direction indicative of improved insight for the experimental group on the BCIS 
composite scale (p=.102), the SUMD-A mental disorder subscale (p=.102) and the 
SUMD-A sumtotal scale (p=.082). 
                                                     




3.3 Hypothesis 2: Will adherence to the protocol lead to improvements in insight and 
symptoms?   
Data for the main adherence variable of interest, total entries, are presented here to 
provide an overview of the effects.   
3.3.1 Adherence Measure 1: Total Entries over 12 weeks 
All partial correlations, controlling for baseline scores, were non-significant for total 
number of entries and all insight measures. There was a trend for a significant positive 
partial correlation between total number of entries and SUMD-A sum total change 
score (r=.405, p=.085) and SUMD-A negative scale change score (r=.428, p=.067). This 
indicates that the higher the total entries, the more unawareness increased – i.e. 
awareness worsened.  This is mirrored by the a weak correlation (r>.300) between 
number of entries and CHOICE subscales indicating that the higher the number of 
entries, the CHOICE scores declined indicating a worsening of scores, however this is 
non-significant. 
TABLE 5 PARTIAL CORRELATIONS CONTROLLING FOR BASELINE SCORES BETWEEN CHANGE IN INSIGHT 
MEASURES AND TOTAL ENTRIES COMPLETED. 1INDICATES POTENTIAL TREND. 
Measure Partial correlation on change 
score 
SUMD-A: sum total r=.405, p=.0851 
SUMD-A:NS r=.428, p=.0671 
CHOICE: Severity r=.-.317, p=.1861 
CHOICE Satisfaction r=.-.347, p=.1151 
 
In addition, although all partial correlations were non-significant between total entries 
and change in symptoms or functioning, there is a notable correlation between 
number of entries and the PANSS positive scale and PANSS negative scale (r >.300); as 
entries increase, symptoms increase, (i.e. symptoms get worse) however, this is non-
significant. There is also a negative correlation between GAF and number of entries (>.-
300), indicating that as entries increased GAF score decreased meaning a worsening in 





TABLE 6 PARTIAL CORRELATIONS BETWEEN CHANGE IN SYMPTOMS/FUNCTIONING AND TOTAL ENTRIES 
COMPLETED, 1INDICATES NOTABLE TRENDS 
Measure Partial Correlation on change 
score 
PANSS: Positive Scale r=.369, p=.1201 
PANSS: Negative Scale r=.377, p=.1121 
 
In terms of the additional three adherence measures (number of entries for week 1, 
number of entries for week 12 and number of days adherent), the significant and 
nearly significant (i.e. with a significance level  <.15  and a correlation coefficient > 
.300) partial correlations are presented in table 7. All of the other correlations 
between insight and symptom variables were non-significant.  
TABLE 7 NOTABLE PARTIAL CORRELATIONS FOR ADDITIONAL MEASURES OF ADHERENCE: * STATISTICALLY 
SIGNIFICANT 
Additional Adherence Measures Partial Correlations on change 
scores 
Week 1  
SUMD-A NS r= .420, p=.073 
PANSS Total r=.417, p=.076 
PANSS PS r= .452, p=.053 
PANSS NS r=.674, p=.002* 
Week 12  
SUMD-A total r=.600, p=.007* 
SUMD-A NS r=.439, p=.060 
# of days adherent  
SUMD-A NS r=.425, p=.069 
GAF r=-.405, p=.085 
 
All of the partial correlations suggested that the higher the number of entries 
completed the greater decline or worsening of insight and symptoms. There was a 
statistically significant positive partial correlation between number of entries at week 1 
and PANSS negative subscale score, indicating that the more entries at week 1, the 
higher the symptoms. There were similar trends for the PANSS total, PANSS positive 
scale and SUMD-A negative scale; the more entries at week one the worse the 
symptoms. The number of entries at week 12 significantly positively correlated with 
SUMD-A sum total and were nearly significant with SUMD negative scale indicating 




number of days adherent was nearly significantly correlated with the SUMD-A negative 
scale indicating that as days increased, unawareness of negative symptoms increased. 
The number of days adherent shows a trend for negative correlation with the GAF 
week 12 score, indicating that as number of days increased, GAF score decreased or 
became worse. In summary, the partial correlations reveal that if there is a correlation, 
this is in the direction of the negative effect of completion rate and score at week 12; 
as the number of entries completed increases, symptoms and insight becomes worse. 
 
3.3.2 Insight in adherent and non-adherent participants 
We explored the hypothesis that those in the adherent group9 would have correlations 
suggesting a positive effect between adherence and change in insight. Baseline 
comparisons (Welch’s t-test statistic) found no significant differences between 
adherent (n=14) and non-adherent (n=6) groups on baseline symptom (PANSS PS: 
p=.732, PANSS NS: p=1.000, PANSS GS: p=.562, PANSS total: p=.664, GAF: p=.805) and 
baseline insight variable scores (BCIS composite: p=.728, SUMD sumtotal: p=.412, 
CHOICE satisfaction: p=.264, CHOICE severity: p=.473).  
Adherent group 
In terms of the adherent group there was a significant positive partial correlation 
between number of entries at week 12 and change in SUMD-A sum total (r=.565, 
p=.044) and a nearly significant positive partial correlation between number of entries 
at week 12 and change in SUMD-A PS (r=.485, p=.093). This indicates that as entries 
increased, lack of insight also increased (i.e. awareness worsened). There was also a 
nearly significant correlation between the BCIS self-reflexivity scale and the number of 
days adherent (r=.485, p=.093). This indicates that as adherence increased, one 
variable of insight, self-reflexivity increased (i.e. self-reflexivity improved). There were 
no other significant correlations for the adherent group. 
 
 
                                                     




Non-adherent group  
For the non-adherent group there was a significant partial correlation between week 1 
entries and change in BCIS self-reflexivity subscale (r=.941, p=.017) indicating that at 
this early time point, as adherence increased, insight increased (i.e. improved). There 
was a nearly significant negative correlation between number of days adherent and 
change in the BCIS self-reflexivity scale (r=-.834, p=.079) indicating that as adherence 
increased insight decreased (i.e. worsened) at this later time point. There was one 
nearly significant correlation between week 1 entries and change in PANSS PS (r=.851, 
p=.068) and a significant correlation between week 1 entries and change in PANSS ns 
scales (r=.894, p=.041) indicating that as entries increased symptoms worsened. 
 
FIGURE 2 CHANGE IN SCORES ON THE SUMD-A TOTAL CHANGE, PANSS PS CHANGE AND PANSS TOTAL 
CHANGE FOR THE THREE ADHERENCE GROUPS. NEGATIVE CHANGE SCORE INDICATES THAT THE OUTCOME 
SCORE IS LOWER (BETTER) THAN THE BASELINE SCORE 
When the 20 experimental group participants are grouped into three categories based 
on levels of adherence (low n=6, mid n=9, high n=5) visual inspection of the change 
scores suggests that the mid and low adherence groups have the highest levels of 
insight at week 12, and better symptoms scores at week 12 (see figure 2). This fits with 
other analyses reported above; low adherence groups have higher insight and fewer 
symptoms compared to the high adherence group. However, statistical testing found 
no statistically significant differences between the three groups. Overall this could 



































whereas those who benefit from improved insight at week 1 no longer make use of the 
app. 
 
3.4 Hypothesis 3: Will improved insight lead to change in symptoms and 
Functioning? 
A secondary analysis was conducted to examine any differences between the 
experimental and TAU groups in symptoms and functioning at week 12.   
3.4.1 Symptoms: PANSS subscales 
An ANCOVA controlling for baseline scores revealed no significant differences between 
groups on the PANSS total score (F(1,37)=1.382, p=.247), the PANSS negative symptom 
scale (F(1,37)=.169, p=.660) and the PANSS general symptom scale (F(1,37)=.491, 
p=.488) at week 12. However, there was a significant difference between groups at 
week 12 on the PANSS positive subscale (F (1,37)=4.406, p=.043) whereby the 
experimental group had improved symptoms (means: experimental 15.4, control 17). 
  
FIGURE 3 MEAN SCORES AND STANDARD ERRORS AT BASELINE AND WEEK 12 ON THE PANSS POSITIVE 
SYMPTOM SUBSCALE 
3.4.2 Global Assessment of functioning (GAF) 
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3.4.3 Partial Correlations between change in insight and symptoms 
There was no evidence that improvement in insight leads to improved PANSS positive 
symptoms (i.e. less delusions and hallucinations). The partial correlation between 
SUMD-A sum total change score and PANSS PS change score was non-significant (r= 
.289, p=.230), controlling for baseline PANSS positive symptoms. The partial 
correlation between BCIS composite change and PANSS PS change scores was also 
non-significant (r=.326, p=.173), however this is suggestive of a weak correlation 
whereby as BCIS insight improves PANSS PS symptoms become worse.  
To examine the hypothesis that improved insight may lead to increased symptoms of 
depression as measured by general item 6 on the PANSS, there were no significant 
partial correlations between change in SUMD-A sum total insight and change in PANSS 
G6 score (r=.132, p=.589) (controlling for baseline PANSS G6 score). There was no 
partial correlation between BCIS change in composite score and change in depression 
score (r=.380, p=.109) (controlling for baseline PANSS G6 score), however there is a 
weak correlation indicating that as insight improves depression scores become worse. 
In summary the quantitative results find minimal statistically significant effects in 
support of the hypothesis that taking part in monitoring via ClinTouch will benefit 
insight. However, the statistically significant ANCOVA (PANSS PS scores improved for 
the experimental group), and the trends for confidence intervals are skewed in the 
hypothesized direction of improved insight for the experimental group (SUMD total, 
MD index, and BCIS composite score). The analysis of adherence provides some 
interesting insight into how participants used the app. The correlational data suggests 
that those who use the app the most have an increase in PANSS PS and NS symptoms 
during the first week and at the end of 12 weeks. Higher total entries, greater number 
of days adherent, and higher number of week 12 entries are related to worse 
awareness of mental disorder as rated by the SUMD-A. Those who use the app 
regularly may decline in levels of insight and experience worse symptoms. There was 
one correlation that indicated a positive effect on insight; as adherence increased self-





3.5 Qualitative Analysis 
The below is a summary of the findings from the interview data. The complete 
iterative categorization process including the coding and theme identification for each 
question can be found in Appendix 8.  
3.5.1 Analysis of Clinical insight 
In order to examine clinical insight at week 12, the questions 1.1 ‘Do you believe you 
have a mental health problem?’ and sub question ‘What is your main problem or 
difficulty at the moment?’ were analysed. The majority of participants confirmed that 
they had a mental health disorder and that this was called either schizophrenia or 
psychosis (N=9). For example Participant 2 said ‘Yes, at the moment it is fairly stable, I 
think it is psychosis because of the things that I experience’. Of these participants, most 
identified a combination of symptoms including paranoia, hearing voices, stress and 
depression. Some participants (N=4) reported that currently their main difficulty was 
not necessarily related to schizophrenia or psychosis. For example Participant 3 
reported ‘I don’t suffer from a mental health difficulty, just trauma from my life just all 
came on top of me’ and Participant 5 ‘When I have a lot of stress I end up making 
things up as I go along, overwhelming feelings that I want to be special’ 
Participants 4, 8, and 10 identified that their way of thinking was different from others, 
for example Participant 8: ‘My thinking is not quite right, not the same as other people’ 
Finally, two participants reported that they felt they did not have a mental health 
difficulty and instead reported that they thought they were addicted to medication or 
that they had no difficulty at all, for example, Participant 12: ‘I don’t really know 100%, 
I am addicted to medication so I need to keep taking it’. Overall the majority (n=9) of 
participants indicated that they believed they had a mental health problem related to 
psychosis or schizophrenia. This corresponds to question 1 of the clinician rated 
SUMD-A questionnaire that rated the majority of individuals (10 out of the N=15 
interviewed) as having awareness of mental health disorder. This indicates that the 
interview and questionnaire data are complementary and that the majority of 




expand on the quantitative findings by providing a broader and more diverse narrative 
of service users understanding and experience. For example, not only do many service 
users understand that they have a mental health disorder but different service users 
attributed this to common (e.g. hearing voices) and uncommon (e.g. thinking 
differently) symptoms.  
 3.5.2 Analysis of Cognitive Insight 
In order examine cognitive insight at week 12, participants were asked 2.1 ‘After 
monitoring your mood, symptoms and behaviour do you have any alternative 
understanding of your unusual experiences (or negative symptoms, or social 
withdrawal or paranoia (when applicable)’ plus the sub-question ‘After self-monitoring 
with the app are you aware of any errors in your thinking or interpretation of 
experiences?’ 
In response to this question several participants made statements and responses that 
indicated an alternative or emerging new understanding of their experiences.  
Correspondingly the responses were categorized into two themes; 1) developed a new 
understanding of self or experiences and 2) an emerging understanding.  
In terms of developed a new understanding of self or experiences, three subthemes 
could be identified. First, three participants, 4,7 and 8 reported that they had a clearer 
understanding that their experiences were in their ‘mind and not in reality’, for 
example participant 8 reported ‘I just realized that it was my imagination, sometimes I 
would see like a ghost’ or participant 4 ‘When it mentioned voices I would click about a 
2 meaning not at all but when it was thoughts I would click higher, so I would start to 
distinguish it in a way‘. Second, participants 3 and 6 reported a ‘new understanding of 
their symptoms’. They understood that it was part of a mental health disorder. For 
example Participant 3 ‘The app helped to understand that paranoia was a symptom 
and it is something you are going through and not reality’ or Participant 6 ‘Previously I 
was getting into problems with people and thinking that they were going to harm me, 
this was the symptoms of psychosis, I understand this better now, as I got the phone I 




1 reported a new ‘understanding of their experiences in everyday life’, Participant 13 
‘When it asked, how do you see yourself compared to the average person, I felt normal’ 
and Participant 1 ‘It helped me to understand that these experiences in the past 
weren’t real’. 
Aside from developing a new or alternative understanding several participants 
reported what could be considered an emerging understanding. For example, 
increased noticing of connections between how they were feeling, what they were 
doing and their symptoms. For example, participant 12 noted ‘it was an unusual 
experience every time there was a new feeling and emotions, I try to understand it and 
figure it out’ or Participant 11 ‘At the moment I think that if I get too stressed then I 
start to get more symptoms of my mental health condition’. Although these reports did 
not necessarily indicate a new or different understanding of experiences it suggests 
that participants were questioning and developing an emerging alternative 
understanding.  For example, participant 2 reported ‘Does that mean that I don’t have 
psychosis, if I don’t experience one of the main symptoms? Or maybe it is a good sign 
that this is recovery’ and Participant 15 ‘When I was paranoid at work I just believed 
them to be true, but I wasn’t 100% sure, after speaking to care coordinator she 
explained that I don’t have any evidence to back up these thoughts, so then I decided 
that they probably weren’t true’. 
 
Finally, some participants found that self-monitoring did not lead to any additional 
knowledge or understanding of patterns in their experiences. Two participants, 7 and 
2, reported increased confusion, for example Participant 2 ‘I wouldn’t say so, more 
confusion about symptoms, questioning if I have psychoses’ and Participant 7 ‘I didn’t 
have an understanding and I don’t know why, At first I thought it was just part of the 
anxiety, but the voices have to do with psychosis as well, it was confusing at first’. 
Other participants noted that the app did not help them learn anything new or to 
notice patterns, for example, Participant 11 ‘I wouldn’t say so, I did glance at the charts 
once, my symptoms did seem to be going up and down but most of the time I wasn’t 




3.5.3 Analysis of self-monitoring/metacognitive regulation 
In order to examine the relationship between adherence to the self-monitoring 
protocol and insight the following interview question was analysed; (1) Question 3.1 ‘Is 
it important/helpful to self-monitor? For example, to keep track of specific patterns or 
connections between mood, behaviour and symptoms?’ The majority of participants 
identified that self-monitoring with the mobile app was helpful (n=13) and their 
responses indicated four themes that qualified the importance or helpfulness of the 
app. Firstly, the app allowed ‘time for reflection’. The majority of participants (n=13) 
recognised the positive experience of reflecting on their thoughts and experiences. 
This took the form of three subthemes or approaches including: 
 Five participants reported ‘Questioning and speaking to themselves’: for 
example, participant 14 reported ‘A lot of people don’t do that, a lot of people 
are too busy, they ask other people, but don’t think to themselves how am I 
doing, made me consider my own feelings instead of everyone else’s, noticed 
that I was feeling quite good the majority of the time’ and Participant 5 ‘Ask 
myself how I feel once in a while’ 
 Four participants reported that they began to notice ‘changes from day to day’, 
for example participant 13 ‘Yes, you could see from day to day how things were 
going and how things were changing’ and participant 15 ‘It helped me see that 
things aren’t always good, notice more the changes that I experience more in 
my thoughts, see that sometimes I am more paranoid and sometimes more 
optimistic’ 
Four participants reported that reflection and thinking led to ‘new learning or 
understanding’ about their feelings, thoughts or experiences, for example participant 
11 ‘Understanding how I am feeling, and acknowledging how I am feeling at the time, 
good or bad and let me think about it more’ and participant 10 ‘Step back and see life 
and notice that I was keeping track of my thoughts and mood’. 
Secondly, four participants reported a realization about themselves in terms of either 
understanding their symptoms or noticing recovery. For example, participant 13 




when I was and sometimes when I wasn’t, I wasn’t as worried as I thought I would be’. 
Thirdly three participants reported that after monitoring they would like to ‘do 
something’ differently. For example, participant 4 reported that they are ‘Trying to do 
more activities to do, but until I find something with a purpose it is hard to be happy’. 
Others were less specific about what they might do, but felt that they should do 
something, for example, participant 11 reported ‘[what] can I do to make me feel a bit 
better, because I am feeling a bit down’.  Fourthly one participant found that the app 
was helpful in terms of its ease of use and accessibility because of the personalized 
questions. For example, participant 1 said: ‘do I trust other people? [those questions] 
were right on point, good questions to be answered by me, felt good because they were 
about me’ 
 
Some participants also reported some uncertainty about the helpfulness of self-
monitoring (n=7). Two participants reported that they found it difficult to integrate 
into everyday life for reasons such as it didn’t always work, didn’t have the time, and 
would need a little more practice to fully integrate it, for example participant 2 said  
‘Sort of helpful, it was slightly irritating, didn’t always work’ and Participant 3 said 
‘Hard to adapt something new into your life, was good when I had it just didn’t always 
have time’. Two participants said that they did not necessarily learn anything new 
about themselves for example, participant 15 said ‘Not sure if the app helped notice 
the connection between work and paranoia’. 
Finally, four participants reported that self-monitoring with the app had a negative 
impact on mood.  Three participants identified that answering the questions 
sometimes made them feel upset, stressed or reminded them of their difficulties. For 
example, participant 6 said ‘Started to get a bit stressed out with the phone, asking me 
silly questions, asking about killing myself’ and participant 8 ‘It started making me feel 
like it was starting to pull me down, sometimes Id think what strategy goals could I do 





In summary, the qualitative interviews not only complemented the questionnaire data, 
for example, the majority of participants demonstrating clinical insight (n=9) in their 
narratives in line with the questionnaires (awareness of a mental disorder) but it also 
added to and expanded on the findings.  Analysis of the interview responses revealed 
that all 15 participants demonstrated some level of cognitive insight in the form of 
either a new understanding or emerging understanding of experiences.  Finally, the 
majority of participants (n=13) identified that self-monitoring was helpful for reflecting 




















In order to examine the hypothesis that intensive self-monitoring, using the ClinTouch 
mobile app, would prompt metacognitive regulation and lead to increased insight, a 
mixed methods design was used.  The quantitative questionnaire data provided limited 
statistically significant evidence for improved insight on the questionnaire variables; 
however, there were trends for significance on the SUMD-A total, MD index and BCIS 
composite variables and statistical significance on the PANSS positive subscale 
indicating that the experimental group had improved scores at week 12. The 
qualitative data expands on the quantitative data by revealing themes and narratives 
of insight, such as new and emerging understanding of experiences, which are not 
captured by the questionnaire data.  Notably when adherence to the intensive, 
prolonged app protocol is examined important negative effects are revealed; those 
who use the app regularly and for the longest appear to experience a worsening of 
insight and symptoms. This is the opposite of the predicted ‘digital placebo effect’; 
people may indirectly experience deterioration in symptoms.  Interestingly, as a whole, 
the group (across all adherence levels) shows trends for improvement in insight, 
potentially indicating that some people may experience a benefit in insight early and 
use the app less or stopping using it when they no longer find the app helpful or useful. 
There was a weak correlation indicating that as insight increased, positive and 
depressive symptoms increased. As people developed insight or awareness of 
symptoms they may have found it distressing or unhelpful to continue to monitor. 
4.2 Does Self-monitoring produce significant effects?  
Previous researchers have suggested a ‘digital placebo effect’ whereby mobile apps 
have the potential to indirectly improve symptoms in individuals with schizophrenia 
(Torous & Firth, 2016). Here we present one of the first examinations into the indirect 





TABLE 8 PRELIMINARY POSITIVE AND NEGATIVE EFFECTS OF SELF-MONITORING 
Support for positive effects of self-monitoring 
 PANSS Positive symptom subscale significantly improved in the experimental 
group (p=.043) 
 Trends for significant improvement in the experimental group for: 
o SUMD-A total (p=.082) 
o MD index (p=.102) 
o BCIS composite scores (p=.102) 
 Positive partial correlation for adherent group: # of days adherent and 
improved self-reflexivity (BCIS) (p=.093), for non-adherent group positive partial 
correlation for week 1 entries and improved self-reflexivity (BCIS) (p=.017) 
 The majority of participants (n=13) reported a positive experience of self-
monitoring in interviews 
 Support for negative effects of self-monitoring 
 As total entries increase, there is an increase in unawareness (i.e worsening) 
(SUMD-A total p=.085, and SUMD-A NS, p=.067), higher week 12 entries 
corresponds to higher unawareness (p=.007) 
 Higher week 1 entries corresponds to higher symptoms (PANSS PS p=.053, NS 
p=.002), higher total entries corresponds to higher PANSS symptoms (PS p=.120, 
NS p=.112), and decrease in functioning (GAF p=.151)  
 Weak partial correlations: as insight increases (BCIS composite scale), positive 
PANSS symptoms worsen (p=.173) and depression symptoms worsen (p=.109) 
 
This study finds preliminary support for and against self-monitoring.  Trends in the 
data suggest that insight may improve in the experimental group, however, this finding 
is not necessarily supported by the analysis of intensive, prolonged adherence to the 
protocol. Initially, high adherence at week 1 corresponds to an increase in PANSS 
symptoms, subsequently, at week 12, participants who adhere to the protocol the 
longest, experience less awareness. Overall, higher total entries correspond with 
increased unawareness, and decreased symptoms and functioning. There could be 
several reasons why there were limited significant or positive effects of self-monitoring 
on insight measures. The following will be discussed below: difficulty in measuring 
metacognitive change, negative effects of self-monitoring and lack of evidence for 






Above and beyond Metacognitive questionnaires 
Metacognitive change may be difficult to detect because of the variability across the 
sample. There is substantial quantitative and qualitative variability in the insight 
profiles of participants (see Appendix 8 Section 8.2 Qualitative results).  Some 
participants show improved insight in some measures and decline in insight on other 
measures and vice versa. The variability in insight could be explained by variability in 
the measures. The field is often criticized for not having a clear definition of insight, 
and many scales have been developed that attempt to capture disparate processes 
considered to be insight (Mintz et al., 2003). These questionnaires may measure 
different dimensions of insight that may change at different rates.  For example, 
clinical insight may improve for some participants whereas cognitive insight has not 
yet developed to the same degree. Additionally insight tends to be examined through 
a medicalized lens, for example, the SUMD-A suggests that only those who 
acknowledge that they have a ‘mental disorder’ or ‘illness’, would be considered to 
have insight. From a psychological and service user perspective this is a limited model 
of insight. Individuals may not necessarily agree that they have mental disorder, but 
may acknowledge that trauma and stress contribute to their unusual experiences; 
equally this is insight into their thoughts and experiences. Recently Connell et al., 
(2015) found that from interviews of people with FEP, recovery meant developing an 
understanding of their experience in a way that allowed for growth and reconnection 
with familiar social roles. For some individuals it may be more helpful to think of their 
symptoms as a period of difficulty instead of a mental illness.  
 
The qualitative interviews in this study provided valuable data on insight that expand 
on the questionnaire data.  Codes from the qualitative interview data and quantitative 
scores on questionnaires are presented in Table 9. The data is presented for 
participants that were the two highest and lowest adherers to the app protocol to 






TABLE 9 VARIABILITY IN INSIGHT MEASURES AND QUALITATIVE REPORT. FOR THE COLUMNS LABELLED 
QUAL 1-3 IT IS INDICATED IF PARTICIPANTS DISCUSS NARRATIVES RELATED TO CLINICAL INSIGHT, COGNITIVE 
INSIGHT OR THE HELPFULNESS OF SELF-MONITORING. THE SCORES OF QUESTION ONE OF THE SUMD-A 
(1=AWARE, 2=SLIGHTLY AWARE/UNAWARE), % OF THE PROTOCOL COMPLETED, BCIS COMPOSITE SCORE 
AT WEEK 12 AND CHANGE IN BCIS COMPOSITE SCORE (POSITIVE INDICATES HIGHER/IMPROVED SCORE AT 
WEEK 12) ARE PRESENTED AS THE QUANTITATIVE DATA. 
































Yes 2.00  3.86 6.00 -5 
9.00 Yes Emerging No 2.00 96.4 8.00 +1 
13.00 Yes Developed Yes 2.00 96.4 7.00 +3 
 
As evident from Table 9 participants vary in terms of narratives indicative of clinical 
insight, cognitive insight and the helpfulness of self-monitoring.  An example of 
‘emerging’ cognitive insight is found from participant 2: ‘Does that mean that I don’t 
have psychosis, if I don’t experience one of the main symptoms? Or maybe it is a good 
sign that this is recovery’ And participant 9: ‘It’s just like a constant cycle, don’t know 
when that cycle is going to end, just taking it one day at a time’ An example of having 
‘developed’ a new understanding is found in participant 13: ‘but the question about 
hearing voices and trusting other people, I noticed I did trust other people, I hadn’t 
really given it too much thought before, after doing the study did feel like could trust 
people more’.  Overall even though there is variability in the quantitative questionnaire 
data, for example, improvement and decline in the BCIS score at week 12, the change 
in BCIS score, and the score on the SUMD-A question 1, all of the participants reported 




provided valuable additional data on participants’ experiences and the nature of 
insight. In the future it could be helpful to develop a quantitative questionnaire that 
rates participants on some of the themes related to insight that emerged from 
participants’ narratives in this study. For example a measure that rates, not only 
participants developed insight (e.g. aware), but also narratives of emerging insight 
such as ‘noticing connections between symptoms and mood’, ‘noticing patterns in 
symptoms’ and beginning to ‘question experiences’  (see Appendix 8 for more 
potential themes and questions) could helpfully capture the variation and change in 
insight.  
 
Negative effect of monitoring: increase in self-focus 
The interview data also provided information on the potential unhelpfulness of self-
monitoring. It should be noted that along with positive experiences such as noticing 
connections between symptoms and striving to improve their mood, many participants 
identified some unhelpful aspects to self-monitoring using the ClinTouch app. Themes 
that emerged included confusion arising from monitoring, difficulty integrating the app 
into everyday life, and a negative impact on mood (see appendix 8 for descriptive 
quotes). This is important to consider when designing future interventions; not all 
participants may find intensive, prolonged self-monitoring helpful, particularly in the 
short term. Participants reported that at times they found the app upsetting, 
particularly when they were asked about suicide or self-harm. This mirrors the weak 
correlational result whereby improved insight related to worse depression symptoms. 
A recent systematic review of smartphone interventions for schizophrenia found that 
none of the studies reported negative effects of the interventions, however, 
Ainsworth, Palmier-Claus, Machin, et al., (2013) found that one participant reported 
that her ruminative symptoms increased while using a mobile text intervention. Ben-
Zeev, Kaiser, & Krzos, (2014) found that the less participants used a mobile 
intervention for psychosis (FOCUS), the greater improvement in their symptoms of 
depression. Wykes & Brown, (2016) proposed that self-monitoring interventions 




experience increased self-focus and an unhelpful shift away from thinking of 
interactions with others and larger engagement with the world.  
 
Lack of evidence for efficacy of smartphone interventions 
Currently there is a lack of evidence for the efficacy of smartphone interventions for 
improving symptoms and functioning (Firth & Torous, 2015). A recent systematic 
review found five research studies examining the feasibility of smartphone apps for 
improving care for people with schizophrenia. Only one trial, Ben Zeev et al (2014), 
found preliminary efficacy for a mobile intervention, in terms of reductions of positive 
and negative symptoms and depression after participants used a mobile self-
management intervention for managing medication, mood and social engagement for 
one month. None of the other smartphone apps identified in the above review 
specifically examined efficacy (Firth & Torous, 2015).  This is an important area that 
requires further examination. 
 
4.3 For whom is self-monitoring useful? 
Wykes and Brown (2016) argue that intensive self-monitoring is only useful if it leads 
to improved understanding of the connections between thoughts, feelings and 
behaviours and/or promotes behaviour change. It could be that intensive self-
monitoring is an effective and appropriate tool for some groups of participants and not 
for others. Interestingly in the current study, participants seemed to self-select into 
three groups; highly adherent, mid-range adherent and low adherent. The 
characteristics of the highly adherent participants indicate that those who adhered to 
the protocol for the duration of the 12 weeks may have experienced worse symptoms 
and insight. However, because there was an overall improvement in positive 
symptoms and trends for improved insight in the experimental group, across the 
different levels of adherence, it could be that monitoring had some positive effect on 
insight with some participants starting to notice their symptoms but perhaps needing a 
longer period of monitoring before insight could improve. Other participants may have 
gained some insight after a short period of self-monitoring, noticed their symptoms 





TABLE 10 CHARACTERISTICS OF ADHERENT AND NON-ADHERENT PARTICIPANTS 
Support for different service user profiles and use of the app 
Intensive, prolonged use by service users 
 Higher adherence at week 12 is correlated with worsening of insight 
 Number of days adherent correlates with worsening of SUMD-A for negative 
symptoms 
 Specific to Adherent group: as week 12 entries increased, unawareness 
scores increased (SUMD total and PS), however, insight was improving: BCIS 
self-reflexivity increased with number of days adherent 
Limited use by service users 
 Higher GAF (higher functioning) correlated with less number of days 
adherent 
 Specific to non-adherent group: Higher week 1 entries and higher PANSS 
score; insight improved early: higher week 1 entries correlated with higher 
BCIS self-reflexivity (improved) 
 
Those who stop using the app early may experience an initial increase in symptoms as 
indicated by the correlation between higher symptoms and higher week one entries 
for non-adherent participants.  It is also indicated that the non-adherent group may 
gain insight early, for example the correlation between high week 1 entries and higher 
BCIS self-reflexivity. Those who experience an initial gain insight may experience a 
worsening of symptoms and then stop using the app early. The correlation between 
increased insight and worse positive and depressive symptoms also supports the 
notion that some participants may have found it unhelpful to become aware of their 
difficulties. 
A key consideration of the future of mobile self-monitoring apps will be to provide the 
service user with choice. It will be important to empower people to use the app for as 
long as they find it helpful and to be able to choose to stop when it is no longer helpful 
or has negative effects such as intensive self-focus (Wykes and Brown, 2016). On one 




an uncomfortable and time-consuming process. Self-discovery may lead to negative 
feelings at first, but it may be crucial for self-acceptance (Lysaker et al, 2005). On the 
other hand avoidance of awareness of current difficulties may be a particularly helpful 
strategy for others as it may increase rumination and self-deprecation. 
 
4.4  Exploration of the Methodology 
This study explored the use of the current methodology for detecting the indirect 
effects of self-monitoring using a mobile app on measures of insight and symptoms. 
Overall the current findings are not strong enough to suggest that further research 
using this methodology will be fruitful. Instead there are some preliminary findings 
that may inform different, but equally interesting and valuable research studies.  
1) The use of a mixed methods approach provided complementary and expansive 
findings in terms of narratives indicating the improvement of insight. Future studies 
may consider continuing to use a mixed methods approach, particularly to capture 
insight. Although the current questionnaires are valid and informative measures they 
missed some valuable narratives of insight. Alternatively, the development of a 
questionnaire that includes assessment of participants’ new insights into their 
experiences or awareness of emerging patterns may be helpful.  
2) It was evident that many participants did not adhere fully to the intensive and 
prolonged self-monitoring 12-week protocol. A briefer intervention may provide 
similar yet more cost effective results. An analysis of a dose response to treatment, for 
example, the minimum amount of adherence required for an effect, could be useful. 
3) The controlled study design comparing a ‘blended’ therapeutic approach, (i.e. an 
automated, mobile phone intervention is used alongside regular clinician support) with 
a mobile intervention without clinical support may provide interesting insights into 
factors that may influence adherence. It could be that the indirect effects of self-
monitoring may need time and additional support from clinicians in order to translate 






4.5 Strengths and Limitations 
One of the main limitations of this research project is that the experimental and TAU 
groups were treated differently. The experimental group received increased payment 
(e.g. £30 for mobile phone top-up) and this could have affected adherence. The 
experimental group also received a weekly supportive phone call from the researcher. 
This could have confounded the positive perception of the intervention for some 
participants. Additionally the ClinTouch mobile app was used in tandem with the 
CareLoop website intervention for staff. Staff may have engaged with the website 
intervention to different degrees; some not at all and some may have used the website 
to increased engagement with service users and to inform clinical practice. This may 
have impacted on service users’ use of and experience of the ClinTouch mobile app. If 
the staff were responsive to the service users entries on the ClinTouch device this 
could have positively impacted on adherence. Unfortunately an analysis of this data 
was beyond the scope of this current work, however it should be carefully examined in 
the future.   
This was an exploratory trial and not a randomized control trial, therefore although the 
majority of participants were randomized not all of the participants were. In addition, 
the exploratory trial is underpowered. This results in a less powerful design. Although 
assessments were conducted independently of the intervention, these were not blind. 
Despite these limitations, this exploratory study provides the first examination of the 
potential indirect effects of self-monitoring on insight and symptoms.  To capture the 
complexity of insight we have used three different insight measures along with 
measures of symptoms and functioning. In addition, we conducted comprehensive and 
expansive qualitative interviews that added greatly to the quantitative data.  We also 
assessed the putative effect of self-monitoring over a prolonged and intensive 12-week 
period instead of just one week or month.  Importantly we found that there may be 
some positive effects of self-monitoring in terms of trends for improved insight 




be carefully considered as the overall there was a negative effect whereby higher 
completion rate led to worse symptoms and less awareness. The ‘digital placebo 
effect’ requires significant unpicking to determine the mechanisms that may 
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1. Beck’s Cognitive Insight Scale (from Appendix A, Beck et al., 
2004) 
 
Below is a list of sentences about how people think and feel. Please read each sentence 
in the list carefully. Please circle the degree to which you agree with each statement: 
 
(1) At times, I have misunderstood other people’s attitudes towards me. 
               I----------------------------I-----------------------------I-------------------------------I   
Do not agree at all                 Agree slightly                 Agree a lot                  Agree completely 
 
 
(2) My interpretations of my experiences are definitely right. 
                I----------------------------I-----------------------------I-------------------------------I   
Do not agree at all                 Agree slightly                 Agree a lot                  Agree completely 
 
 
(3) Other people can understand the cause of my unusual experiences better than I can. 
          I----------------------------I-----------------------------I-------------------------------I   
Do not agree at all                 Agree slightly                 Agree a lot                  Agree completely 
 
 
(4) I have jumped to conclusions too fast. 
          I----------------------------I-----------------------------I-------------------------------I   
Do not agree at all                 Agree slightly                 Agree a lot                  Agree completely 
 
 
(5) Some of my experiences that have seemed very real may have been due to my imagination. 
          I----------------------------I-----------------------------I-------------------------------I   
Do not agree at all                 Agree slightly                 Agree a lot                  Agree completely 
 
 
(6) Some of the ideas I was certain were true turned out to be false. 
          I----------------------------I-----------------------------I-------------------------------I   
Do not agree at all                 Agree slightly                 Agree a lot                  Agree completely 
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(7) If something feels right, it means that it is right. 
          I----------------------------I-----------------------------I-------------------------------I   
Do not agree at all                 Agree slightly                 Agree a lot                  Agree completely 
 
 
(8) Even though I feel strongly that I am right, I could be wrong. 
          I----------------------------I-----------------------------I-------------------------------I   
Do not agree at all                 Agree slightly                 Agree a lot                  Agree completely 
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(9) I know better than anyone else what my problems are. 
          I----------------------------I-----------------------------I-------------------------------I   
Do not agree at all                 Agree slightly                 Agree a lot                  Agree completely 
 
 
(10) When people disagree with me, they are generally wrong. 
          I----------------------------I-----------------------------I-------------------------------I   
Do not agree at all                 Agree slightly                 Agree a lot                  Agree completely 
 
 
(11) I cannot trust other people’s opinion about my experiences. 
          I----------------------------I-----------------------------I-------------------------------I   
Do not agree at all                 Agree slightly                 Agree a lot                  Agree completely 
 
 
(12) If somebody points out that my beliefs are wrong, I am willing to consider it. 
          I----------------------------I-----------------------------I-------------------------------I   
Do not agree at all                 Agree slightly                 Agree a lot                  Agree completely 
 
 
(13) I can trust my own judgment at all times. 
          I----------------------------I-----------------------------I-------------------------------I   
Do not agree at all                 Agree slightly                 Agree a lot                  Agree completely 
 
 
(14) There is often more than one possible explanation for why people act the way they do. 
          I----------------------------I-----------------------------I-------------------------------I   
Do not agree at all                 Agree slightly                 Agree a lot                  Agree completely 
 
 
(15) My unusual experiences may be due to my being extremely upset or stressed. 
          I----------------------------I-----------------------------I-------------------------------I   
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The questionnaire is made up of 20 statements. You can either fill it in on your own, or 
we can go through it together. It should take 8- 10 minutes to complete. 
 
 
For each statement, please begin by reading it carefully. You will then be asked to 
answer the same 2 questions about each statement. Please put a cross on the line for 
each question to show how you have felt about it over the last week. For each 
statement the questions will be: 
 
 





yourself for this?              0     1     2     3     4     5     6     7     8     9     10 
worst                                                                                 best  
 
(b) How satisfied are 
you with this? 
 
             0     1     2     3     4     5     6     7     8     9     10 
not at all satisfied                                               very satisfied 
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1.  The ability to approach problems in a variety of ways    
 
(a) How would you rate 
yourself for this? 
      0      1      2      3      4      5      6      7      8      9      10 
worst                                                                             best  
(b) How satisfied are you 
with this? 
      0      1      2      3      4      5      6      7      8      9      10 
not at all satisfied                                                  very satisfied  
 
2.  Self-confidence 
 
(a) How would you rate 
yourself for this? 
      0      1      2      3      4      5      6      7      8      9      10 
worst                                                                            best  
(b) How satisfied are you 
with this? 
      0      1      2      3      4      5      6      7      8      9      10 
not at all satisfied                                               very satisfied  
 
3.  Positive ways of relating to people 
 
(a) How would you rate 
yourself for this? 




worst                                                                            best  
(b) How satisfied are you 
with this? 
      0      1      2      3      4      5      6      7      8      9      10 
not at all satisfied                                               very satisfied  
 
4.  The effect of unpleasant experiences (e.g. beliefs, thoughts, voices, feelings) on my 
life 
 
(a) How would you rate 
yourself for this? 
      0      1      2      3      4      5      6      7      8      9      10 
worst                                                                            best  
(b) How satisfied are you 
with this? 
      0      1      2      3      4      5      6      7      8      9      10 
not at all satisfied                                               very satisfied  
 
5.  Feeling overwhelmed by negative feelings (e.g. fear, depression, anger) 
 
(a) How would you rate 
yourself for this? 
      0      1      2      3      4      5      6      7      8      9      10 
worst                                                                           best  
(b) How satisfied are you 
with this? 
      0      1      2      3      4      5      6      7      8      9      10 
not at all satisfied                                               very satisfied  
 
6.  Knowing I am not the only person who has unusual experiences   
 
(a) How would you rate 
yourself for this? 
      0      1      2      3      4      5      6      7      8      9      10 
worst                                                                            best  
(b) How satisfied are you 
with this? 
      0      1      2      3      4      5      6      7      8      9      10 
not at all satisfied                                               very satisfied  
 
7.  The ability to question the way I look at things  
 
(a) How would you rate 
yourself for this? 
      0      1      2      3      4      5      6      7      8      9      10 




(b) How satisfied are you 
with this? 
      0      1      2      3      4      5      6      7      8      9      10 
not at all satisfied                                               very satisfied  
 
8.  The ability to relax 
 
(a) How would you rate 
yourself for this? 
      0      1      2      3      4      5      6      7      8      9      10 
worst                                                                            best  
(b) How satisfied are you 
with this? 
      0      1      2      3      4      5      6      7      8      9      10 
not at all satisfied                                               very satisfied  
 
 
9.  Coping: 
(i) Ways of dealing with everyday life stresses 
 
(a) How would you rate 
yourself for this? 
      0      1      2      3      4      5      6      7      8      9      10 
worst                                                                            best  
(b) How satisfied are you 
with this? 
      0      1      2      3      4      5      6      7      8      9      10 
not at all satisfied                                               very satisfied  
 
(ii) Ways of dealing with distressing experiences (e.g. beliefs, 
thoughts, voices) 
 
(a) How would you rate 
yourself for this? 
      0      1      2      3      4      5      6      7      8      9      10 
worst                                                                            best  
(b) How satisfied are you 
with this? 
      0      1      2      3      4      5      6      7      8      9      10 
not at all satisfied                                               very satisfied  
 
(iii)    Ways of dealing with unpleasant feelings and emotions (e.g. 
depression, worry, anger) 
 
(a) How would you rate 
yourself for this? 
      0      1      2      3      4      5      6      7      8      9      10 




(b) How satisfied are you 
with this? 
      0      1      2      3      4      5      6      7      8      9      10 
not at all satisfied                                               very satisfied  
 
 (iv) Ways of dealing with a crisis 
 
(a) How would you rate 
yourself for this? 
      0      1      2      3      4      5      6      7      8      9      10 
worst                                                                            best  
(b) How satisfied are you 
with this? 
      0      1      2      3      4      5      6      7      8      9      10 
not at all satisfied                                               very satisfied  
 
(v) Ways of dealing with group situations 
 
(a) How would you rate 
yourself for this? 
      0      1      2      3      4      5      6      7      8      9      10 
worst                                                                            best  
(b) How satisfied are you 
with this? 
      0      1      2      3      4      5      6      7      8      9      10 
not at all satisfied                                               very satisfied  
 
 
10.  Feeling that there is someone who understands and listens to me 
 
(a) How would you rate 
yourself for this? 
      0      1      2      3      4      5      6      7      8      9      10 
worst                                                                           best  
(b) How satisfied are you 
with this? 
      0      1      2      3      4      5      6      7      8      9      10 
not at all satisfied                                               very satisfied  
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11.  The ability to see things from another point of view 
 
(a) How would you rate 
yourself for this? 
      0      1      2      3      4      5      6      7      8      9      10 
worst                                                                           best  
(b) How satisfied are you 
with this? 
      0      1      2      3      4      5      6      7      8      9      10 
not at all satisfied                                               very satisfied  
 
12.  Feeling safe and secure 
 
(a) How would you rate 
yourself for this? 
      0      1      2      3      4      5      6      7      8      9      10 
worst                                                                            best  
(b) How satisfied are you 
with this? 
      0      1      2      3      4      5      6      7      8      9      10 
not at all satisfied                                               very satisfied  
 
13.  Facing my own upsetting thoughts and feelings  
 
(a) How would you rate 
yourself for this? 
      0      1      2      3      4      5      6      7      8      9      10 
worst                                                                            best  
(b) How satisfied are you 
with this? 
      0      1      2      3      4      5      6      7      8      9      10 
not at all satisfied                                               very satisfied  
 
14.  Peace of Mind 
 
(a) How would you rate 
yourself for this? 
      0      1      2      3      4      5      6      7      8      9      10 
worst                                                                            best  
(b) How satisfied are you 
with this? 
      0      1      2      3      4      5      6      7      8      9      10 
not at all satisfied                                               very satisfied  
 





(a) How would you rate 
yourself for this? 
      0      1      2      3      4      5      6      7      8      9      10 
worst                                                                            best  
(b) How satisfied are you 
with this? 
      0      1      2      3      4      5      6      7      8      9      10 
not at all satisfied                                               very satisfied  
 
16.  Understanding myself and my past 
 
(a) How would you rate 
yourself for this? 
      0      1      2      3      4      5      6      7      8      9      10 
worst                                                                            best  
(b) How satisfied are you 
with this? 
      0      1      2      3      4      5      6      7      8      9      10 
not at all satisfied                                               very satisfied  
 
17.  Understanding my experiences (e.g. beliefs, thoughts, voices, and related feelings) 
 
(a) How would you rate 
yourself for this? 
      0      1      2      3      4      5      6      7      8      9      10 
worst                                                                            best  
(b) How satisfied are you 
with this? 
      0      1      2      3      4      5      6      7      8      9      10 
not at all satisfied                                               very satisfied  
 
18.  Positive ways of thinking  
 
(a) How would you rate 
yourself for this? 
      0      1      2      3      4      5      6      7      8      9      10 
worst                                                                            best  
(b) How satisfied are you 
with this? 
      0      1      2      3      4      5      6      7      8      9      10 
not at all satisfied                                               very satisfied  
 





(a) How would you rate 
yourself for this? 
      0      1      2      3      4      5      6      7      8      9      10 
worst                                                                            best  
(b) How satisfied are you 
with this? 
      0      1      2      3      4      5      6      7      8      9      10 




20.  A sense of being in control of my life 
 
(a) How would you rate 
yourself for this? 
      0      1      2      3      4      5      6      7      8      9      10 
worst                                                                             best  
(b) How satisfied are you 
with this? 
      0      1      2      3      4      5      6      7      8      9      10 
























3. CLINICIAN OR RESEARCHER RATED: The 
abbreviated version of the Scale to Assess Unawareness 
in Mental Disorder in schizophrenia 
Items (current awareness) 
 
Modalities of response 
1. Awareness of mental disorder: In the most general 
terms, does the subject believe that he or she has a mental 
disorder? 
Not applicable = 0 or missing 
Aware = 1 
Slightly aware/ unaware = 2 
Seriously unaware = 3 
 
2. Awareness of the consequences of mental disorder: 
What is the subject’s belief regarding the reason(s) he or 
she has been unemployed, evicted, hospitalized, etc.? 
Not applicable = 0 or missing 
Aware = 1 
Slightly aware/ unaware = 2 
Seriously unaware = 3 
 
3. Awareness of the effects of drugs: Does the subject 
believe that medications have diminished the severity of 
his or her symptoms? 
Not applicable = 0 or missing 
Aware = 1 
Slightly aware/ unaware = 2 
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Seriously unaware = 3 
 
4. Awareness of hallucinatory experiences: Does the 
subject believe that he or she experiences hallucinations as 
such? Rate his or her ability to interpret this experience as 
primarily hallucinatory. 
Not applicable = 0 or missing 
Aware = 1 
Slightly aware/ unaware =2 
Seriously unaware = 3 
 
5. Awareness of delusional ideas: Does the subject believe 
that he or she experiences delusions as such, that is, as 
internally produced erroneous beliefs ? Rate his or her 
awareness of the implausibility of the belief if applicable. 
Not applicable = 0 or missing 
Aware = 1 
Slightly aware/ unaware = 2 
Seriously unaware = 3 
 
6. Awareness of disorganized thoughts: Does the subject 
believe that his or her communications are disorganized? 
Not applicable = 0 or missing 
Aware = 1 
Slightly aware/ unaware = 2 
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7. Awareness of blunted affect: >Rate the subject’s 
awareness of  his or her affect as communicated by his or 
her expressions, voice, gestures, etc. Do not rate his or 
her evaluation of his or her mood. 
Not applicable = 0 or 
missing 
Aware = 1 
Slightly aware/ unaware = 
2 
Seriously unaware = 3 
 
8. Awareness of anhedonia: Is the subject aware that his 
or her behaviour reflects an apparent decrease in 
experiencing pleasure while participating in activities 
normally associated with such feelings? 
Not applicable = 0 or 
missing 
Aware = 1 
Slightly aware/ unaware = 
2 
Seriously unaware = 3 
 
9. Awareness of lack of sociality: Is the subject aware 
that he or she shows no interest in social relationships? 
Not applicable = 0 or 
missing 
Aware = 1 
Slightly aware/ unaware = 
2 













APPENDIX 2  
Participant Information Sheet 
 
The effect of self-monitoring using novel mobile experience sampling method (ESM) technology on 
metacognition in psychosis 
We would like to invite you to take part in a research study. Before you decide whether or not 
to take part, please read this information sheet. It explains what the research is about, why it is 
being done and how you could be involved. If you would like to take part or you have any 
questions about the study please contact the research team in your area using the contact 
details on the back page. You might wish to speak to someone who you trust to ask their 
opinion too.  
 
What is the study about?  
Previous research has shown that some people with severe mental health problems may not 
always be aware that they are experiencing symptoms. At times this can be a significant 
barrier to accessing helpful treatment and support. This study will discover whether 
monitoring your symptoms and mood every day has an effect on understanding your mental 
health and diagnosis. Active monitoring might help people gain more of an understanding of 
how their mood, behaviour and symptoms interact. It may also help people become aware of 
certain triggers and situations that make their symptoms better or worse.   
 
The purpose of the current study is to investigate some of the effects of active self-monitoring 
using the mobile phone ClinTouch. We will invite participants in the ClinTouch study from both 
the ClinTouch (mobile phone use) and comparison (no mobile phone use) groups. We will ask 
you to complete a few more measures to help us assess whether your understanding changes 
after you have taken part in the ClinTouch study. Those in the mobile phone use group will also 
be invited to attend a short interview about their experience. 
 
The results of this study will improve our understanding of the potential effects of using the 
ClinTouch mobile phone app on people’s understanding of the links between feelings, 
behaviours and symptoms. We hope that this mobile phone app will also help individuals gain 
a better understanding of what may help them on their recovery journey.  
 
Who is doing the research? 
This project is being carried out by the University of Manchester and the Institute of 
Psychiatry, King’s College London in collaboration with Manchester Mental Health and Social 
Care Trust and South London and Maudsley NHS Foundation Trust.  
 




You have been invited to participate in the study because you have experienced psychosis and 
are taking part in the ClinTouch study; participants of the ClinTouch group (mobile phone use) 
and comparison group (no mobile phone use) are invited to take part.  
 
Do I have to take part?  
Your participation is entirely voluntary and you do not have to take part. You are free to 
withdraw at any point without giving a reason. If you agree to participate, you will be asked to 
sign a consent form.  
 
What will happen to me if I take part? 
Consent and First Assessment session  
If you decide to take part in the study, we will ask you to meet with us. We will go through this 
information sheet with you and answer any questions you may have. We will then ask you to 
sign a consent form to show you have agreed to take part. After this we will ask you to 
complete a few questionnaires which will take about 20 minutes. 
 
Final assessment session 
If you are part of the ClinTouch group after 12 weeks of using the ClinTouch mobile phone you 
will be invited to take part in the final assessment. If you are part of the comparison group who 
did not use the ClinTouch mobile you will be invited to take part in the final assessment after 
12 weeks of receiving care from your doctor, nurse or mental health worker as usual. 
 
At the final assessment session you will be asked to complete the same questionnaires as in 
the first assessment which should take approximately 20 minutes. This session enables us to 




If you are part of the ClinTouch group, during the final assessment you may be invited to 
attend a brief interview.  During this interview we would like to better understand your 
experience of tracking your symptoms using the mobile. The length of the interview is flexible 
but is likely to be around 20 minutes long. The interview will be informal and you will be asked 
a range of questions. The interview will be audio-recorded but your real name will not be used 
in any subsequent written report or published material. The recordings and written notes 
based on these interviews will be securely stored at King’s College London. The interview 
recordings will be destroyed once they have been typed up. 
 
Will I still receive normal care? 
You will receive normal care whilst participating in this study and whilst using ClinTouch. 
 
Will I be paid?     
We will pay travel expenses to and from the research site e.g. if you attend an interview 
outside of your own home.  The payment schedule for each session of the ClinTouch study is 
outlined in the ‘Participant information sheet: ClinTouch-CareLoop version 3.1’. Participation in 
this study will mean additional shopping vouchers of £5 for your first 20 min session and £10 
for your second 20 min session for a total of £15. If you agree to do the extra interview you will 
be paid an additional £5 in vouchers. 
 
Involvement of the general practitioner (GP) and psychiatrist 
With your consent we will tell your GP and psychiatrist that you have agreed to take part in 




with healthcare staff unless you ask us to do so. The only exception to this will be if the 
researcher becomes concerned that you may be at serious risk of harming yourself or others. If 
this is the case, the researcher will raise these concerns with your health care provider. 
 
What if there is a problem? 
In the event of any question or complaint about how this study has been run, in the first 
instance please contact one of the researchers whose contact details can be found below. If 
they are unable to resolve your concern or you wish to make a complaint regarding the study, 
You can also contact the Patient advice and Liaison Services (PALS) in your area: 
Manchester PALS     London PALS 
 
PALS, MMHSCT     PALS, The Maudsley Hospital  
11th Floor, Hexagon Tower       Denmark Hill   
Crumpsall Vale      London     
Manchester. M9 8GQ              SE5 8AZ 
Tel: 0161 882 2084 Ext. 2085      Tel: 0800 731 2864  




Researcher Contact information: 
 
Dr Clare Killikelly and Professor Til 
Wykes 
Institute of Psychiatry, Psychology 
and Neuroscience 
PO BOX 78 






 Institute of Psychiatry 
Henry Wellcome Building 
King's College London 
SE5 8AF 
Tel: 020 7848 5411  
CONSENT FORM 
 
Study Title: The effect of self-monitoring using novel mobile experience sampling 
method (ESM) technology on metacognition in psychosis Version 2.0 
 
Name of principal researcher: Prof Til Wykes 
 
 
1. I confirm that I have read and understand the information sheet (dated ____v___) for 
the above study and have had the opportunity to ask questions. 
 
2.  I understand that my participation is voluntary and that I am free to withdraw at any 
time, without giving any reason and without my care being affected in any way. 
 
3. I agree to my healthcare team and GP being informed about my participation in the 
study. 
 
4. I understand that relevant sections of my medical notes and data collected during the 
study may be looked at by individuals from the University of Manchester, The 
Institute of Psychiatry at King’s College London, from regulatory authorities or from 
the applicable NHS Trust, where it is relevant to my taking part in this research. I give 
permission for these individuals to have access to my data 
 
5. I understand that when this research is completed the data and audio file will be 
retained and securely archived for a period of 10 years. This archive can only be 
accessed by request from the research team and all files will be destroyed at the end 
of that period 
 
6. I give my consent for GCP trained researchers to have access to my medical notes, 
where it is relevant to me taking part. I understand that they follow a code of ethical 
conduct and are bound by a duty of confidentiality. 




I agree to be contacted about other ethically approved studies                     Yes        No 
 
8. I agree to the use of anonymised quotations from interviews being reported in 








Please initial the box if you 






9.             I agree to take part in the qualitative interview study                                       Yes        No 
 
 





____________________ _______________ ________________ 
Name of Participant Date Signature 
 
 
__________________ ______________ ______________ 
Researcher   Date  Signature 
 















APPENDIX 3 ClinTouch Info 
 
Thank you for taking part in the ClinTouch study.  
 
Here are some basic instructions to help you get started. If you want to see 
more information about how to use ClinTouch please tap ‘instructions’ once the 
app is open or touch the ‘help’ button whilst you are using the app.  
If you experience any problems with the app or would like more information or 





Contact:  Sally Preston 





London Office  
 
Contact:  Zhimin He,  




Our offices are open between 9am and 5pm from Monday to Friday. 
ClinTouch is designed to help you keep track of symptoms from day to day and 
to discuss this information with your key worker at routine meetings. It cannot 
help you seek support if you are in an emergency situation. 
If at any point during the study you feel in crisis or suicidal please seek help 
from a friend, family member, GP, keyworker, telephone helpline or from your 
local hospital emergency department. 
Useful helpline telephone numbers 
 
Samaritans 
Tel: 08457 90 90 90 
 
Mind information line 
Tel: 0300 123 3393 
 
SANEline 
Tel: 0845 767 8000 
 
NHS Direct 
Tel: 0845 46 47 
 
Manchester Crisis Point 
Tel: 0161 839 5030 
 
South London and Maudsley  
Crisis Information Line 





1. When should I use the ClinTouch app? 
 
 You only need to use ClinTouch when you hear a set of short ‘beeps’ 
coming from the phone. We call these ‘beeps’ an alert. An alert will 
sound four times a day for the 12 weeks that you are taking part in the 
study.  
 When you hear the alert, this means it is time to answer the questions. 
 If you tap, ‘answer questions,’ the first question will appear. 
 You do not need to use ClinTouch at any other time unless you want to 
use it. 
 
2. How many alerts will I receive? 
 
 You will receive four alerts per day, every day for twelve weeks. 
 The alerts will start being delivered to your phone the day after your key 
worker meets with you to agree the settings. 
3. How many questions will I need to answer each time an alert arrives? 
 The number of questions you answer will depend on the answers that 
you give but you will never be asked to answer more than 18 questions 
during an alert.  
 It is important that you do not spend too long thinking about the answers 
you give. 
Your first instinct is usually the right answer! 
 Most people who use the ClinTouch app complete all the questions in 
less than 2 minutes.  
 
4. How do I answer and move between questions?  
 
 When you have heard the alert and tapped the ‘answer questions’ button 
some writing will appear with a coloured bar beneath it.  
 Tap the bar in the centre and slide the ball up or down to say how much 
you agree or disagree with the words above it.   
 For example, you might see the words, ‘I feel optimistic about the future’. 
If you are feeling positive about the future at that moment you should 
slide the ball towards the word ‘agree’. If you are not feeling optimistic 





 Once you have decided how much you agree or disagree with the words 
by moving the ball up or down you should tap ‘next’ to move to the next 
question.   
 You can slide the ball up and down the bar as many times as you like 
until you are happy with your answer, but we ask that you answer the 
questions as quickly as you can without thinking about them for too long. 
 You will not always see every question at every alert and the questions 
will not always come in the same order. This is because what you see 
will depend on how you have answered the previous questions.   
 Once you have completed the questions a box will pop up telling you that 
the questions are complete and the ClinTouch application will close.  
 If you have chosen to see a positive thought or picture, ClinTouch will 
show you this before closing the questions and taking you back to the 
main screen.  
 You can then re-place the phone in a safe place until you hear the next 
alert.  
 
5. What if I am finding it difficult to answer a question?  
 
 Please try to answer all of the questions. If you experience any difficult 
feelings when answering a question and would like to speak to someone 
from the study team please call us using the contact details provided.   
6. What if I am busy when I hear the alert? 
 You will be given the chance to delay the questions just once for five 
minutes. 
 You can do this by tapping the ‘snooze’ button, instead of the ‘answer 
questions’ button, when you first hear the alert.  
 The phone will then beep again after five minutes have passed.  
 If you miss the second beep you will not be able to complete the 
questions again until you hear the next beep. 
 
7. What happens if I miss an alert? 
 
 Don’t worry; just listen out for the next beep. 
 If you missed the alert because you could not hear the phone, please 
move it to somewhere you can hear it better or try pressing the top part 
of the grey volume button. This button can be found on the left-hand side 
of the handset. It is best to press this button when the next alert arrives. 
This should increase the volume. If you still cannot hear the alerts please 
contact us using the details we have provided.  
 
8. Where should I keep the phone? 
 Please try to keep your phone with you between 9am and 9pm every day 




to leave the phone out somewhere you can hear it at home. If you go out 
please make sure you take your phone with you in a zipped pocket or 
bag and make sure that you can still hear it.  
9. How often should I charge the phone? 
 Please charge the phone overnight at least three times a week, or when 
the green battery sign is running low, using the charger we have 
provided. Thanks. The more you use the phone the more charge it will 
need. 
10. Can I make or receive calls from / to the phone? 
 You cannot make or receive phone calls as there is not enough credit to 
do this.  
 
11. Can I change the appearance or settings on the phone, e.g. screen 
saver, volume or ringtones? 
 
 Please do not change any of the phone settings or download any new 
apps. The appearance and sound of the phone have been set to appear 
in a certain way and ring at the right volume. Thanks for your 
cooperation.  
12. Can I adjust the volume that the phone beeps? 
 Your keyworker will adjust the volume of the alert to your liking during the 
first appointment. Please do not change the volume settings or switch the 
sounds off.  
 
13. How do I wake the phone up when it is in the ‘locked’ mode? 
 
 Briefly press and release the grey button on the right hand side of the 
phone near the top.  
 Once the page is lit up, slide your finger across the screen in a horizontal 
direction.  
 If the phone is unlocked you will see the main screen showing the time 
and date.  
 
14. How do I switch the phone on and off? 
 
 The phone can stay switched on for the duration of the study provided 
that you charge it regularly.  
 If you would prefer to switch the phone off overnight, please press and 
hold down the grey button on the right hand side of the handset and tap 




 Press and hold down the same button to switch the phone back on 
again. You will need to press this button down for at least 3 seconds 
before the phone will switch back on again. 
 The alerts should not disturb you at night because ClinTouch does not 
beep between 9pm and 9am. If you hear any alerts after 9pm please 
check what time it says on the main phone screen and contact the 
research team. 
15. How often will I see or speak to the research team? 
 We will ring you once a week just to check whether you would like any 
support on the contact number you would prefer, but please feel free to 





















APPENDIX 4 ClinTouch Mobile phone questions 
Question set 1: 
Hopelessness 
I have felt optimistic about the future (reversed) 
I have felt that there is little point in trying 
I feel like the future holds little for me 
I feel like giving up 
 
Depression 
I have felt sad 
I have felt miserable 
I have had no interest in seeing other people 
My mood has affected my appetite or sleep 
I have felt worthless 
I have had thoughts about harming myself 
 
Hallucinations 
I have heard voices 
I have found it difficult to concentrate on other things 
This stopped me from doing things 
Hearing the voice(s) upset me 
I have seen things that other people can't see 
I have found it difficult to concentrate on other things 
This stopped me from doing things 
Seeing these things upset me 
 
Question set 2: 
Anxiety 
I have felt worried, nervous or anxious 
My heart has been racing or I have been shaking 
My anxiety has stopped me from doing things 
This has affected my appetite or sleep 
 
Grandiosity 
Compared to the average person, I am 
I have felt like I am special 
I have felt like I have powers or abilities that other people don’t have 
 
Suspiciousness 
I have worried about saying too much 
I have been suspicious 
I have felt like someone or something meant me harm 
This has stopped me from spending time with others 




I have found it difficult to concentrate on other things 
 
Delusions (if any) follow after this - up to 4 questions for each delusion 
 
Each user may have two delusion questions added to the battery, and each delusion 
has three follow-up probe questions (‘this upset me’, ‘this stopped me from doing 
things’ and ‘I have found it difficult to concentrate on other things’). The 12 delusions 
are: 
 
1. I have felt like I could read other people\'s thoughts 
2. I have felt like other people were reading my thoughts 
3. I have felt that my thoughts were being controlled or influenced 
 
4. I have felt like my thoughts were alien to me in some way 
5. I have felt like the world is not real 
6. I have felt like I am not real 
7. I have felt like people were not what they seemed 
8. I have felt like things on the TV, in books or magazines had a special meaning for 
me 
9. I have felt like there was a conspiracy against me 
10. I have been jealous 
11. I have felt like something bad was about to happen 
















APPENDIX 5 Qualitative Questions 
Metacognitive CareLoop Study Qualitative Questions: 12 week Outcome interview 
Ensure consent for audio recording:  YES                        NO 
Topic Guide covers 5 main topics. The sub-questions below the main topic questions can be 
used as a guide but should be open questions when possible 
TOPIC 1: CLINICAL INSIGHT: awareness of medical problem 
1. Do you believe you have a mental health problem? 
• What is your main problem or difficulty at the moment?  
2. Did you learn anything from monitoring your mood and symptoms over the past 3 months 
that suggests that you have a mental health problem or difficulties?   
o How does this make you feel?  
o  (if no) Does anything suggest that you do not have a mental health problem? 
   
TOPIC 2: COGNITIVE INSIGHT: awareness of thoughts and cognitions 
3. After monitoring your mood, symptoms and behaviour do you have any alternative 
understanding of your unusual experiences (or negative symptoms, or social withdrawal or 
paranoia (when applicable))  
 Does this cause you any worry or distress?  
4. After self-monitoring with the app are you aware of any errors in your thinking or 
interpretation of experiences?  
 Does this cause you any worry or distress? 
 
TOPIC 3: METACOGNITIVE REGULATION; awareness of the effect of self monitoring 
5. Is it important/helpful to self monitor? For example, to keep track of specific patterns or 
connections between mood, behaviour and symptoms?  Why or why not? will you continue to 
self monitor without the app?  
6. Can you tell me about any specific patterns in your mood or symptoms you noticed while 
using the app?   
• Any connections between how you feel and your symptoms?  
• Any connections between what you were doing and your symptoms or mood?  
• Did you notice anything about your environment that affected your mood, symptoms 
or unusual experiences? (eg time of day, specific events, places or people?)  
     
7. Are these new patterns that you had not noticed before?  (eg new triggers, effect of  new 
medication, drug/alcohol use) was there anything unexpected in your ratings?  
 (if no) Did using the app confirm what you already knew about yourself and 






TOPIC 4: Metacognitive Knowledge; awareness of own beliefs 
8. Do you believe that you are more self-aware (eg aware of your thoughts and feelings) since 
monitoring your mood, symptoms and behaviour with the app? Can you give me an example? 
Do you have a better understanding of yourself?  
9. After self monitoring with the app do you believe that you are managing and able to cope 
with your difficulties? Do you do anything differently now since using the app? 
10. Empowerment and control: since using the app have you felt more in control of your 
mental health?  Have you learned anything positive about yourself?  
 
TOPIC 5: SUPPORT  
• Tell me about the support you received from your care coordinator during the 12 
weeks ClinTouch study: 
• Did you and your care coordinator use the data from the mobile app to discuss 
your symptoms, mood or warning signs?  Would this have been helpful? Would 
you have liked more support from your care-coordinator during these 12 
weeks?  
•  Did keeping track of your symptoms alert you to times when you might be 


















APPENDIX 6 Method of Qualitative Analysis 
1) Data Coding 
Below is a sample of how the interview data was summarized and organized into 
deductive codes.  The data was entered in excel to form a framework matrix (see 
Figure 1 for an example of how the data is organized); the interview topic questions (or 
deductive codes) are entered in the columns and the rows represent the individual 
cases. The data was first coded using the deductive codes according to each of the 
structured interview questions e.g. 1.1 Do you believe you have a mental health 
problem.  
 
Figure 1  Sample from the Microsoft excel to show the organization of the Framework 
Matrix for deductive and inductive coding 
Next the data were coded across the whole data set according to inductive codes such 
as recovery, noticing patterns, understanding of self or experiences. These codes are 




Please see Neale (2016) Figures 1-7 for more examples of a sample of iterative 
categorization.  
 
2) Data Analysis: Iterative Categorization 
After the data were coded using the framework matrix, each interview topic question 
was analyzed in a separate word document. The data for each participant was 
analyzed line by line and categorized under different themes and subthemes that 
emerged from the data. For example Figure 2 displays how the responses to the 
question ‘Do you believe you have a mental health problem’ were categorized into two 
main themes; theme 1 identification of psychosis or schizophrenia, theme 2 Description 
of symptoms.  
 
Figure 2 Iterative Categorization of participants responses to question 1.1 Do you 










APPENDIX 7 Quantitative Results and Figures 
Figures depicting nonsignificant results are presented below. 
 
  
Figure 1 Means and standard errors for baseline and week 12 scores for the BCIS Composite scale 
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Figure 3 Mean baseline and outcome scores on the BCIS self-reflexivity scale 
 
Figure 4 SUMD-A index subscales for Mental Disorder (MD), Positive Symptoms (PS) and Negative 
Symptoms (NS) 
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TABLE 5 PARTIAL CORRELATIONS CONTROLLING FOR BASELINE SCORES BETWEEN CHANGE IN INSIGHT 
MEASURES AND TOTAL ENTRIES COMPLETED. 1INDICATES POTENTIAL TREND. 
Measure Partial correlation on change 
score 
BCIS: Self reflexivity r=.172, p=.482 
BCIS: Self certainty r=-.037, p=.882 
BCIS: Composite score r=.231, p=.342 
SUMD-A: sum total r=.405, p=.0851 
SUMD-A: MD r=.098, p=.691 
SUMD-A: PS r=.099, p=.687 
SUMD-A:NS r=.428, p=.0671 
CHOICE: Severity r=.-.317, p=.1861 
CHOICE Satisfaction r=.-.347, p=.1151 
 
TABLE 6 PARTIAL CORRELATIONS BETWEEN CHANGE IN SYMPTOMS/FUNCTIONING AND TOTAL ENTRIES 
COMPLETED, 1INDICATES NOTABLE TRENDS 
Measure Partial Correlation on change 
score 
PANSS: Total r=.243, p=.317 
PANSS: Positive Scale r=.369, p=.1201 
PANSS: Negative Scale r=.377, p=.1121 
PANSS: General Scale r=.056, p=.818 





















TABLE 7 NOTABLE PARTIAL CORRELATIONS FOR ADDITIONAL MEASURES OF ADHERENCE: * STATISTICALLY 
SIGNIFICANT 
Additional Adherence Measures Partial Correlations on change 
scores 
Week 1  
SUMD-A NS r= .420, p=.073 
PANSS Total r=.417, p=.076 
PANSS PS r= .452, p=.053 
PANSS NS r=.674, p=.002* 
Week 12  
SUMD-A total r=.600, p=.007* 
SUMD-A NS r=.439, p=.060 
# of days adherent  
SUMD-A NS r=.425, p=.069 



















APPENDIX 8 Qualitative Results 
Iterative Categorization of three interview topic questions 
The process of iterative categorization for the three interview topic questions is presented below. 
The main themes identified are presented in bold and the emergent subthemes are underlined.  
 
TOPIC 1 Clinical Insight 
1.1 Do you believe you have a mental health problem? 
 
Theme 1 identification of psychosis/schizophrenia 
P1 Yes, called psychosis 
P2 Yes, at the moment it is fairly stable, I think it is psychosis because of the things that I 
experience 
P5 Depression, psychosis, been diagnosed with bipolar but there are a number of things 
P6 Yes, psychosis 
P7 Yes, anxiety and psychosis 
P9 Psychosis or schizophrenia 
P11 Schizophrenia 
P13 Psychosis 
P15 paranoid thoughts and delusions, because of psychosis 
N=9 who identified psychosis  
 
Theme 2 Description of symptoms 
Paranoia 
P2 Paranoia, I notice the most, other people what they are saying, or thinking something is going to 
happen without the evidence, strange beliefs, thinking I can see things that aren’t there, having an 
extended part of me like a scorpion’s tale, thinking people can hear my thoughts, sometimes 
withdrawn, think people have things against me 
P9 Bad thoughts I get every day that people are going to come and harm me 
P15 believing that people are out to get me, believing that people can read my mind and steal my 
energy, had some paranoid thoughts last week 
 
Hearing voices/thoughts 
P1 hearing other thoughts, hearing other people’s thoughts, how I interact with people is a bit 
strange 
P11 Main difficulty at the moment is hearing voices, I’ve got used to it but it is still on going 
 
Combination of experiences 
P7 panic attacks, mood alterations, depression, hear voices, still experiencing all of them 
P5 When I have a lot of stress I end up making things up as I go along, overwhelming feelings that I 
want to be special, borderline mania 
P6 damage to the brain, get these weird feelings to the brain sometimes, I’ll be itching my brain, it 
is from when I was smoking weed, like a headache running from the back of my head 
P11 In the past Paranoia, anxiety, hallucinations, feelings that people could read my thoughts and 
people were trying to harm me 
P13 Hearing voices and paranoia 
 





Theme 3 Yes, but not necessarily psychosis 
Experiences in life  
P3 Yes, I think I believe that I was going through a period of a mental health episode, but not a 
mental health problem, things just came on top, I don’t suffer from a mental health difficulty, just 
trauma from my life just all came on top of me 
P6 main problem at the moment is not being allowed to smoke weed 
P8 Main problem is back pain 
P8 Mostly been in the past, wrong use of alcohol, being misunderstood in the past, trying to talk to 
people and trying tell them what I was going through my mind, someone was telling me the wrong 
thing, in the long run, things from the past started building up 
 
Different ways of thinking 
P8 thinking is not quite right, not the same as other people 
P4 Yes, just a bit different to the normal person, Different perception, get ideas in my head but 
someone else will deem them not true, I still believe that some of the things I went through are 
true, just going with  medication because they say it's good 
P8 Mental and physical distraction, bad pattern that set in that is not normal 
P10 Confidence, believing in myself 
P10 I think so, my way of thinking, sometimes I just shut down, I get anxious, confusion 
 
Theme 4 No identification of psychosis 
P12 I don’t really know 100%, I am addicted to medication so I need to keep taking it 
P12 The council and social services haven’t done their job to look after me, there was a time that I 
was desperate for help and ended up in hospital, had to take medication and now I am in horrible 
situation 
P14 I don’t really feel like I have a difficulty 
 
 
TOPIC 2 Cognitive Insight 
2.1 After monitoring your mood, symptoms and behaviour do you have any alternative 
understanding of your unusual experiences (or negative symptoms, or social withdrawal or 
paranoia (when applicable) 
 
Theme 1 Developed New understanding of self/experiences 
Understanding that it was in mind/not reality 
P4 That I hear thoughts instead voices, still waiting for the one year mark to make sure that it is just 
thoughts and the voices havent come back 
P4 When it mentioned voices I would click about a 2 meaning not at all but when it was thoughts I 
would click higher, so I would start to distinguish it in a way 
P4Now I know it is my thoughts 
P8 I just realized that it was my imagination sometimes I would see like a ghost 
P7 Using the phone let me know that they were not really there 
 
Understanding of symptoms as mental illness: 
P3 The app helped to understand that paranoia was a symptom and it is something you are going 
through and not reality, knew that I was going through something so I would try and understand it 
more, you can talk to yourself about it and understand it 
P6 Previously I was getting into problems with people and thinking that they were going to harm 
me, this was the symptoms of psychosis, I understand this better now, as I got the phone I 








P13 but the question about hearing voices and trusting other people, I noticied I did trust other 
people,  I hadnt really given it too much thought before, after doing the study did feel like could 
trust people more 
P1 It helped me to understand that these experiences in the past weren’t real in the past, 
P13 How do you see yourself compared to the average person, felt normal 
 
Theme 2 Emerging understanding 
 
Noticing Connections 
P12 Difficult to say, but gives me an idea that what the medication helps me with, ask why are 
these questions here 
P12 Sometimes, it was unusual experience every time there was a new feeling and emotions, try to 
understand it and figure it out 
P14 I may have been a bit happier when I was around certain people, but I was always thinking 
positively so that helped, didn’t really matter what I was doing 
P10 Monitor my thinking and feeling as the day goes on, and to help me see what are the things 
that are helping my thinking 




P15 When I was paranoid at work I just believed them to be true, but I wasn’t 100% sure, after 
speaking to care coordinator she explained that I don’t have any evidence to back up these 
thoughts, so then I decided that they probably werent true 
P2 Does that mean that I don’t have psychosis, if I don’t experience one of the main symptoms? Or 
maybe it is a good sign that this is recovery 
P4 Used to think that people choose what they wear and the colours has a special meaning and 
reading into their thoughts feelings,  used to be very focused on this, overtime using the mobile 
phone doing the questionniare and talking to Michelle, let that go, concentrating on myself more 
and what makes me happy instead of focuses on others 




P5 Helped to realize that hearing voices was happening quite frequently 
P9 The fear is still there, even though nothing bad happens 
P9 Its just like a constant cycle, don’t know when that cycle is going to end, just taking it oneday at 
a time 
P13 confirmed that I have some difficulties 
P3 No, still the same paranoia as I had before, but I identified it a bit more, I got to understand 
certain levels of paranoia, can differentiate how you feel when you use the app, the help clarified 
how you were feeling 
 
Theme 3 No understanding from using app 
 
Confusion 
P7 Not until I met the Dr yesterday, I didn’t have an understanding and I don’t know why, At first I 
thought it was just part of the anxiety, but the voices have to do with psychosis as well, it was 
confusing at first 
P2 I wouldn’t say so, more confusion about symptoms, questioning if I have psychosis 
 
No patterns 





P8 monitoring didn’t really help with this 
no new understanding of the voices or visions 
P11  I wouldn’t say so, I did glance at the charts once, my symptoms did seem to be going up and 
down but most of the time I wasn’t really monitoring the charts 
P15 after monitoring I didn’t really think about it too much, didn’t stop to think about the questions 
P6 Don’t have a different understanding, now I am fine I don’t feel that there is anyone trying to 




TOPIC 3 Self-monitoring, Metacognitive Regulation 
3.1 Is it important/helpful to self-monitor? For example, to keep track of specific patterns or 
connections between mood, behaviour and symptoms? 
 
 
Theme 1 Time for Reflection 
Questioning and asking self 
P2 but sort of having a think about the way that I felt was helpful bc it got me questioning why am I 
thinking that 
P6 It helped me to think about things, and also wonder how long am I going to have this phone 
P5 Ask myself how I feel once in a while  
P12Going through words and visually the words into your mind means that you talk about your 
problems, it means that there is a way out 
P14 A lot of people don’t do that, a lot of people are too busy, they ask other people, but don’t 
think to themselves how am I doing, made me consider my own feelings instead of everyone else’s, 
noticed that I was feeling quite good the majority of the time 
 
Changes from day to day 
P4 It made me see where I am at which part of the day, there were some days when I was happy 
P5 Helped to notice symptoms, didn’t know that anything was wrong until recently, app confirmed 
how things were changing from day to day 
P13 Yes, you could see from day to day how things were going and how things were changes 
P15 It helped me see that things aren’t always good, notice more the changes that I experience 
more in my thoughts, see that sometimes I am more paranoid and sometimes more optimistic and 
sometimes I’m not, the app highlights the fluctuations and the different ways that you think 
 
Learning and noticing 
P5 Yes, any knowledge about things help you, by paying more attention to it I got more knowledge 
about 
P10 Step back and see life and notice that I was keeping track of my thoughts and mood 
P10 Yes, it did help, you just start to notice more 
P7 Sometimes it would be helpful, sometimes feel under the weather and it would take my mind 
off of my mood at the time, I knew that I was helping someone, so I was happy to do it 
P11 Understanding how I am feeling, and acknowledging how I am feeling at the time, good or bad 
and let me think about it more 
 
 
Theme 2 Realization about self 
Understanding symptoms P4 I was more judgemental, before using the app I never thought I was a 
depressed person 
Noticing recovery P6 Phone was helping me to understand that I wasn’t having these symptoms 
anymore, I could still hear people moving around and not so nice people, sharing a bathroom again, 
was disgusting, but I was still doing ok and wasn’t hearing muffled voices or thinking people were 




P6 Phone was asking me silly questions, I realized that I wasn’t going through any of those 
questions, eg questions like do you think people are trying to harm you, helped to reflect and 
realized I wasn’t going through any of that stuff 
P13 Feeling worried nervous and anxious realizing that there were sometimes when I was and 
sometimes when I wasn’t, I wasn’t as worried as I thought I would be 
P14 Yes, it was, confirmed that I was doing well 
 
Theme 3 Do something about it 
Activities P4 There were only a few days, I would ask myself am I really that miserable? I put on a 
smile on my face but when I go home I am very down, how to you change being down?  Trying to 
do more activities to do, but until I find something with a purpose it is hard to be happy 
 
Questioning what can I do P4 Yes, today I was so moody all the time in the morning, so now trying 
to find a way to change that 
P7 Not necessarily a check in, every few days I look back on the last few days and I think about how 
things have been for my mood and what I could have done to change my mood, think about how I 
can change what I can do to avoid having a bad mood, if I feel slightly anxious before I go out then I 
wont go out, the phone helped to keep track of how anxious I was feeling 
P11 It was a new experience, it was slightly challenging, but in a good way, help me to develop and 
think, how can I do this to make me feel a bit better, because I am feeling a bit down 
 
Theme 4 Integration into life 
Personalized P1 The questions that I found helpful, do I hear voices?  do I trust other people, they 
were right on point, good questions to be answered by me, felt good because they were about me 
Easy to use P1 It wasn’t hard for me, I found it very easy, P1 It wasn’t annoying to answer the 
questions, P1 Yes, it was helpful 
 
Theme 5 uncertainty about self-monitoring with app  
P6 It was useful to a certain degree 
P12 A little 
Integrating into life 
P2 Sort of helpful, it was slightly irritating, didn’t always work,  
P3 Hard to adapt something new into your life, was good when I had it just didn’t always have time 
P3 Would want to phone a little bit more before I would be able to do it on my own, need to 
integrate it into my life a bit more, eg use a pen and paper 
No new knowledge  
P15 Not sure if the app helped notice the connection between work and paranoia 
P15 Answered the questions without giving it much thought 
P7 It wasn’t that helpful because I already knew 
Helping others  
P9 Maybe it was helpful for the researchers, maybe it helps them in someway 
 
Theme 6 Negative impact on mood 
P2 always found that putting numbers to things doesn’t always, I don’t know, annoying to put 
mood and feelings into a number, when your mood isnt great it grates 
P6 Started to get a bit stressed out with the phone, asking me silly questions, asking about killing 
myself I would answer no, but I would think what kind of questions are these, upsetting and a bit 
stressful 
P8 It started making me feel like it was starting to pull me down, sometimes Id think what strategy 
goals could I do not to worry so much, pull myself together 
P9 Don’t think that it was helpful, sometimes it reminded me that I was frightened, but then just 





Summary of Relationship between questionnaire and interview reports: Profile of Participants 
In order to better profile any putative changes in insight captured by the mixed 
methods approach, the table below summarizes both the types of responses to the 
qualitative questions from section 3.5.1 and 3.5.2 and the quantitative questionnaire 
data from the SUMD-A sum total and the BCIS composite outcome scores for each of 

























1.00 Y N Y Developed 1.00 71.7 4.00 L 
2.00 Y Emerging Sometimes N 1.00 4.16 12.00 H 
3.00 Unrelated Emerging Sometimes N 1.00 12.2 -2.00 L 
4.00 Unrelated Y Y Emerging 1.00 53.27 10.00 H 
5.00 Y Y Y Emerging 1.00 46.72 9.00 L 
6.00 Y Emerging Y N 1.00 57.73 11.00 H 
7.00 Y N Sometimes N 1.00 28.86 8.00 H 
8.00 Unrelated Y N Emerging 2.00 73.21 15.00 H 
9.00 Y Emerging N Emerging 2.00 96.4 8.00 H 
10.00 Unrelated Y Y Emerging 2.00 3.86 6.00 L 
11.00 Y Y Y Emerging 1.00 71.4 12.00 no 
change 
12.00 N Y Sometimes Emerging 1.00 37.79 -1.00 L 
13.00 Y Y Y Developed 2.00 96.4 7.00 H 
14.00 N Emerging Y Emerging 2.00 11.9 7.00 L 
15.00 Y N Sometimes Developed 1.00 17.8 12.00 H 
Table 1 Coded responses to interview questions along with Question 1 SUMD outcome score, % of 
the ClinTouch app protocol complete, BCIS composite outcome score, + or – BCIS baseline score 
 
From the above table it is evident that it is difficult to quantify the nature of clinical and cognitive 
insight using the quantitative questionnaires. In terms of the interview report, those who said ‘no’ 
to having a mental health disorder (n=2) had subsequently lower cognitive insight scores after self-
monitoring and they had an emerging level of understanding. Interestingly those who had 
‘developed’ codes in terms of a different understanding of their experiences, had worse outcome 


















































Chapter 3: Service Related Project 
 
 
Service users’ perspectives on the 
SLaM ECT service: The development of 
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Aim: Along with assessing service users’ satisfaction and acceptability of 
electroconvulsive therapy (ECT) this newly developed questionnaire includes specific 
measures of psychological factors such as control and empowerment.   
Methods:  We developed an in-depth questionnaire to collect information on service 
users’ knowledge, experience, attitude and psychological empowerment after 
receiving a course of ECT treatment.  This version of the questionnaire had 47 
questions across 4 subscales and for the first time included psychologically informed 
questions on knowledge, consent, fear and powerlessness. Patients understanding of 
side effects and overall satisfaction with ECT was also examined.  
Results: 17 service users were asked to complete the questionnaire as part of an audit 
of the SLaM NHS ECT service.  Service users piloted the questionnaire and 10 agreed to 
completed the final version of the questionnaire. Service user’s experiences are 
described in terms of four main psychological themes: understanding and knowledge, 
consent, fear, and powerlessness. Overall the majority of service users reported 
satisfaction with their experience of the ECT service (e.g. 50% of service users would 
recommend to family or friends). However, it was also found that psychological 
processes such as empowerment might be important factors that shape an individual’s 
experience and attitude towards ECT (e.g. 60% frightened or slightly frightened by the 
procedure). 
Conclusions: The evaluation and feedback from the psychologically based patient 
experience of ECT may improve shared knowledge, access and understanding of ECT as 













Chapter 3 Table of Contents 
Abstract ......................................................................................................................... 193 
1. Introduction .............................................................................................................. 196 
1.1 ECT evidence base and application ................................................................ 196 
1.1.1 Older Adults and ECT .............................................................................. 197 
1.2 Patient Experience and Satisfaction with ECT and Measuring Patient 
Experience ................................................................................................................. 199 
1.3 Psychological Factors involved in ECT ............................................................ 201 
1.4 The Service Issue: motivation for the SEP and design of the questionnaire . 203 
1.4.1 Service Need............................................................................................ 203 
1.4.2 Design of questionnaire .......................................................................... 204 
1.5 Service User Involvement ............................................................................... 205 
1.6 Aims and Objectives ............................................................................................ 206 
2. Methodology ............................................................................................................. 206 
2.1 Sample ................................................................................................................. 206 
2.2 Procedure ............................................................................................................ 207 
2.2.1 Development of the questionnaire .............................................................. 207 
2.2.2 Administration and main pilot to assess the questionnaire ......................... 208 
2.3 Measure ............................................................................................................... 208 
2.4 Ethical Approval ................................................................................................... 209 
3. Results ....................................................................................................................... 209 
3.1 Participant Information ....................................................................................... 209 
3.2 Descriptive Statistics ............................................................................................ 210 
3.3 Summary of Qualitative Feedback ...................................................................... 216 
4. Discussion .................................................................................................................. 217 
4.1 Experience of the Service: Results from the Questionnaire ............................... 217 
Themes ................................................................................................................... 217 
4.2 Service Implications and Recommendations ...................................................... 220 




4.4 Areas of future development .............................................................................. 223 
References ..................................................................................................................... 224 
APPENDIX 1 Questionnaires .......................................................................................... 230 
APPENDIX 2 Qualitative Feedback: Patient Quotations ............................................... 237 
APPENDIX 3 Ethical Approval ........................................................................................ 238 
APPENDIX 4 Draft Short Questionnaire ........................................................................ 246 
 
 
List of Tables Chapter 3 
Table 1 Demographic characteristics……………………….…..…..209 
Table 2 Subscale 1…………………………………………………….….…..210 
Table 3 subscale 2……………………………………………….….…….….212 
    Table 4 Subscale 3………………………………………….…………………214 
 Table 5 Subscale 4……………………………………………….…….……..215 
      Table 6 Summary……………………………………………………………..220 
 
 
List of Figures Chapter 3 
Figure 1 Knowledge……………………………………………………….……….211 
Figure 2 Knowledge side effects………………………………………….….212 
Figure 3 Experience of ECT……………………………………………………..214 
Figure 4 Consent………………………………………………………………….…215 














1. Introduction  
Electroconvulsive therapy is found to be one of the most effective short term 
treatments for severe depression, perhaps even more effective than pharmacotherapy 
(Tharyan & Adams, 2005; Van der Wurff, Stek, Hoogendijk, & Beekman, 2003). ECT 
may be particularly effective for people with late life depression as there is a lack of 
side effects (older adults are more prone to the side effects of anti-depressant 
medication) and no evidence of neural or physiological harm (Van der Wurff et al., 
2003). Despite strong evidence for the efficacy of ECT, it remains a contentious 
treatment option, potentially due to lack of shared knowledge among the general 
public, clinicians and service users in terms of the current treatment process and 
therapeutic effects. 
1.1 ECT evidence base and application 
ECT was first introduced as a treatment for neuropsychiatric disorders in the 1930’s. It 
involves the administration of a brief electric current to the head to artificially induce a 
tonic/clonic convulsion.  Since the 1930s the procedure of administering ECT has been 
modified to improve safety and effectiveness. Thorough research has guided the 
placement of electrodes, the dosage and type of electrical waveform used and the 
frequency of administration. Service users are now put under general anesthetic and 
are usually prescribed a course of 6-12 treatments where they receive 2 treatments a 
week (Greenhalgh, Knight, Hind, Beverley, & Walters, 2005).   
Over the last 20 years a series of robust, well designed studies have confirmed the 
efficacy and safety of ECT as a treatment for depression (Daly et al., 2001; Max Fink et 
al., 2007; McCall, 2004; Rasmussen, Knapp, et al., 2007; Rasmussen, Mueller, et al., 
2007; Scott, 1993). Several systematic reviews and meta-analysis by leading 
international collaborators have also provided strong evidence for the efficacy of ECT 
(Scott, 1993; Tharyan & Adams, 2005; The UK ECT Group, 2003). In 2003 the UK ECT 
group published a highly influential review of the efficacy and safety of ECT in the 




studies which found that real ECT (ECT with electrical current) was more effective than 
sham ECT (no electrical current applied) and 18 trials with 1144 participants found that 
ECT was significantly more effective than medication.  
In 2005 Cochrane Review published a review of ECT for schizophrenia. They reviewed 
26 studies and pooled data from 798 participants. They found that when compared 
with sham ECT or placebo, real ECT was more effective. The data also indicated lesser 
rates of relapse following real ECT and higher likelihood of being discharged from 
hospital after a course of ECT. They found some evidence to suggest that antipsychotic 
medication in combination with continuation or maintenance ECT treatment may be 
more beneficial than medication alone for people with schizophrenia. The UK NICE 
guidelines for ECT (NICE, 2009) are detailed and are based on evidence from a 2003 
(updated 2009) Cochrane review and a commissioned systematic review from the 
department of health. NICE guidelines suggest that ECT should only be used for the 
following conditions; severe depressive illness, severe mania and catatonia. Although 
there is strong evidence for the effectiveness of ECT for treatment of depression and 
schizophrenia, there may be some patient groups that benefit more than others from 
ECT treatment.  
Older Adults and ECT 
The Maudsley and Bethlem ECT services treat patients of all ages, however older 
adults are significantly represented.  For this service evaluation project more than 60% 
of the patients consenting to take part were over the age of 50. Depression is a 
common and debilitating disorder in older adults which can lead to increased disability 
and mortality (Van der Wurff et al., 2003). 12.5% of older adults suffer from a 
depressive disorder and 2% of adults age 60 and over experience major depressive 
disorder. Although life events, physical health , personality are contributors to risk 
factors for depression in the elderly biological factors are increasingly thought to be 
involved, for example, hyperactivity of the hypothalamic-pituitary-adrenocoritcal 
(HPA) system.  This may be an important biological risk factor for the etiology of 




Treatment for depression in older adults using pharmacotherapy is found to less 
effective for several reasons (1) increased physical illness and (2) increased medication 
use make older adults more likely to experience side effects of anti depressant 
medication (3) older adults with depression may have cerebral changes that may also 
mediate the effectiveness of antidepressant medication (Haines & Katona, 1992; 
Katona, 2001; Van der Wurff et al., 2003). 
Biological risk factors and intolerance to antidepressant medication may be two main 
reasons that ECT is shown to be effective particularly for older adults. A higher 
proportion of older adults receive ECT when compared with younger adults with the 
same presentation (Plakiotis, George, & OʼConnor, 2014). In 2003 Cochrane Review 
published a review of ECT for the depressed elderly (Van der Wurff et al., 2003). They 
reviewed 4 randomized control trials of the efficacy of ECT in older adults and found 
that only one study with 35 participants found that ‘real’ ECT was more effective than 
sham ECT.  They suggested that a well designed RCT study needed to be conducted. 
Subsequently several studies have reported that ECT is particularly effective in older 
adults. Mitchell & Subramaniam, (2005) reviewed treatment of young-old adults (65+ 
years old) and old-old adults (80+ years old). They found several studies confirming 
that ECT in old-old adults was an effective treatment for depression. For example 
O’Connor et al 2001 found that younger service users did not response as well to ECT 
treatment as older service users. This is also confirmed by Wilkinson, Anderson, & 
Peters, (1993) who concluded that those service users over the age of 65 benefited 
more from ECT treatment.  Tew et al., (1999) found that those under age 59 
experienced less remission rates (54%) compared to 60-74 year olds (73%). 
Over the years several studies have repeatedly confirmed the effectiveness of ECT for 
treating depression in older adults (Benbow, 1991; Cattan et al., 1990; O’Connor, 
Gardner, Eppingstall, & Tofler, 2010). However there are concerns about some of the 
side effects of ECT, particularly for older adults who have cognitive impairment 
(Dybedal, Tanum, Sundet, & Bjølseth, 2015). Post ECT side effects can include 
retrograde and anterograde amnesia and post treatment confusion (Bjølseth et al., 
2015; Kellner et al., 2010; Kessler et al., 2014).  However a meta-analysis by Semkovska 




Retrograde amnesia may be permanent for both personal events and world events, 
however there is still not a consensus in the literature (Ingram, Saling, & Schweitzer, 
2008; Kessler et al., 2014; McCall, Dunn, & Kellner, 2000; Sackeim, 2000; Semkovska & 
McLoughlin, 2013). Two recent studies have confirmed that there is no long term 
cognitive impairment post ECT (Fernie, Bennett, Currie, Perrin, & Reid, 2014; Maric et 
al., 2015). 
Although side effects of ECT are a remaining concern for some professionals, others 
suggest that the amnesia found post ECT is similar to the effects of medications and to 
cognitive difficulties commonly found in those severely depressed (Fink, 2001).  Indeed 
some professionals have expressed concern and confusion as to why ECT is not more 
widely used and is only considered a ‘last resort’ treatment (Fink, 2000). Fink even 
suggested that by not considering ECT more widely, clinicians are failing to provide a 
duty of care. To date research has focused on establishing and re-establishing the 
safety and effectiveness of ECT, however it seems that clinical effectiveness is not the 
only measure of ECTs acceptability. An area that is gaining interest is service users’ 
experience of ECT. Research into service users perspectives and experience of ECT may 
not only improve procedural aspects ECT but may also target barriers in public and 
professional opinion that prevent the wide spread acceptability of ECT as an affirmed 
alternative to medication. 
1.2 Patient Experience and Satisfaction with ECT and Measuring Patient Experience  
Despite several international reports expertly confirming the safety and efficacy of ECT 
it still remains a controversial treatment.  In the 1950’s ECT was subject to restrictions 
and even legal sanctions because of public and professional concerns over safety (Fink, 
1991; Sterling, 2000). Some professionals argue that ECT is completely safe (Fink, 
2000), while others maintain that it can cause significant and lasting brain damage 
(Sterling 2000). To date there has been no conclusive evidence that ECT increases the 
risk of mortality or that ECT can directly lead to lasting cognitive impairment (APA 
2001). However there are studies confirming anterograde memory loss (Sackeim, 
2000; Verwijk et al., 2012) and anecdotal reports of memory loss, cognitive difficulties 
after ECT treatment and overall negative experiences with ECT treatment (Ejaredar & 




In 2003 Rose et al., conducted a systematic review of service users’ experience of ECT.  
They reported on 35 articles that examined service users’ views after ECT treatment 
(26 studies by clinicians and 9 user led studies with service users collaborating with 
clinicians or independently). They sought to systematically review service users’ 
perceived benefit of ECT and side effects including memory loss. They found that 
studies that were led by clinicians as opposed to service users had higher ratings of the 
benefit of ECT. Only 20-40% of participants in patient led studies reported ECT as 
‘helpful’ whereas the Royal College of psychiatrists fact sheet says that 80% of service 
users are satisfied with ECT treatment. This could reflect how clinician based studies 
usually take place relatively soon after treatment (less instances of remission) and the 
use of less complex questionnaires. When more in depth questionnaires are used 
service users perspectives are found to be less straightforward and complex. Rose et 
al., (2003) argue that service users weigh the advantages and disadvantages of ECT 
treatment and are not necessarily for or against treatment. Previous questionnaires 
have not always provided an opportunity to capture the complexity of service users’ 
experience. 
Chakrabarti, Grover, & Rajagopal, (2010)recently conducted a systematic review of 75 
studies examining service users’ knowledge attitudes and experience of ECT. In total 
these studies report results from 6000 service users in 17 different countries. They 
collated evidence on service users’ knowledge of ECT, experience of the procedure, 
side effects and overall satisfaction with treatment. One of their main findings was 
that service users have poor knowledge of ECT, in terms of procedure, purpose and 
side effects.  Of the 13 studies assessing service users’ knowledge of ECT 0% to 59% of 
service users had some knowledge of ECT. On average 66% of service users felt that 
they had not received enough explanation of the treatment prior to receiving ECT. 
They also found that service users were not satisfied with the procedure of 
establishing consent.  In several instances service users reported perceived coercion 
for example in terms of feeling pressured into receiving ECT or not having the right to 
refuse (20%-35% of service users).  Some suggest that service users go forward with 
ECT despite reservations because they trust their clinicians, others argue that a sense 




receiving ECT have also been reported, with 47-75% of service users reporting feeling 
anxious before ECT treatment. Reports of adverse side effects suggest that memory 
impairment is the most common. 3-100% of service users report memory loss across 
the range of studies.   
Several important themes emerge from studies of patients’ perspectives of ECT 
treatment including; 1) service users feel that they have not received enough 
information about ECT in terms of side effects and risks 2) service users feel forced or 
coerced into receiving ECT 3) fear and anxiety about the process of ECT 4) memory loss 
as a distressing and common side of ECT. These 4 themes are important indicators of 
service users’ satisfaction with ECT and could be areas to improve on in the ECT clinic. 
Several questionnaires have been developed that attempt to capture these 4 themes 
and these are discussed more below. One area that is often missing for patient 
satisfaction questionnaires are specific psychological factors that impact of service-
users experience. Several authors (Ejaredar and Hagan, 2014; Chakrabarti et al., 2010) 
have noted that when patients are provided with the time and space to speak openly 
about their experience a more complex perspective of ECT is revealed. 
1.3 Psychological Factors involved in ECT  
A recent qualitative study analyzed the interviews of 9 women who had received 
treatment with ECT (Ejaredar and Hagen, 2014).  In the qualitative analysis of the 
interviews four main themes emerged including; 1) he really didn’t say much (relating 
to information about the ECT procedure) 2) Im going to be very upset with you 
(relating to feelings of pressure or coercion) 3) I was just desperate (relating to the 
vulnerability of giving informed consent when unwell) 4) it was like we were cattle 
(relating to the experience of waiting for the procedure). Overall the authors 
concluded that an in-depth qualitative analysis provided a very negative picture of 
individuals experienced with ECT treatment.  The authors attributed this negative 
experience to lack of knowledge and lack of power of service users. They suggested 
that these are important constructs that were not considered throughout the 




Some authors have argued that the negative psychological aspects of ECT outweigh 
the short term benefit of treatment (Ejaredar & Hagen, 2014; Johnstone, 1999).  Fisher 
et al., (2011) emphasizes the importance of service users having a clear understanding 
of ECT prior to treatment.  Fear before ECT treatment is linked to lack of information 
and misinformation about ECT (Fisher, Johnstone, & Williamson, 2011). Those who feel 
fearful before receiving ECT are also more likely to have a negative experience of ECT 
(Fisher, 2012).  Johnstone (1999) suggests that negative of experiences of ECT not only 
impact on the individual but also rupture trust in mental health professionals, reduce 
help seeking and impact on therapeutic relationships. 
Fisher (2012) examined the psychological aspects of the experience ECT treatment.  He 
explored the potential role for increased input and involvement from psychological 
professionals to support shared decision making and the experience of ECT.  Fisher 
reviewed previous quantitative and qualitative accounts of service users experience 
with ECT and identified several areas of psychological focus; consent, fear, 
powerlessness, memory and identity. Fisher identified that service users’ experience 
and perception of their treatment throughout the course of ECT can have a significant 
impact on their outcomes.  He recommend that psychologists had an important role in 
improving the procedures of consent, assisting in formulating a shared understanding 
of the service users experience, and empowering service user to share their opinions 
and experiences of ECT.  
There have also been qualitative and anecdotal reports of the positive effects and 
experience of ECT (Fisher et al., 2011; L. Morrison, 2009; Ng, 2009). In many accounts 
service users have highlighted clear benefits and minimal side effects. Morrison (2009) 
provides a detailed account of her experience and concludes that for her it is a 
preferred treatment option. A better understanding of the psychological factors that 
contributed positively in these cases could help guide procedure and shared 
understanding; for example services that ensure that patients are feeling comfortable 
and trust professionals with their care.  
Exploration of the psychological factors impacting upon service users’ experience of 




the acceptability of ECT and strengthen the anecdotal and qualitative evidence base 
for practice. 
1.4 The Service Issue: motivation for the SEP and design of the questionnaire 
Service Need 
At the Maudsley and Bethlem ECT clinics approximately 60% of service users are 
deemed to have capacity to give informed consent. For those deemed able to give 
consent NICE guidelines (2008) state: ‘To help in the discussion, full and appropriate 
information about ECT should be given, including information about its potential risks 
and benefits, both general and specific to the individual.’ However Rose et al (2003) 
highlighted that patient knowledge of the ECT procedure may not always be clear and 
accurate. In fact, providing this patient group with the appropriate knowledge and 
information about ECT may be particularly difficult due to the severity of depressive 
impairment prior to treatment and reports of significant memory loss during 
treatment. Therefore extra care and effort may be required to ensure that service 
users have understood and retained information about the ECT process.  We therefore 
sought to develop a questionnaire that could assess service users’ current knowledge 
of ECT and could also provide feedback for how to improve the service specifically in 
terms of providing service users with information about ECT and ensuring adequate 
knowledge sharing. Additionally as previously mentioned, a significant number of 
patients who are referred for ECT treatment are older adults. In previous surveys of 
patient experience of ECT the older adult experience has not been represented. For 
example the average age of participants in Rajagopal, Chakrabarti, & Grover, (2013) 
survey was 36 years (range 18-67), and Tang, Ungvari, & Chan, (2002) was 43.6 years 
(sd= +- 17.9). This service evaluation project sought to develop a survey that would be 
accessible and useable for older adults as well as younger. 
The aim of the current project was two fold; firstly to develop an in depth 
questionnaire to assess service users experience and knowledge of ECT and second to 
pilot the questionnaire in terms of feasibility and utility in the ECT service as a measure 
of quality of care. Evidently several previous studies have examined service users’ 
knowledge, experience and attitude towards ECT treatment. Most of these studies 




perhaps fail to capture the complexity of the decision making process and experience. 
We sought to develop a questionnaire that was more in depth and detailed as 
described below. 
Design of questionnaire 
The design of the questionnaire could have a significant impact on the type of 
response that is given and the interpretation of these responses. For example Rose et 
al., (2003) found that reports of patient satisfaction depended on how a response was 
elicited.  When designing a Patient satisfaction questionnaire Rose et al., (2003) 
reviewed and rated studies on the following characteristics; interval between 
treatment and interview, number of questions, complexity of interview, setting of 
interview and status of interviewer.  Rose et al., (2003) rated the following surveys 
highly in terms of the above criteria; Freeman & Kendell, (1980), Rogers & Pilgrim, 
(1993), United Kingdom Advocacy Network (1995). Following these criteria we 
designed our questionnaire based on an updated version of (1) Freeman and Kendall’s 
(1980) well-cited questionnaire; Rajagopal, Chakrabarti, Grover, & Khehra, (2012) and  
(2) Goodman, Krahn, & Smith, (1999) the Patient Satisfaction Survey (PSS).  Rajagopals’ 
updated 2012 questionnaire is one of the most in-depth questionnaires to explicitly 
collect information on service users’ attitude, knowledge and experience of ECT. 
Additionally the original PSS  (Goodman et al., 1999) has 44 questions across 5 
subscales for overall satisfaction with ECT, satisfaction with results of ECT, education or 
information about ECT, satisfaction with staff and ‘your feelings’. The PSS is found to 
have good reliability, high specificity and internal consistency (Rajagopol et al., 2013). 
We combined aspects of both questionnaires in order to capture satisfaction along 
with knowledge, attitude and experience of ECT.  
We developed an ECT questionnaire that has several unique features. (1) Originally the 
questionnaire was designed to be administered before and after treatment. Service 
users’ knowledge of the ECT process was to be reviewed and compared before and 
after ECT treatment and service users were to be asked to comment on their 
expectations and experience of treatment.  (2) Very few studies have used a 
qualitative interview approach (Froede & Baldwin, 1999; Koopowitz, Chur-Hansen, 




2009) and due to constraints in terms of the feasibility of conducting in depth 
interviews in the clinic environment we did not include a qualitative interview. 
However service users had the opportunity to comment openly on what they would 
improve about the service and what worked well.  (3) We also incorporated some 
specific psychologically informed questions into this adapted questionnaire. We 
incorporated specific questions from the Empowerment scale (Rogers, Chamberlin, 
Ellison, & Crean, 1997) to assess service users’ feelings of powerlessness and control 
throughout the experience.  (4) Additionally in line with Rose et al., (2003) and 
Chakrabarti et al., (2010), the questionnaire was designed and administered by a 
psychologist from outside of the ECT service. 
1.5 Service User Involvement  
The “South London and Maudsley NHS Trust. (SLaM): Patient and Public Involvement 
Policy, Guiding Principles and Resource Pack”, presents guidelines for assuring service 
user involvement including the following: 
1. To increasingly involve and consult with service users regarding the service 
provision/ care they receive.  
2. A policy to involve and consult with service users in the planning and provision of 
services within SLAM and in any proposed changes to services.  
The project has prioritized service user involvement in the following importantly ways. 
Firstly the aim of the project is to provide service users of all ages, specifically older 
adults aged 65+, with the opportunity to voice their individual experiences of the ECT 
service, so as to ensure quality and acceptability of the service. Secondly this service 
evaluation project will assess service users’ access to information and understanding of 
the information provided that explains the ECT process and experience. Thirdly 
throughout the development and assessment of the questionnaire service users were 
consulted. The questionnaire was initially piloted on two service users who gave 






1.6 Aims and Objectives  
The aim of the service evaluation project is to develop and pilot a new psychologically 
informed service user experienced questionnaire.  This questionnaire focuses 
specifically on including questions on the process of consent and knowledge of service 
users, inclusion of the older adult service user, and inclusion of psychological questions 
of control and empowerment.  
Along with developing and piloting a new service experience questionnaire, a 
secondary aim of the current service evaluation project is to review participants’ 
experiences of ECT treatment at the Maudsley and Bethlem ECT clinics. Information 
acquired from the service evaluation project will be used to further develop the ECT 
service, for example improving service users’ access to information about ECT and 
improving their experience during the treatment. Additionally a better understanding 
of ECT may lead to improved patient experience which in turn may improve shared 
knowledge, access and understanding of ECT as a therapeutic option. 
2. Methodology  
The questionnaire was designed to provide a comprehensive picture of service users’ 
experience of the ECT clinic. This questionnaire is longer and more in depth than other 
similar questionnaires, and therefore provides rich and detailed data from a smaller 
number of participants who consented to complete the questionnaire. These results 
will inform the development of a shorter user friendly questionnaire that could be 
administered to service users routinely.  
2.1 Sample 
The current sample of service users were referred to the project by psychiatrists at the 
Maudsley and Bethlem ECT clinics between May 2014 and May 2015. 17 service users 
were referred to complete the questionnaire and 10 service users subsequently agreed 
to participate and had capacity to consent to answer the questionnaires. Service users 
who were referred met the following criteria; recently completed a series of ECT 




health disorder, above age 18. The demographic details of the participating service 
users are detailed in Table 1 in section 3.2 below. Capacity to consent to treatment 
was assessed by the referring psychiatrist. For a patient who would like to participate 
in the audit but did not consent to treatment, specific capacity to participate in the 
audit was assessed separately by a team psychiatrist.  Additionally a statement was 
included on the questionnaire to clarify that participating or not participating in this 
project would not affect the service users’ treatment in any way. Within 1 week of 
completing ECT treatment service users were asked to fill out a brief questionnaire 
about their experience of the service and had the opportunity to comment openly 
about the negative and positive aspects of their experience with the service.  
2.2 Procedure  
This service evaluation project took part in two phases. The first was the development 
of the questionnaire. The second was the administration and assessment of the newly 
developed questionnaire. 
2.2.1 Development of the questionnaire 
The development of questionnaire took part in several stages. (1) The first step was to 
decide on a questionnaire and to amend the questionnaire to meet the needs of the 
service. This was done through a series of discussions with the teams’ psychiatrists, 
nurses, ward nurses and psychologists. In the initial plans for the questionnaire we had 
hoped to have two versions of the questionnaire; pre treatment questions and post 
treatment questions (see Appendix 1). However after piloting it was determined that 
many service users would be too unwell to complete the questionnaire before 
treatment. Therefore a post treatment questionnaire was developed and contained a 
wide breadth of questions. 
(2) The questionnaire was initially piloted on 2 service users. Service users provided 
verbal feedback on the length of the questionnaire, the clarity of the questions, and 
the content of the questions. All participants found the questionnaire to be acceptable 





(3) The questionnaire was piloted and assessed on 10 consenting service users in the 
main pilot described below. 
(4) After the main pilot the questionnaire was refined and shortened with the aim of 
being acceptable for use in the clinic, with the feedback from service users and the 
clinical team.  
2.2.2 Administration and main pilot to assess the questionnaire 
The questionnaire was administered to referred service users in person by the author 
or by a member of the nursing staff. If the patient had been discharged from the 
service before receiving the questionnaire a telephone interview was conducted. 
Feasibility and utility of the questionnaire was assessed by administering the 
questionnaire to 10 consenting service users.  
Data was grouped by different subscales of the questionnaire and the descriptive 
statistics were calculated using excel. These will be presented in detail in Section 3. 
When the qualitative sections of the questionnaires were filled out important themes 
are discussed in section 3.3 and full quotations are found in Appendix 2. 
2.3 Measure 
As previously mentioned the aim of this questionnaire was to obtain detailed and in 
depth information about service users experience with the intention to refine and 
shorten the questionnaire for practical and accessible use in the service. The content 
and duration of the questionnaires was decided with clinicians and with service user 
feedback. This specific measure was developed with permission based on Rajagopal et 
al’s 2013 Patient Satisfaction Survey (PSS).  We amended and built on this measure to 
include specific psychological factors as recommended by Fisher (2012).  This resulted 
in a questionnaire of with a total of 47 questions on a three point scale divided into 4 
subsections; Knowledge and information about ECT; Experience of the ECT procedure; 
the process of consent; empowerment. The questions were based on Rajagopal et 
al.,’s 2013 PSS which included questions that were specifically designed to be 




a space where participants could write additional comments. On average the 
questionnaire took approximately 20 minutes to complete.  
2.4 Ethical Approval 
Ethical approval was granted by South London and Maudsley Clinical Governance and 
Audit committee for the Mental Health of Older Adults and Dementia CAG on May 12th 
2014. For details please see Appendix 3. 
3. Results  
3.1 Participant Information 
During the period of recruitment (May 2014 until May 2015) there were 38 service 
users referred to the Bethlem and Maudsley ECT clinics. Due to the nature and severity 
of mental illness in this population only those well enough to consent to complete the 
questionnaire were referred to the project therefore resulting in a small sample size. 
Of the 38 service users treated by the ECT service 17 were referred to complete the 
questionnaire, of which 10 consented to complete the questionnaire. See Table 1 for 
the demographic and clinical profile of the service users.  The majority of the service 
users who consented to completing the questionnaire were middle age females with a 
diagnosis of psychosis or psychosis related disorder. This also reflected the gender 
statistics of referrals to the ECT service (24 females and 14 males). The average age of 
respondents was 56.9 (range: 28 to 81 years) with 60% of service users over age 50. 
The majority of those who completed the questionnaire had also had previous courses 
of ECT treatment (average 2.1 courses of ECT). This ranged from 1 previous to 4 
previous courses of ECT.  
Table 1 Demographic and Clinical Profile of the Service users 
 
Demographic and Clinical Profile of Service users                                                          (%) (N=10) 
 
Gender, Males 40 (4/10) 
Age (mean) 56.96 
Primary Diagnosis 
          Schizophrenia/ other psychotic disorders 60 (6/10) 




On average service users completed the questionnaire 18.8 days after receiving the 
last ECT treatment session. One patient completed the questionnaire 48 weeks after 
receiving the last course of ECT treatment. These assessment time frames are in line 
with those assessed by Rajagopal et al (2013). 
3.2 Descriptive Statistics 
The results are presented as tables based on frequency counts and percentage scores 
for each response option. Each of the four subscales of the questionnaire are 
presented below. 
 Table 2 Subscale 1 Knowledge and information about ECT 
Subscale 1:  Knowledge and Information about ECT 
                                                                                                                          Service users’ Response: N 
Questions: Procedure Correct Incorrect Don’t 
know 
1. During ECT, anesthetic /other medications 
are used  
9 0  1 
2. How often is ECT given per week?  10 0  0 
3. How many ECTs do most service users 
require in one course? 
4 1 5 
4. Where is the current applied? 6 1  3 
5. Who can administer ECT? 7 0 3 
6. What is ECT?  7 1 2 
7. Certain investigations are needed before 
ECT 
4 1 5 
8. How long is the current applied?  4 1 5 
9. How is ECT given? 7 0 3 
10. ECT is often used to … 7 1 2 
Questions: Side effects Correct Incorrect Don’t 
know 
11.  Use of ECT leads to temporary impairment 
of memory 
8 0 2 
12. Use of ECT leads to permanent loss of 
memory 
5 1 4 
13. ECT results in permanent damage to brain 4 0 6 
14. ECT can damage other body-parts 
permanently 
5 0 5 
15. During the ECT chances of death are very 7 1 2 
Previous treatment with ECT 
         Service users who had previously received ECT 60 (6/10) 
         Service users who had not received ECT previously 40 (4/10) 
         Average time since last ECT, days (mean) 18.8 (1 outlier) 






16. Headache is a common side effect of ECT 1 5 4 
17. Most of service users receiving ECT develop 
epilepsy later 
4 0 6 
 
In terms of knowledge and information about the procedure ECT 65% of responses 
were correct (see figure 1).  Questions 1 (During ECT, anaesthetic /other medications 
are used) and 2 (How often is ECT given per week?) had the highest number of correct 
responses, while questions 3 (How many ECTs do most service users require in one 
course?) 7 (Certain investigations are needed before ECT) and 8 (How long is the 
current applied?) had the lowest number of correct responses.  In terms of side effects 
(see figure 2), only 48.5% of responses were correct. It was found that over 50% of 
respondents replied ‘Don’t know’ to question 13 (ECT results in permanent damage to 
brain), 14 (ECT can damage other body-parts permanently) and 17 (Most of service 
users receiving ECT develop epilepsy later).  Only 1 participant correctly identified that 
headache is a common side effect of ECT.  
 
 






Figure 2 Knowledge: side effects, questions 11-17 
 
Table 3 Subscale 2 Experience of ECT 
Subscale 2: Experience of ECT 
                                                                                                                          Service users’ Response: N 





1. How helpful was ECT in your case? 6 2 2 
2. Does your experience suggest that ECT is better 
than drugs?  
6 0 4 
3. Experience of night prior to the day of ECT  5 0 5 
4. Experience of waiting for your turn for ECT  4 2 4 
5. Experience of procedure of ECT  4 1 5 
6. Experience after waking up after receiving ECT  4 5 1 
7. Experience with any long term side effects  4 1 5 
8. How do you rate our overall experience with 
ECT?  




How frightening or upsetting was ECT compared 
to what you expected?  
4 6 0 
10. How do you compare receiving ECT to visiting a 
dentist?  
2 3 5 
11. Did ECT upset you so much that you would be 
reluctant to accept it again?  
7 2 1 
12. Considering the effect of ECT, was it delayed in 
your case?  
1 3 6 
13. How was your experience with the process of 
informed consent?  
3 0 7 
14. Do you feel you received sufficient information 
regarding ECT prior to treatment?  
5 3 2 




accepting ECT?  









17. How likely are you to recommend our service to 
friends and family if they needed similar care or 





1 4   
 
For subscale 2 ‘Experience of ECT’ the ‘positive experience’ category reflects that the 
respondent answered the question to indicate that they had a positive experience of 
the service, whereas the ‘negative experience’ category indicates that the respondent 
answered the question to indicate they had a negative experience of the service. In 
terms of positive experience more than 70% of participants responded ‘No’ to the 
following; Question 11 (Did ECT upset you so much that you would be reluctant to 
accept it again?). 60% of respondents said that they were not forced into accepting 
ECT. 60% of respondents said that they found ECT to be helpful and found ECT to be 
more helpful than medication. 50% of respondents said that they were likely to 
recommend the service to friends of family if they needed similar care. In terms of 
ambivalence or negative experiences, when asked to rate their overall experience with 
ECT, 60% of respondents were undecided.  On question 9 (How frightening or 
upsetting was ECT compared to what you expected?) responses indicating very 
frightening and slightly frightening are pooled under the ‘negative experience’ 
responses to indicate that 60% of responses were in this category.  60% of respondents 
indicated that they did not know if the effect of ECT was delayed and 70% of 
respondents were undecided about the process of informed consent. 
 
The following pie chart in figure 3 summarizes the proportion of negative, positive and 






Figure 3 Experience of ECT, proportion of responses. Questions 1-15 of the experience subscale 
were included in this pie chart. 
 
Table 4 Subscale 3 The process of consent 
Subscale 3: The process of consent 
                                                                                                                          Service users’ Response: N 
Questions Yes No Don’t know 
1. Who discussed consent with you? (Dr) 7 (Nurse) 0 3 
2. Did you sign a form giving consent? 5 3 2 
3. Were you in distress when giving consent? 1 5 4 
4. Did you feel supported and listened to while 
giving consent? 
6 1 3 
5. Would you have preferred additional 
support and advice prior to giving consent? 
5 3 2 
 
In terms of the process of consent 60% of respondents said ‘yes’ to feeling supported 
and listened to while giving consent. 50% indicated that they would like additional 
support or advice prior to giving consent (question 5) however 50% of respondents 










Table 5 Subscale 4 Empowerment 
Subscale 4: Empowerment 
                                                                                                                          Service users’ Response: (N) % 
Questions Yes No Don’t know 
1. Did you experience feelings of powerlessness? 4 3 3 
2. Did you experience feelings of humiliation? 0 9 1 
3. Did you experience feelings of lack of control? 3 4 3 
4. If recommended, I would receive ECT treatment 
again 
6 1 3 
5. In the future I would prefer psychological therapy 
over ECT 
0 5 5 
6. Did you feel involved in making decisions about 
your care? 
6 3 1 
7. Were you given a choice of options other than ECT? 3 1 6 
8. Did you feel alone before during or after the ECT 
process? 
 
2 6 2 
 
In terms of experience of empowerment 40% of respondents indicated that they did 
experience feelings of powerlessness. 50% of participants responded ‘don’t know’ 
when asked if they would prefer psychological therapy over ECT.  60% of respondents 
indicated that they did not know if they were given a choice of options other than ECT. 




receive ECT again. 60% indicated that they did not feel alone during the ECT process 
and felt involved in making decisions about their care.  
 
Figure 5 Experience of Empowerment. All 8 questions were included in this pie chart, with 
questions 1,2,3, 5 and 8 reverse scored. 
 
3.3 Summary of Qualitative Feedback 
At the end of each questionnaires service users were asked to provide open feedback 
about their experience. They were asked if there was anything else they would like to 
comment on or anything specific that they found positive or negative about the 
experience. Of the 10 respondents 6 chose to write in the additional comments 
section. This indicates that the majority of service users would provide qualitative 
feedback about their experience if given the option. A full transcript of the feedback is 
presented in Appendix 2. The responses were both positive and negative for example  
‘I don’t want to have no more ECT, I want to concentrate on depot 
injection.’ 
‘Yes it was beneficial for me, got rid of my depression. I didn’t feel 
isolated anymore’ 
Responses centred around themes of (1) requesting information (2) ECT vs medication 






4. Discussion  
In summary, we developed an in-depth questionnaire to collect information on service 
users’ knowledge, experience, attitude and psychological empowerment after 
receiving a course of ECT treatment.  This version of the questionnaire had 47 
questions across 4 subscales. 10 service users consented to complete the 
questionnaire. Overall the results provide insight that will inform current practice in 
the service and will the assist with the development of a shorter, user friendly, 
psychologically informed questionnaire. 
4.1 Experience of the Service: Results from the Questionnaire 
Overall the majority of service users reported satisfaction with their experience of the 
ECT service. Two questions in particular captured patient satisfaction; from subscale 2 
question 11 ‘Did ECT upset you so much that you would be reluctant to accept it 
again?’ 70% of respondents answered no, indicating that they would receive ECT again; 
and question 17 ‘How likely are you to recommend our service to friends and family if 
they needed similar care or treatment?’ 50% of respondents said that they were likely 
to recommend the service. However for question 8: ‘How do you rate our overall 
experience with ECT?’ only 30% of respondents indicated a positive experience with 
the majority (60%) indicating ambivalence. This is in line with what Rose et al., (2003) 
report that service users’ experience of ECT is complex and is not necessarily good or 
bad.  However it also indicates that there are some improvements that could be made 
in the ‘overall’ experience of the ECT service.  
Themes 
Researchers, clinicians and service users have identified several themes that impact 
upon their experience of ECT (Chakrabart et al,. 2010; Fisher et al., 2012; Rose et al., 
2003). As reviewed above, knowledge and information about ECT, the process of 




all important factors that shape an individual’s experience and attitude towards ECT. 
The results of this questionnaire highlight some interesting findings in terms of each of 
these themes and confirm that these are important areas of consideration for the ECT 
service. 
Knowledge 
The results of this questionnaire confirm that shared knowledge and information 
about ECT is still an area that can be improved upon. Service users had better 
knowledge of procedure (65% correct) than side effects (49% correct).  In terms of 
procedure only 29% did not know the correct answer and only 6% responded 
incorrectly. In terms of side effects 41% of service users did not know the answer and 
only 10% responded incorrectly.  It seems that service users are poorly informed, 
particularly in terms of side effects. These findings are in line with previous reports. 
Rose et al., (2005) found that about 50% of service users felt they had enough 
information to make an informed decision. Misinformation and stigma around the side 
effects of ECT can have a negative effect of service user experience. Fisher et al., 
(2011) found that service users’ fear of ECT is linked to their prior, perhaps, incorrect 
knowledge of ECT.  Sharing more information about side-effects of ECT particularly in 
terms of worries about brain damage or permanent memory loss, may help to clarify 
patients concerns and resolve any unfounded fears.  
Consent 
The process of consent was overall positive. 60% of service users indicated that they 
felt supported and listened to while giving consent to treatment. 50% of service users 
also said that they had received enough information about ECT prior to giving consent. 
This in line with previous accounts, for example, Fisher et al., (2011) and Rose et al., 
(2005) found that 50% of patients felt they had received enough information prior to 
treatment. Fisher et al., (2012) suggested that rates of coercion seemed to increase 
overtime, however in this current report, when service users were asked if they felt 
forced into receiving ECT 60% indicated that they had had a positive experience and 
had not been forced or coerced. There is the potential to improve the process of 




providing additional support and advice prior to giving consent. Additionally 70% of 
service users said that they were ambivalent about the process of informed consent. 
Only one service user said that they were in distress while giving consent and the 
majority (50%) said that they were not.  
Fear 
Service users did indicate some fear or anxiety about the overall experience of ECT. 
When asked if ECT was as frightening as what they expected 60% answered that it was 
either slightly frightening or very frightening. Chakrabarti et al (2010) also reported 
that over 50% of service users experienced some fear or anxiety throughout ECT 
treatment.  30% said that it was worse than visiting a dentist and 50% rated the 
experience of waking up after ECT as negative.  However 70% said that it did not upset 
them so much that they would not accept it again. When asked to rate the procedure 
of ECT, waiting for ECT and waking up after ECT 40% reported a positive experience. 
These ratings are not dissimilar from other procedures. For example Lu et al., (2011) 
found that 69% of people in treatment for psychosis met criteria for PTSD, with many 
people reporting a frightening treatment experience that was related to feelings of 
having no control.  
Psychological factors: Empowerment 
When asked if service users experienced feelings of powerlessness 40% said yes, 30% 
said no and 30% were undecided. This powerlessness perhaps comes from feelings of 
lack of control (30%) and feelings of being alone (20%). However no service users had 
any feelings of humiliation and 60% said that they felt involved in making decisions 
about their care and confirmed that they would receive ECT again if required. Fisher et 
al., (2011) found similarly mixed results. Some participants reported feelings of 
powerlessness while others felt supported and content with the treatment procedure. 
Fisher (2012) suggests that service users may experience feelings of powerlessness at 
different times throughout the treatment process. Johnstone (1999) found that in her 
study feelings of humiliation and worthlessness during ECT were related to early life 
experiences of feeling weak and vulnerable. It is evident that service users do have 




where these come from and what could be done to reduce them. This could be an 
important role for psychological work.  
4.2 Service Implications and Recommendations 
Experience of the service: Summary  
In summary there were several indicators of positive practice in the ECT service. These 
should be highlighted and reinforced. There were a few areas of negative feedback 
that could perhaps be further explored and considered for improvement. Both the 
positive and negative feedback are outlined in the table 6 below. 
Table 6 Summary of feedback 
Theme Positive Feedback  Negative Feedback 
Overall 50% of service users would recommend to 
family or friends 
60% confirmed that they would receive ECT 
again if recommended 
60% ambivalent about the 
experience of ECT 
 
Knowledge 65% had correct knowledge about ECT 
procedure 
51% did not know correct answers 
about side effects 
Consent 60% felt supported during the process of 
consent 
60% did not feel forced into consenting 
70% were ambivalent about the 
process of consent  
50% would like additional 
guidance prior to consenting 
Fear 70% were not so frightened that they would 
refuse ECT  
60% frightened or slightly 
frightened by the procedure 
50% negative experience waking 
up after ECT 
Powerlessness None experienced humiliation 
60% felt involved in decision making 
process 
40% had feelings of 
powerlessness 
 
Based in this information the following recommendations are made to the ECT service. 
In terms of knowledge and information, if possible more time could be allocated to the 
initial discussion about ECT and perhaps a detailed leaflet with explanations of side 
effects could be offered. Given that the majority of the patient group is comprised of 
older adults perhaps clear audio visual aids could also be considered.  For example 
Chakrabarti et al., (2010) recommend that information is presented to service users in 




also suggest that there is enough time in the pretreatment meeting to ensure that 
service users have processed and retained the information. More time for discussion 
during the initial meeting could also provide service users with a space to discuss any 
worries and fears and this may help service users to feel empowered and involved in 
their care.  
In order to provide additional guidance during the process of consent, additional 
support could be offered by inviting a relative or other members of the patients care 
team to support the patient during the initial consultation and throughout the 
procedure to ensure that questions about procedure and consent are asked and can 
be revisited outside of the clinic.  A concise but informative information pack could be 
given to patients and their carers to ensure that clear information is given and patients 
have the opportunity to re-examine the information at their own pace. 
Finally as mentioned in more detail below, patients could be offered the opportunity 
to speak with a psychologist about their feelings towards treatment. A psychologist 
could provide a space for the patient to discuss their fears and anxieties about 
treatment. A psychologist may also over clarification and reassurance about the 
procedure and to explore expectations. A shared formulation could also be developed 
that may help the patient and the team to have a clear understanding of the reasons 
for treatment and expectations.  
 Further development of the questionnaire; recommendations 
The aim of this project was to pilot a newly developed in-depth questionnaire that 
could be further refined for use in the ECT service. This questionnaire has some 
advantages over previously developed questionnaires; however there were also some 
difficulties. A refined version of the questionnaire might include some of the following 
recommendations. See Appendix 4 for a draft version. 
This pilot questionnaire was specifically developed with the following features; (1) it 
focused on 4 important themes with several questions for each in order to get a wide 
breadth of patient feedback on the areas of knowledge and information, consent, side 




questionnaire to include questions about empowerment, (3) it includes the Friends 
and family question (an NHS service wide feedback measure) (Chakrabarti et al., 2010; 
Fisher, 2012) and  (4) It was administered by a practitioner from outside of the service 
who did not have the status of Dr or medical professional (trainee). It therefore aimed 
to provide in depth unbiased account of patients experiences. (5) The questionnaire 
was administered to service users with different presentations (depression, psychosis) 
and different ages (range from 28-81 years).  
However there were some disadvantages to this questionnaire. One of the main 
difficulties with this long questionnaire was the impractically of using in the clinic 
environment. There are 3 main reasons why this was difficult. Firstly, it was difficult to 
get feedback from servicer users. Many service users who are referred for ECT are 
extremely unwell to the point where they may not be able to move or speak. It is 
therefore extremely difficult to ask them to complete a long questionnaire one week 
after treatment. It may be more feasible to administer a shorter more refined 
questionnaire at a longer interval after treatment. This pilot questionnaire was also 
limited in the complexity of the response options which currently include 3 options 
(yes, no, or I don’t know). This could be improved by adding a 5 point response scale 
instead of 3. There were also questions that may could be further refined and 
specified, for example more questions on side effects could be helpful.  
Ultimately the aim of the questionnaire should be to get helpful feedback about the 
service from as many service users as possible. Based on these suggestions we have 
designed a refined shorter questionnaire that may be more feasible to be used with 
this patient group (see appendix 4). 
4.3 Feedback to Service 
 A summary report was collated and presented to representatives for the CQC 
visit 
 The data from this report will be presented to service managers at a Business 
meeting 
 This report will be prepared as a publication to help disseminate knowledge 




 A brief report will be placed visibly and accessibly in the ECT service and the 
MHOA team service so that it is visible to service users and their families 
 
4.4 Areas of future development  
Ensuring that servicer users are receiving quality care and that they are satisfied with 
the experience is the top priority of any NHS service. Given the controversial stance 
towards ECT that many people and professionals still take, a well designed feedback 
questionnaire for the ECT service is an important area of research and development. It 
would be interesting further develop a range of feedback tools that could be used at 
different time points in service users’ treatment and recovery. Perhaps initially service 
users may not feel well enough to engage in a long questionnaire or qualitative 
interview, but a short tailored questionnaire may be appropriate. When service users 
are well a longer more complex feedback survey could be used that could incorporate 
more qualitative questions to get a wider range of feedback.  
Based on the questionnaire feedback, for example 40% of service users experiencing 
powerlessness, and 50% of service users requesting more advice prior to consent; it 
would seem that psychology could have a more prominent role in the ECT service. 
Fisher (2012) outlined how a psychologist could help improve the experience of service 
users in the ECT service. He suggested that psychologists could assist with the process 
of consent, for example, offering service users a place to express fears and anxieties 
prior to or after treatment. This may help limit stigma and feelings of powerlessness. 
Psychologists’ could also assist with the assessment of capacity, for example, based on 
shared formulation psychologists could explore why service users have agreed to 
treatment and could advise when service users consent because they think that the 
treatment may harm them or kill them. Formulation could also help service users to 
understand their experience of ECT, for example in the context of previous health care 
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APPENDIX 1 Questionnaires 
 






Date of Birth:______________________________ 
 
 
Please read the following questions and CIRCLE the answer that you think is correct.  
This is not a test and your answers will not affect your treatment, they will be used 
to help improve the service. Please use the space at the end to make any comments 
or recommendations. 
 
Thank you for your assistance. 
 
Procedure                                                                                 Answers: 
1. During ECT, anaesthetic /other 
medications are used  
Yes No Don’t 
know 
2. How often is ECT given per 
week?  






3. How many ECTs do most 
patients require in one 
course? 
























7. Certain investigations are 
needed before ECT 
Yes No Don’t 
know 


























11. ECT is given to only those 
patients who have little 
chance of improvement  
No Yes Don’t 
know 
12. ECT can also be given to older 
persons (>60-65 yr)  
Yes No Don’t 
know 
13. ECT is given only to inpatients No Yes Don’t 
know 
14. Pregnant women can also 
receive ECT 
 
Yes No Don’t 
know 
Effectiveness/mechanism of action 
15. ECT is useful in treating 
psychiatric disorders 
Yes No Don’t 
know 
16. Compared to medications, 




Not useful Don’t 
know 
17. ECT often worsens the 
psychiatric illness 
No Yes Don’t 
know 











19. The side effects of ECT last 
only for a short while 
Yes No Don’t 
know 
20. Scientific evidence favours the 
usefulness of ECT 
Yes No Don’t 
know 
Side effects 
21.  Use of ECT leads to temporary 
impairment of memory 
Yes No Don’t 
know 
22. Use of ECT leads to permanent 
loss of memory 
No Yes Don’t 
know 
23. ECT results in permanent 
damage to brain 
No Yes Don’t 
know 
24. ECT can damage other body-
parts permanently 
No Yes Don’t 
know 
25. During the ECT chances of 
death are very high 
No Yes Don’t 
know 
26. Headache is a common side 
effect of ECT 





27. Most of patients receiving ECT 
develop epilepsy later 









POST TREATMENT QUESTIONNAIRE 
Name:________________________________   Date: 
______________________________ 
 
Date of birth:______________________________________ 
 
Please read the following questions and circle the answer that best applies to you. 
Please use the space at the end to make any comments or recommendations. Please 
know that your answers will not affect your treatment and will be anonymous and 
confidential. We will use the information to help improve the ECT service. 
 
Thank you for your assistance. 
 
Post Treatment Questions:  
Experience of ECT 
1. How helpful was ECT in your 
case? 
Very helpful 
 Undecided  
Not at all helpful  
2. Does your experience suggest 




3. Experience of night prior to the 
day of ECT  
Not unpleasant  
Undecided 
Unpleasant 
4. Experience of waiting for your 
turn for ECT  
Not unpleasant  
Undecided  
Unpleasant 
5. Experience of procedure of ECT  Not unpleasant 
Undecided 
Unpleasant 
6. Experience after waking up after 
receiving ECT  






7. Experience with any long term 




8. How do you rate our overall 




9. How frightening or upsetting 
was ECT compared to what you 
expected?  
Not at all frightening 
Very frightening 
slightly frightening 
10. How do you compare receiving 
ECT to visiting a dentist?  
Less unpleasant 
Undecided 
More/ equally unpleasant 
11. Did ECT upset you so much that 
you would be reluctant to 




12. Considering the effect of ECT, 




13. How was your experience with  





14. Do you feel you received 
sufficient information regarding 




15. Did you ever feel you were 




16. Why did you agree to have ECT? Illness had lasted too long 
Illness was very severe 
Trusted doctor’s advice 
 
The process of consent 















20. Did you feel supported and 





21. Would you have preferred 
additional support and 









Throughout the ECT procedure: 










24. Did you experience feelings 





I experienced the following side effects directly after ECT: 
1. Memory loss Mild 
Severe  
Don’t remember 
2. Headache Mild 
Severe  
Don’t remember 
3. Confusion Mild 
Severe  
Don’t remember 
4. Clumsiness Mild 
Severe  
Don’t remember 
5. Nausea or vomiting Mild 
Severe  
Don’t remember 
6. Eyesight problems Mild 
Severe  
Don’t remember 












Patients’ Attitudes towards ECT 
1. I am glad that I 
received ECT 
Agree                   Don’t 
know 
Disagree 
2. I will advise a close 
relative to receive ECT 
if recommended 
Agree                   Don’t 
know 
Disagree 
3. Treatment with ECT is 
cruel 
Agree                   Don’t 
know 
Disagree 
4. ECT is an inhuman 
treatment 
Agree                   Don’t 
know 
Disagree 
5. ECT is dangerous and 
should not be used 
Agree                   Don’t 
know 
Disagree 
6. ECT is often given to 
people who do not 
need it 
Agree                   Don’t 
know 
Disagree 
7. ECT is given 
indiscriminately to 
people 
Agree                   Don’t 
know 
Disagree 
8. ECT is often given as a 
punishment to 
violent/angry patients 
Agree                   Don’t 
know 
Disagree 




Agree                   Don’t 
know 
Disagree 
10. Treatment with ECT 
should be outlawed 
Agree                   Don’t 
know 
Disagree 
11. Treatment with ECT is 
outdated 
Agree                   Don’t 
know 
Disagree 
12. ECT gets you better 
quicker than 
medications 
Agree                   Don’t 
know 
Disagree 
13. ECT is at times life 
saving 






14. Following discovery of 
new medicines, 
treatment with ECT is 
never required 
Agree                   Don’t 
know 
Disagree 
15. Once a person is given 
ECT, in future 
whenever he becomes 
ill ECT is the only 
treatment option 
Agree                   Don’t 
know 
Disagree 
16. If ECT fails in a 
patient, then no other 
treatment will 
succeed 




17. If recommended, I would 





18. In the future I would prefer 





















APPENDIX 2 Qualitative Feedback: Patient 
Quotations 
1. ‘I don’t want to have no more ECT, I want to concentrate on depot injection.’ 
2. no comments 
3. no comments 
4.  ‘All my life I have experienced difficulty thinking. I believe the medication is of 
some benefit in curing this but ECT is far more effective. I have not been cured 
fully yet, but have come along way towards it. In the past I believed without 
understanding fully as my condition meant that I couldn’t think lucidly, that a 
person had 2 souls, and a schizophrenic person was someone who had used 
this fact to trick society, by showing one of these souls to the world and hiding 
the other soul. What then happened was that they forgot, that they had done 
this and the two souls came into conflict with each other. Whether this is true 
or not I don’t know, but ECT is a brilliantly effective treatment for whatever 
medical condition I have and perhaps if more people realized this then there 
would be less reliance on medication and a cure.’ 
5. no comments 
6. ‘Staff were very nice, I was a bit nervous beforehand. It was not a long wait. 
The 2nd time was more collaborative because I was more well. I was moved 
from one team to another team and it was difficult with aftercare the first time 
out of the hospital. Any information on long term side effects, memory and 
length of course? I experience side effects such as word finding difficulty. My 
grandfather had it and it worked, is there a genetic component?  I do feel that 
it has worked for me. During the 1st course the paranoia went away straight 
away. More recently Ive had major depression and this second time it has gone 
more gradually.  Now I feel much more like myself. Also wondering how long 
does the effect last (meaning recovery)?’ (quotation from phone interview) 
7. no comments 
8. ‘Feeling fine now’ 
9. ‘Yes it was beneficial for me, got rid of my depression. I didn’t feel isolated 
anymore, Im eating less and back on track. Hopeful now for the future, agreed 
to take medication even thought I thought it wouldn’t help, but it is helping. 
Sometimes still not feeling that good because of the medication. After ECT I 
wanted to get back to work and get a job. (quotation from phone interview) 
10. ‘I have had ECT 3 times, twice as an inpatient. It has been successful (or 








Project Proposal Form (PPF) for Clinical Audit, Service Evaluation   and other 
Quality Improvement Projects 
Should you require any assistance with completing this proforma, please contact 
your Local Clinical Audit Project Officer or, for Trustwide audits, the Clinical Audit & 
Effectiveness Team (details are available on the SLaM Clinical Audit & Effectiveness 
Internet Site).  For local team-based or CAG-wide projects please send your 
completed PPF to your local Audit Project Manager/Officer, for ethical approval. For 
Trustwide projects please send your completed PPF to the Corporate Audit Dept. All 
relevant contact details are on the SLaM Clinical Audit & Effectiveness Team Intranet 
site.  
1(a)  Project lead details: 
Name: Drs Dene Robertson and Andrew 
Mogg 
Job title: Consultant Psychiatrists 
 
Work Address: Bethlem Hospital, Maudsley Hospital 
Telephone:  02032284897 E-mail: dene.robertson@slam.nhs.uk; 
andrew.mogg@slam.nhs.uk 
Within CAG (please specify)    MHOA CAG 
Multiple-CAG (please specify) The majority of patients receiving ECT are cared for 
exclusively by the MHOA CAG, though ECT is also delivered to patients from other CAGs 
by the MHOA CAG. This project evaluates the delivery of ECT, not other aspects of 
treatment, so this project is contained within the MHOA CAG. 
Trustwide:     
1(b) Project Title: Patient Perspectives on the SLaM ECT service 




1(c) Please tick  one box: Is this project a: 
Clinical Audit           
(i.e. measures a standard) 
Service Evaluation           
(e.g. patient survey)                                   
Other Quality             
Improvement Project 
(please specify) 
__________                                   
2 (a) Overall project aim or purpose of the audit: 
The aim of the current service evaluation project is to review participants’ experiences 
of ECT treatment at the Bethlem and Maudsley ECT clinic. Specifically, patients’ 
knowledge of the ECT process will be reviewed before and after ECT treatment. 
Patients will be asked to comment on their expectations and experience of treatment 
with the aim to inform and improve how knowledge of the ECT process is shared and 
disseminated to patients. Patients will also have the opportunity to comment openly on 
what they would improve about the service and what worked well. Patient outcomes 





2(b) Specific objectives. What are the audit standards or criteria?   The definition of a 
clinical audit is that it compares practice to agreed standards such as those defined in 
NICE guidelines and clinical policies, protocols and procedures.  Please also state the 
source of your standards or criteria (for non-audit projects, clarify measures). 
The primary standards/criteria relates to those relating to service user involvement, as 
in accordance with SLAM policy. These guidelines have been taken from the “South 
London and Maudsley NHS Trust. (SLaM): Patient and Public Involvement Policy, 
Guiding Principles and Resource Pack”, specifically those relating to service users: 
1. To increasingly involve and consult with service users regarding the service 
provision/ care they receive.  
3.   A policy to involve and consult with service users in the planning and provision of 
services within SLAM and in any proposed changes to services.  
The project will allow service users to voice their individual experiences of the ECT 
service, so as to ensure quality and acceptability of the service. 
For those deemed able to give consent NICE  guidelines (2008) state: ‘To help in the 
discussion, full and appropriate information about ECT should be given, including 
information about its potential risks and benefits, both general and specific to the 
individual.’ This audit will assess patients access to information and understanding of 
the information provided that explains the ECT process and experience. 
2 (c) In which ways do you think the project will improve patient care / outcomes? 
Information acquired from the audit will be used to further develop the ECT service, for 
example improving patients’ access to information about ECT and improving their 
experience during the treatment. Additionally a better understanding of the ECT 
process may lead to improved patient experience which in turn may improve shared 
knowledge, access and understanding of ECT as a therapeutic option. 
 
3(a) Who will be on the audit steering group?  
 Jo Cresswell, ECT lead nurse, Dr Dene Robertson, Dr Andrew Mogg, Clare 





3(b) What consideration has been given to the involvement of patients, carers or the 
public? 
   Full user involvement at all stages of the audit   
 Partial user involvement (please state which stages)  
This audit will work with patients as advisors across various different stages of the 
project development. Interviews will be with service users, whose account will shape 
overall themes. Outcomes and changes to service delivery will be fed back to 
participants if they wish to be kept informed.  
 No user involvement (please state why not) 
_____________________________________ 
3(c) Are you planning to collect data on any of the following equalities protected 
characteristics?   (please tick all that apply) 
 Age   Disability    Ethnicity     
 Gender re-assignment    
Pregnancy and maternity     Religion or Belief      Sex      Sexual 
orientation     
3(d) Will you analyse your results or service outcomes to see if there is variation 
between equalities protected characteristics? 
Yes        No             
Comments: _________________________________________________ 
 
4. Information Governance Requirements:   When planning an audit, each project 
should be evaluated with regard to whether Personal Identifiable Information (PII) 
needs to be used. Unless there is genuine justification, all PII should be taken out to 
effectively anonymise the data for audit and research purposes. If you are unsure or 
need guidance and advice, please contact:  dataprotectionoffice@slam.nhs.uk Personal 
identifiable information (PII) is any piece of information which can potentially be used 
to uniquely identify, contact, or locate an individual including name, address, full post 
code, date of birth, gender, ethnicity, NHS number, photographs, videos, audio-tapes 
etc. 
4(a) Will the 
data be fully 





anonymised? If yes, how: 
Questionnaires will be 
allocated a number which 
will be linked to 
participant initials in a 
password protected 
electronic data base. Data 
will therefore be kept 
anonymously, but can be 
removed should an 
individual wish to no 
longer participate. All 
names and service details 
will be anonymised 
and/or changed to 
protect the identity of the 
participant when 
qualitative data is 
reported.  
If no, why not: ______________________ 
If no, which personal identifiers will be 
used: ______________________________ 
If no, have you made arrangements to gain 
consent from data subjects?         
 Yes          No 
4(b) Where 
will the data 
be recorded? 
    Manual forms                            
   Electronic 
spreadsheet       
 
 Electronic forms  
   Electronic database                     
 Other (please specify)                                                               
4(c) Security 
arrangements 
    Locked cabinet 
  Locked office 
 Other (please specify) 
____________________ 
 On shared folder on SLaM network 
 On secure network outside SLaM  
 Files Password protected 
   Login required  




 Yes, in an anonymised format                     Yes, outside the EU 
 Yes, with identifiers         No 
You must contact dataprotectionoffice@slam.nhs.uk to register any 




If yes, how? 
Physically in person   
Physically using a           secure 
courier                                                                          
Physically using registered mail 
services            
Electronically using email                                                                       
NHS.net e-mail (NHSmail) 
Electronically using file 
encryption and other email 
Electronically using encrypted 
portable media    
Other (please specify) 
4(e) Information Asset 
Owner: (Individual 
responsible for the data)  
Name: Clare Killikelly CAG: 
Job title: Trainee Clinical 
Psychologist 
Organisation: SLaM, IoP 
Data Collection (please answer ALL of the following questions) 
5(a) Where from?  e.g. clinical records/ePJS, 
INSIGHT/CRIS, other service records, direct 
from patients or clinicians, observations of 
practice, DATIX. 
From service users and clinical records (ePJS) 
Patients who are deemed to have capacity to 
consent to ECT treatment will be approached 
for this audit. Capacity to consent to 
treatment is assessed by the referring 
psychiatrist. For a patient who would like to 
participate in the audit but did not consent to 
treatment, specific capacity to participate in 
the audit will be assessed separately by a 
team psychiatrist.  Additionally a statement 
will be included on the questionnaire to 
clarify that participating or not participating 
in this study will not affect the patients’ 




5(b) How? The data source will obviously 
influence the method used to collect data.  
e.g. survey, interview, focus groups, data 
collection proforma. Please include any other 
significant aspects of your methodology.   
New referrals will be approached within 1 
week prior to their first ECT session and asked 
to complete a short questionnaire to 
determine their understanding of the 
upcoming ECT treatment. Patients will also 
have the opportunity to ask questions or to 
make open comments about their experience 
so far. Within 1 week of completing ECT 
treatment patients will be asked to fill out a 
brief questionnaire about their experience of 
the service and will have the opportunity to 
comment openly about the negative and 
positive aspects of their experience with the 
service. 
5(c) How much?  As a rough guide, a sample 
should include 20-50 cases. 
A total of 20 patients (minimum) will be 
asked to participate. Participants will be 
those referred to the ECT department and in 
receipt of ECT for any reason.   
5(d) Pilot Audit? Yes A brief pilot audit will be undertaken; 
patients will be asked to comment on  the 
development of the questionnaires 
6(a) With whom and where will the final report be shared? e.g. which committees or service 
meetings 
The final report for this service evaluation will be shared with service users and the ECT 
teams. The main results and overall themes will be disseminated via academic publication. 
 __________________________________________________________________________ 
6(b) Who will take responsibility for disseminating the results of the project and following 
through recommendations and actions? And how and when will the recommendations and 
actions be evaluated, monitored and reviewed? 
 _____C.Killikelly and the ECT team______________ 
All completed projects must be followed up with a completed action plan form, available on 
the SLaM Clinical Audit & Effectiveness Intranet site 




7) Project Approval 
7(a) Information Governance Approval: 
  IG Audit approval given by: 
_________________________________ 
Date Audit IG 
approved:_________________________ 
 
7(b) Project Ethical approval given by: 
Clinical Audit Ethical approval given by: 
__________________________________ 
Date of Committee 
Approval:______________________________ 
 Quality Governance Committee 
 Drugs and Therapeutics Committee 

















APPENDIX 4 Draft Short Questionnaire 
Recommended questions for shorter version of questionnaire with 26 questions and 
where possible 5 response options for each question (including strongly agree, agree, 
disagree, strongly disagree and don’t know)  
Knowledge 
1. Certain investigations are needed 
before ECT 
Yes No Don’t know 
2. How long is the current applied?  To the head To the arms Don’t know 













5. How many ECTs do most service 
users require in one course?  
Usually 1-10 More than 20 Don’t know 
 
Side Effects 
6. Use of ECT leads to temporary 
impairment of memory 
Strongly agree, agree, disagree, strongly 
disagree and don’t know 
7. Use of ECT leads to permanent loss 
of memory 
Strongly agree, agree, disagree, strongly 
disagree and don’t know 
8. ECT results in permanent damage to 
brain 
Strongly agree, agree, disagree, strongly 
disagree and don’t know 
9. ECT can damage other body-parts 
permanently 
Strongly agree, agree, disagree, strongly 
disagree and don’t know 
10. During the ECT chances of death are 
very high 
Strongly agree, agree, disagree, strongly 
disagree and don’t know 
11. Headache is a common side effect of 
ECT 
Strongly agree, agree, disagree, strongly 
disagree and don’t know 




develop epilepsy later strongly disagree and don’t know 
 
Experience of ECT Procedure 
13. How helpful was ECT in your case? Strongly agree, agree, disagree, strongly 
disagree and don’t know 
14. Does your experience suggest that 
ECT is better than drugs?  
Strongly agree, agree, disagree, strongly 
disagree and don’t know 
15. Did ECT upset you so much that 
you would be reluctant to accept it 
again? 
Strongly agree, agree, disagree, strongly 
disagree and don’t know 
16. How frightening or upsetting was 
ECT compared to what you 
expected? 
Strongly agree, agree, disagree, strongly 
disagree and don’t know 
17. Experience after waking up after 
receiving ECT  
Strongly agree, agree, disagree, strongly 
disagree and don’t know 
18. Experience with any long term side 
effects  
Strongly agree, agree, disagree, strongly 
disagree and don’t know 
19. How do you rate our overall 
experience with ECT? 
Strongly agree, agree, disagree, strongly 
disagree and don’t know 
20. Do you feel you received sufficient 
information regarding ECT prior to 
treatment?  
Strongly agree, agree, disagree, strongly 
disagree and don’t know 
21. Did you ever feel you were being 
forced into accepting ECT?  
Strongly agree, agree, disagree, strongly 
disagree and don’t know 
22. How likely are you to recommend 
our service to friends and family if 
they needed similar care or 
treatment? 
Strongly agree, agree, disagree, strongly 
disagree and don’t know 
 
Psychological Factors 
23. Did you experience feelings of 
powerlessness? 
Strongly agree, agree, disagree, strongly 
disagree and don’t know 




decisions about your care? disagree and don’t know 
25. Did you experience feelings of lack 
of control? 
Strongly agree, agree, disagree, strongly 
disagree and don’t know 
26. Would you have preferred 
additional support and advice prior 
to giving consent? 
Strongly agree, agree, disagree, strongly 
disagree and don’t know 
 
 
 
